CINXE.COM

Atopic Dermatitis

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><script src="https://cmp.osano.com/6olh2SicG0V81Mlk/1f9d883d-3834-40b9-9a96-6f89a1cda98b/osano.js"></script><title>Atopic Dermatitis</title><meta name="description" content="The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood."/><meta property="og:url" content="https://www.ajmc.com/compendium/atopic-dermatitis "/><meta property="og:title" content="Atopic Dermatitis"/><meta property="og:image" content="https://s3.amazonaws.com/mjhlifesciences.com/sitelogos/AJMC_1200x637.png"/><meta property="og:site_name" content="AJMC"/><meta property="og:description" content="The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood."/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Atopic Dermatitis"/><meta name="twitter:image" content="https://s3.amazonaws.com/mjhlifesciences.com/sitelogos/AJMC_1200x637.png"/><meta name="twitter:site" content="@@AJMC_Journal"/><meta name="twitter:description" content="The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood."/><meta name="robots" content="max-image-preview:large"/><meta name="robots" content="max-video-preview:-1"/><link rel="preconnect dns-prefetch" href="https://cmp.osano.com"/><link rel="preconnect dns-prefetch" href="https://res.lassomarketing.io"/><link rel="preconnect dns-prefetch" href="https://www.lightboxcdn.com"/><link rel="preconnect dns-prefetch" href="https://pub.doubleverify.com"/><link rel="preconnect dns-prefetch" href="https://cdn.doubleverify.com"/><link rel="preconnect dns-prefetch" href="https://cdn.segment.com"/><link rel="preconnect dns-prefetch" href="https://securepubads.g.doubleclick.net"/><link rel="preconnect dns-prefetch" href="https://pagead2.googlesyndication.com"/><link rel="preconnect dns-prefetch" href="https://cdn.sanity.io"/><link rel="preconnect dns-prefetch" href="https://www.google-analytics.com"/><link rel="preconnect dns-prefetch" href="https://www.googletagmanager.com"/><link rel="preconnect dns-prefetch" href="https://player.vimeo.com"/><link rel="preconnect dns-prefetch" href="https://youtube.com"/><link rel="preconnect dns-prefetch" href="https://connect.facebook.net"/><link rel="preconnect dns-prefetch" href="https://www.facebook.com"/><link rel="preconnect dns-prefetch" href="https://static.ads-twitter.com"/><link rel="preconnect dns-prefetch" href="https://ad.doubleclick.net"/><link rel="preload" href="https://securepubads.g.doubleclick.net/tag/js/gpt.js"/><link rel="preload" href="https://pub.doubleverify.com/signals/pub.js#ctx=20083417&amp;cmp=DV464021"/><link rel="icon" href="/favicon.ico"/><script async="" src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script><script src="https://pub.doubleverify.com/signals/pub.js#ctx=20083417&amp;cmp=DV464021"></script><script src="https://one.ajmc.com/tagmanager/scripts/one.js"></script><script>window.dataLayer = window.dataLayer || []; window.dataLayer.push({ event: "page_dimensions", pageTitle: "Atopic Dermatitis", dimension9: "compendium/atopic-dermatitis", dimension11: "", dimension12: "", dimension13: "", dimension14: "", dimension15: "compendium/atopic-dermatitis", dimension18: "", dimension19: "", dimension20: "", });</script><script type="module"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NK5KQXS'); </script><script type="module"> var ALGOLIA_INSIGHTS_SRC = "https://cdn.jsdelivr.net/npm/search-insights@2.4.0"; !function(e,a,t,n,s,i,c){e.AlgoliaAnalyticsObject=s,e[s]=e[s]||function(){ (e[s].queue=e[s].queue||[]).push(arguments)},i=a.createElement(t),c=a.getElementsByTagName(t)[0], i.async=1,i.src=n,c.parentNode.insertBefore(i,c) }(window,document,"script",ALGOLIA_INSIGHTS_SRC,"aa");</script><link rel="canonical" href="https://www.ajmc.com/compendium/atopic-dermatitis"/><meta name="next-head-count" content="10"/><script async="" type="text/javascript" src="https://www.lightboxcdn.com/static/lightbox_mjh.js"></script><script defer="" src="https://res.lassomarketing.io/scripts/lasso-imp-id-min.js" type="text/javascript"></script> <script defer="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js"></script> <script type="module"> !function(){var analytics=window.analytics=window.analytics||[];if(!analytics.initialize)if(analytics.invoked)window.console&&console.error&&console.error("Segment snippet included twice.");else{analytics.invoked=!0;analytics.methods=["trackSubmit","trackClick","trackLink","trackForm","pageview","identify","reset","group","track","ready","alias","debug","page","once","off","on","addSourceMiddleware","addIntegrationMiddleware","setAnonymousId","addDestinationMiddleware"];analytics.factory=function(e){return function(){var t=Array.prototype.slice.call(arguments);t.unshift(e);analytics.push(t);return analytics}};for(var e=0;e<analytics.methods.length;e++){var key=analytics.methods[e];analytics[key]=analytics.factory(key)}analytics.load=function(key,e){var t=document.createElement("script");t.type="text/javascript";t.async=!0;t.src="https://cdn.segment.com/analytics.js/v1/" + key + "/analytics.min.js";var n=document.getElementsByTagName("script")[0];n.parentNode.insertBefore(t,n);analytics._loadOptions=e};analytics.SNIPPET_VERSION="4.13.1"; window.LassoImpressionID = lassoImpID(); analytics.load("BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN"); analytics.page({ 'LassoImpressionID': window.LassoImpressionID }); }}(); </script> <link rel="preload" href="/_next/static/css/e5225e6dc4ca333b.css" as="style"/><link rel="stylesheet" href="/_next/static/css/e5225e6dc4ca333b.css" data-n-g=""/><link rel="preload" href="/_next/static/css/1fd9d1dcb68b7a42.css" as="style"/><link rel="stylesheet" href="/_next/static/css/1fd9d1dcb68b7a42.css" data-n-p=""/><link rel="preload" href="/_next/static/css/73c00cd95dc66651.css" as="style"/><link rel="stylesheet" href="/_next/static/css/73c00cd95dc66651.css" data-n-p=""/><link rel="preload" href="/_next/static/css/0f1de527bcd6b2b3.css" as="style"/><link rel="stylesheet" href="/_next/static/css/0f1de527bcd6b2b3.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="/_next/static/chunks/webpack-7bb91bc5bbba1ada.js" defer=""></script><script src="/_next/static/chunks/framework-45ce3d09104a2cae.js" defer=""></script><script src="/_next/static/chunks/main-c1ce322a402d266c.js" defer=""></script><script src="/_next/static/chunks/pages/_app-c3a05645a08041c3.js" defer=""></script><script src="/_next/static/chunks/8eec4907-bd18a9d50c17fbc1.js" defer=""></script><script src="/_next/static/chunks/065a3ddb-42216585c327b2a5.js" defer=""></script><script src="/_next/static/chunks/9814d858-cb162ab048445baf.js" defer=""></script><script src="/_next/static/chunks/69bd6bf3-c7219ac9ecb38ac9.js" defer=""></script><script src="/_next/static/chunks/f36c6662-e730e1316f9aa347.js" defer=""></script><script src="/_next/static/chunks/72585f70-0d4479e14d41a365.js" defer=""></script><script src="/_next/static/chunks/59b4e022-12a1c6f09c31aa87.js" defer=""></script><script src="/_next/static/chunks/aeb74aa0-4e0b515016d20a9f.js" defer=""></script><script src="/_next/static/chunks/e893f787-08b93252db7fc864.js" defer=""></script><script src="/_next/static/chunks/e1efa4cc-06e900eb45581c19.js" defer=""></script><script src="/_next/static/chunks/c8eae200-9f0c2beb62006a40.js" defer=""></script><script src="/_next/static/chunks/a29ae703-70c961c34719afa8.js" defer=""></script><script src="/_next/static/chunks/4592-37f767f9d2e595fc.js" defer=""></script><script src="/_next/static/chunks/1212-e69ee8c76b24c02a.js" defer=""></script><script src="/_next/static/chunks/4179-91956f2d2c4bf724.js" defer=""></script><script src="/_next/static/chunks/9879-c84885d45ee98d34.js" defer=""></script><script src="/_next/static/chunks/9355-c793747e2dd7fab4.js" defer=""></script><script src="/_next/static/chunks/3499-b4daf1c9382343af.js" defer=""></script><script src="/_next/static/chunks/4386-1eb6319d7e5f2437.js" defer=""></script><script src="/_next/static/chunks/8421-a4cb4c694745bc83.js" defer=""></script><script src="/_next/static/chunks/8412-bd07abe8ce76d08f.js" defer=""></script><script src="/_next/static/chunks/430-ec5773e97694cd78.js" defer=""></script><script src="/_next/static/chunks/173-0c8dbb3c1f76b4a8.js" defer=""></script><script src="/_next/static/chunks/7707-950f90aec08fbabe.js" defer=""></script><script src="/_next/static/chunks/475-90949f2271d616fd.js" defer=""></script><script src="/_next/static/chunks/9323-6b03066a987bc392.js" defer=""></script><script src="/_next/static/chunks/4978-ee388caa09ad5169.js" defer=""></script><script src="/_next/static/chunks/4063-ea283543a8930e92.js" defer=""></script><script src="/_next/static/chunks/pages/%5B...slug%5D-1b8b61a43bc98d83.js" defer=""></script><script src="/_next/static/jIKMoC-9mMyLq4v4Ma7Tv/_buildManifest.js" defer=""></script><script src="/_next/static/jIKMoC-9mMyLq4v4Ma7Tv/_ssgManifest.js" defer=""></script><style id="__jsx-1661e6713d4eb9b5">.leaderboardAdWrapper.jsx-1661e6713d4eb9b5{min-height:90px;background:#fff}.leaderboardAdWrapper.jsx-1661e6713d4eb9b5 .AD728x90.jsx-1661e6713d4eb9b5{}@media screen and (min-width:768px){.leader-fixed.jsx-1661e6713d4eb9b5{position:fixed;margin-top:1rem;z-index:999999}}.leaderboardAdWrapper.jsx-1661e6713d4eb9b5 .AD728x90.jsx-1661e6713d4eb9b5 div[id*="google_ads_iframe"].jsx-1661e6713d4eb9b5:empty{height:0px!important}@media screen and (max-width:668px){.leaderboardAdWrapper.jsx-1661e6713d4eb9b5{min-height:0px;position:fixed;background:white;left:0;right:0;top:55px;padding-top:.5rem;padding-bottom:.25rem;z-index:9999}}</style><style id="__jsx-1215160397">.bottomDiv.jsx-1215160397{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-1215160397::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-1215160397::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-1215160397{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-1215160397{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-1215160397{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore0undefined.jsx-1215160397:hover{background:var(--secondary)}.view-more-wrap0undefined.jsx-1215160397{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap0undefined.jsx-1215160397:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-1215160397{background-position:right bottom}.text-white.jsx-1215160397{color:var(--primary)}</style><style id="__jsx-1637274924">.bottomDiv.jsx-1637274924{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-1637274924::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-1637274924::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-1637274924{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-1637274924{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-1637274924{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore1undefined.jsx-1637274924:hover{background:var(--secondary)}.view-more-wrap1undefined.jsx-1637274924{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap1undefined.jsx-1637274924:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-1637274924{background-position:right bottom}.text-white.jsx-1637274924{color:var(--primary)}</style><style id="__jsx-286612495">.bottomDiv.jsx-286612495{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-286612495::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-286612495::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-286612495{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-286612495{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-286612495{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore2undefined.jsx-286612495:hover{background:var(--secondary)}.view-more-wrap2undefined.jsx-286612495{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap2undefined.jsx-286612495:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-286612495{background-position:right bottom}.text-white.jsx-286612495{color:var(--primary)}</style><style id="__jsx-2915913710">.bottomDiv.jsx-2915913710{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-2915913710::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-2915913710::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-2915913710{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-2915913710{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-2915913710{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore3undefined.jsx-2915913710:hover{background:var(--secondary)}.view-more-wrap3undefined.jsx-2915913710{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap3undefined.jsx-2915913710:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-2915913710{background-position:right bottom}.text-white.jsx-2915913710{color:var(--primary)}</style><style id="__jsx-2363373513">.bottomDiv.jsx-2363373513{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-2363373513::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-2363373513::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-2363373513{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-2363373513{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-2363373513{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore4undefined.jsx-2363373513:hover{background:var(--secondary)}.view-more-wrap4undefined.jsx-2363373513{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap4undefined.jsx-2363373513:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-2363373513{background-position:right bottom}.text-white.jsx-2363373513{color:var(--primary)}</style><style id="__jsx-19ede9f0a5a45918">.jsx-19ede9f0a5a45918::-webkit-scrollbar{display:none}</style><style id="__jsx-2785488040">.bottomDiv.jsx-2785488040{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-2785488040::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-2785488040::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-2785488040{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-2785488040{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-2785488040{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore5undefined.jsx-2785488040:hover{background:var(--secondary)}.view-more-wrap5undefined.jsx-2785488040{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap5undefined.jsx-2785488040:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-2785488040{background-position:right bottom}.text-white.jsx-2785488040{color:var(--primary)}</style><style id="__jsx-1434825611">.bottomDiv.jsx-1434825611{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-1434825611::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-1434825611::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-1434825611{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-1434825611{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-1434825611{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore6undefined.jsx-1434825611:hover{background:var(--secondary)}.view-more-wrap6undefined.jsx-1434825611{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap6undefined.jsx-1434825611:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-1434825611{background-position:right bottom}.text-white.jsx-1434825611{color:var(--primary)}</style><style id="__jsx-4064126826">.bottomDiv.jsx-4064126826{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-4064126826::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-4064126826::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-4064126826{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-4064126826{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-4064126826{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore7undefined.jsx-4064126826:hover{background:var(--secondary)}.view-more-wrap7undefined.jsx-4064126826{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap7undefined.jsx-4064126826:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-4064126826{background-position:right bottom}.text-white.jsx-4064126826{color:var(--primary)}</style><style id="__jsx-187450181">.bottomDiv.jsx-187450181{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-187450181::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-187450181::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-187450181{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-187450181{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-187450181{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore8undefined.jsx-187450181:hover{background:var(--secondary)}.view-more-wrap8undefined.jsx-187450181{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap8undefined.jsx-187450181:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-187450181{background-position:right bottom}.text-white.jsx-187450181{color:var(--primary)}</style><style id="__jsx-609564708">.bottomDiv.jsx-609564708{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-609564708::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-609564708::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-609564708{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-609564708{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-609564708{width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore9undefined.jsx-609564708:hover{background:var(--secondary)}.view-more-wrap9undefined.jsx-609564708{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap9undefined.jsx-609564708:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-609564708{background-position:right bottom}.text-white.jsx-609564708{color:var(--primary)}</style><style id="__jsx-ad50481d5ee26850">@media(min-width:980px)and (max-width:1200px){.article-detail.jsx-ad50481d5ee26850{width:47%}}@media(min-width:1201px)and (max-width:1400px){.article-detail.jsx-ad50481d5ee26850{width:55%}}</style></head><body><div id="__next" data-reactroot=""><div class="-mb-6"><div id="frame-nav" class="sticky top-0 z-[999999]"><div class="h-full w-full"><nav role="navigation" class=" w-full mx-auto hidden lg:block bg-white shadow-md relative"><div class="bg-primary" id="topnav"><div class="container px-4 relative justify-between h-16 flex items-center md:items-stretch mx-auto "><div class="h-full flex items-center flex-1 justify-between mr-4"><a role="img" aria-label="logo" class="focus:outline-none relative h-12 w-40 mr-6 flex items-center" href="/"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left"/><noscript><img sizes="100vw" srcSet="/_next/image?url=%2Fajmc_logo_inverted.png&amp;w=640&amp;q=75 640w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=750&amp;q=75 750w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=828&amp;q=75 828w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=%2Fajmc_logo_inverted.png&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left" loading="lazy"/></noscript></span></a><div class="hidden md:block"><div class="bg-primary py-2 whitespace-nowrap"><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 items-end"><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">News<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/news" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">All News</a><a href="/press-release" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Press Releases</a><a href="/approvals-launches" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Product Approvals and Launches</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Video<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/video-hub" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">All Video Types</a><a href="/interviews" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">AJMC TV</a><a href="/insights" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Insights</a><a href="/onlocation" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">OnLocation</a><a href="/payer-perspectives" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Payer Perspectives</a><a href="/peer-exchange" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Peer Exchange</a><a href="/post-conference-perspectives" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Post Conference Perspectives</a><a href="/stakeholder-summit" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Stakeholder Summit</a></div></div><a class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center text-sm tracking-normal capitalize text-white" href="/podcasts">Podcasts</a><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Conferences<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/latest-conference" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Conference Coverage</a><a href="/conference" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Conference Listing</a><a href="/post-conference-perspectives" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Post Conference Perspectives</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Journals<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/publications" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">All Journals</a><a href="/publications/issue" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">The American Journal of Managed Care</a><a href="/publications/ajac" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Population Health, Equity &amp; Outcomes</a><a href="/publications/evidence-based-oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Evidence-Based Oncology</a><a href="/supplement" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">About Supplements and Featured Publications</a><a href="/publications/supplement" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Supplements and Featured Publications Issues</a><a href="/submit-a-manuscript" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Submit a Manuscript</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Events<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/ivbmevents" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Institute for Value-Based Medicine</a><a href="https://pcoc.ajmc.com/" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Patient-Centered Oncology Care</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Resources<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/interactive-tools" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Interactive Tools</a><a href="/clinical-spotlight" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Clinical Spotlight</a><a href="/custom-email" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Microsites</a><a href="/sponsored" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Sponsored Content</a></div></div><a class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center text-sm tracking-normal capitalize text-white" href="/continuing-education">CE</a><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">About AJMC<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/editorial" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">AJMC Staff</a><a href="/anniversary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Anniversary</a><a href="/about/seema-sonnad-nomination" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Seema Sonnad Award</a><a href="/partners" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Strategic Alliance Partners</a></div></div></div></div></div></div></div><div class="md:flex items-center justify-end hidden"><div class="flex items-center"><div class="md:pr-10 lg:pr-0 h-full flex items-center"><button class="w-6 h-6 relative"><svg xmlns="http://www.w3.org/2000/svg" class="text-white stroke-current icon icon-tabler icon-tabler-search" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"></path><circle cx="10" cy="10" r="7"></circle><line x1="21" y1="21" x2="15" y2="15"></line></svg></button><div class="hidden bg-secondary p-4 rounded shadow-lg top-16 right-0 overflow-hidden absolute grid place-items-center z-[99999] "><form method="GET" action="/search"><div class="relative"><div class="text-gray-600 absolute ml-3 inset-0 m-auto lg:w-4 lg:h-4 md:w-6 md:h-6"><button aria-label="submit" type="submit" class="absolute block inset-0"><svg xmlns="http://www.w3.org/2000/svg" class="text-gray-600 stroke-current icon icon-tabler icon-tabler-search" viewBox="0 0 24 24" stroke-width="2" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"></path><circle cx="10" cy="10" r="7"></circle><line x1="21" y1="21" x2="15" y2="15"></line></svg></button></div><input type="text" required="" name="searchTerm" class="block border border-gray-200 focus:outline-none focus:border-indigo-700 lg:w-48 xl:w-64 rounded text-sm text-gray-800 pl-8 py-2" placeholder="Search"/></div></form></div></div></div><a href="https://one.ajmc.com/subscribe" class="bg-subscribe-btn rounded text-white py-1.5 px-3 text-[14px] ml-4 uppercase font-semibold">Subscribe</a></div></div></div><div class="bg-white" id="bottomnav"><div style="max-height:60px" class="px-4 transition-all container justify-between h-14 flex items-center md:items-stretch mx-auto"><div class="h-full w-full flex items-center justify-between relative"><div class="flex flex-row gap-2 mr-4"><div class="relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Specialty Area<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Specialty Area" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiorenalmetabolic</span><a href="/compendium/cardiovascular" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiovascular</a><a href="/compendium/ckd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Chronic Kidney Disease</a><a href="/compendium/diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Diabetes</a><a href="/compendium/heart-failure" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Heart Failure</a><a href="/compendium/type1diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Type 1 Diabetes</a></div><div><a href="/compendium/dermatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Dermatology</a><a href="/compendium/alopecia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Alopecia</a><a href="/compendium/atopic-dermatitis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Atopic Dermatitis</a><a href="/compendium/psoriasis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Psoriasis</a></div><div><a href="/compendium/hematology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hematology</a><a href="/compendium/all" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">ALL/AML</a><a href="/compendium/cll" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">CLL/SLL</a><a href="/compendium/gvhd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">GVHD</a><a href="/compendium/hemophilia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hemophilia</a><a href="/compendium/multiple-myeloma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Myeloma</a><a href="/compendium/myelodysplastic-syndromes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myelodysplastic Syndromes</a><a href="/compendium/mpn" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myeloproliferative Neoplasms</a><a href="/compendium/nhl" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non-Hodgkin Lymphoma</a><a href="/compendium/rareblood" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Blood</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hepatology</span><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver</a></div><div><a href="/compendium/immunology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immunology</a><a href="/compendium/autoimmune" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Autoimmune</a><a href="/compendium/Inflammation" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Inflammation</a><a href="/compendium/lupus" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Lupus</a><a href="/compendium/myasthenia-gravis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myasthenia Gravis</a></div><div><a href="/compendium/infectious-disease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Infectious Disease</a><a href="/compendium/covid-19" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COVID-19</a><a href="/compendium/hiv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">HIV</a><a href="/compendium/rsv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">RSV</a><a href="/compendium/vaccines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Vaccines</a></div><div><a href="/compendium/mental-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Mental Health</a><a href="/compendium/mdd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Major Depressive Disorder</a><a href="/compendium/sleep" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Sleep</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Neurology</span><a href="/compendium/dmd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Duchenne Muscular Dystrophy</a><a href="/compendium/epilepsy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Epilepsy</a><a href="/compendium/multiple-sclerosis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Sclerosis</a><a href="/compendium/parkinson" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Parkinson Disease</a></div><div><a href="/compendium/obesity" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Obesity</a></div><div><a href="/compendium/oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Oncology</a><a href="/compendium/breast-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Breast Cancer</a><a href="/compendium/cholangiocarcinoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cholangiocarcinoma</a><a href="/compendium/colorectal-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Colorectal Cancer</a><a href="/compendium/immuno-oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immuno-Oncology</a><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver Cancer</a><a href="/compendium/lung-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Lung Cancer</a><a href="/compendium/nsclc" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non–Small Cell Lung Cancer</a><a href="/compendium/ovarian-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ovarian Cancer</a><a href="/compendium/prostate-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Prostate Cancer</a><a href="/compendium/skincancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Skin Cancer</a><a href="/compendium/soft-tissue-sarcoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Soft Tissue Sarcoma</a></div><div><a href="/compendium/ophthalmology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ophthalmology</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonology</span><a href="/compendium/copd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COPD</a><a href="/compendium/pah" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonary Arterial Hypertension</a></div><div><a href="/compendium/raredisease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Disease</a><a href="/compendium/sma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Spinal Muscular Atrophy</a></div><div><a href="/compendium/respiratory" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Respiratory</a><a href="/compendium/asthma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Asthma</a><a href="/compendium/ipf" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Idiopathic Pulmonary Fibrosis</a></div><div><a href="/compendium/rheumatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rheumatology</a></div><div><a href="/compendium/womens-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Women&#x27;s Health</a></div></nav></div></div></div></div></div></div><div class="relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Topics<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Topics" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><a href="/topic/center-on-health-equity-and-access" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Center on Health Equity &amp; Access</a></div><div><a href="/compendium/digital-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Digital Health</a></div><div><a href="/formulary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Formulary</a></div><div><a href="/compendium/gene-therapy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Gene Therapy</a></div><div><a href="/guidelines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Guidelines</a></div><div><a href="/topic/healthcare-cost" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Cost</a></div><div><a href="/topic/healthcare-delivery" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Delivery</a></div><div><a href="/topic/insurance" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Insurance</a></div><div><a href="/topic/policy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Policy</a></div><div><a href="/compendium/population" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Population Health</a></div><div><a href="/approvals-launches" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Product Approvals and Launches</a></div><div><a href="/topic/technology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Technology</a></div><div><a href="/topic/value-based-care" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Value-Based Care</a></div></nav></div></div></div></div></div></div></div><div class="flex flex-1 items-center gap-3 overflow-hidden justify-start"><span class="text-md font-semibold whitespace-pre !text-primary filter brightness-75">Spotlight</span><ul id="spotlight-links" class="flex gap-2 h-4 overflow-hidden flex-wrap"><li class="text-xs pt-0.5 whitespace-pre cursor-pointer hover:underline text-gray-800"><a href="/ivbmevents?display=home">Free In-Person Regional Events Focused on Oncology and Population Health</a></li></ul></div></div></div></div></nav><nav class="lg:hidden"><div class="w-full shadow-md bg-primary sticky top-0 z-40"><div class="flex mx-auto container"><div class=" py-4 flex items-stretch justify-between mx-4 items-center w-full"><div class="flex items-center justify-end"><div class="flex items-center"><div class="h-full flex items-center"><button id="menu" aria-label="open menu" aria-expanded="false" class="focus:outline-none focus:ring-2 focus:ring-gray-700 rounded-md text-white"><svg width="30" height="30" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M21 10H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path><path d="M21 6H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path><path d="M21 14H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path><path d="M21 18H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path></svg></button></div></div></div><div aria-label="logo" role="img" tabindex="0" class="focus:outline-none relative h-10 w-40"><a role="img" aria-label="logo" class="focus:outline-none relative h-12 w-40 mr-6 flex items-center" href="/"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:center"/><noscript><img sizes="100vw" srcSet="/_next/image?url=%2Fajmc_logo_inverted.png&amp;w=640&amp;q=75 640w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=750&amp;q=75 750w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=828&amp;q=75 828w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=%2Fajmc_logo_inverted.png&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:center" loading="lazy"/></noscript></span></a></div><div class="relative w-8 h-8 my grid items-center"><a class="absolute lg:hidden inset-0 mt-1" href="/search"><svg xmlns="http://www.w3.org/2000/svg" class="text-white stroke-current icon icon-tabler icon-tabler-search" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"></path><circle cx="10" cy="10" r="7"></circle><line x1="21" y1="21" x2="15" y2="15"></line></svg></a></div></div></div><div style="max-height:50px" class="bg-white px-4 transition-all h-12 md:items-stretch mx-auto" id="bottomnav-mobile"><div class="container justify-between h-12 flex items-center md:items-stretch mx-auto"><div class="h-full w-full flex items-center justify-between relative"><div class="flex flex-1 justify-center xs:justify-start items-center relative group h-full z-50 gap-2"><div class="z-1 relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Specialty Area<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Specialty Area" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiorenalmetabolic</span><a href="/compendium/cardiovascular" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiovascular</a><a href="/compendium/ckd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Chronic Kidney Disease</a><a href="/compendium/diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Diabetes</a><a href="/compendium/heart-failure" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Heart Failure</a><a href="/compendium/type1diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Type 1 Diabetes</a></div><div><a href="/compendium/dermatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Dermatology</a><a href="/compendium/alopecia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Alopecia</a><a href="/compendium/atopic-dermatitis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Atopic Dermatitis</a><a href="/compendium/psoriasis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Psoriasis</a></div><div><a href="/compendium/hematology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hematology</a><a href="/compendium/all" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">ALL/AML</a><a href="/compendium/cll" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">CLL/SLL</a><a href="/compendium/gvhd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">GVHD</a><a href="/compendium/hemophilia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hemophilia</a><a href="/compendium/multiple-myeloma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Myeloma</a><a href="/compendium/myelodysplastic-syndromes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myelodysplastic Syndromes</a><a href="/compendium/mpn" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myeloproliferative Neoplasms</a><a href="/compendium/nhl" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non-Hodgkin Lymphoma</a><a href="/compendium/rareblood" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Blood</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hepatology</span><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver</a></div><div><a href="/compendium/immunology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immunology</a><a href="/compendium/autoimmune" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Autoimmune</a><a href="/compendium/Inflammation" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Inflammation</a><a href="/compendium/lupus" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Lupus</a><a href="/compendium/myasthenia-gravis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myasthenia Gravis</a></div><div><a href="/compendium/infectious-disease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Infectious Disease</a><a href="/compendium/covid-19" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COVID-19</a><a href="/compendium/hiv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">HIV</a><a href="/compendium/rsv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">RSV</a><a href="/compendium/vaccines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Vaccines</a></div><div><a href="/compendium/mental-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Mental Health</a><a href="/compendium/mdd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Major Depressive Disorder</a><a href="/compendium/sleep" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Sleep</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Neurology</span><a href="/compendium/dmd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Duchenne Muscular Dystrophy</a><a href="/compendium/epilepsy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Epilepsy</a><a href="/compendium/multiple-sclerosis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Sclerosis</a><a href="/compendium/parkinson" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Parkinson Disease</a></div><div><a href="/compendium/obesity" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Obesity</a></div><div><a href="/compendium/oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Oncology</a><a href="/compendium/breast-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Breast Cancer</a><a href="/compendium/cholangiocarcinoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cholangiocarcinoma</a><a href="/compendium/colorectal-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Colorectal Cancer</a><a href="/compendium/immuno-oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immuno-Oncology</a><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver Cancer</a><a href="/compendium/lung-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Lung Cancer</a><a href="/compendium/nsclc" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non–Small Cell Lung Cancer</a><a href="/compendium/ovarian-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ovarian Cancer</a><a href="/compendium/prostate-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Prostate Cancer</a><a href="/compendium/skincancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Skin Cancer</a><a href="/compendium/soft-tissue-sarcoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Soft Tissue Sarcoma</a></div><div><a href="/compendium/ophthalmology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ophthalmology</a></div><div><span class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonology</span><a href="/compendium/copd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COPD</a><a href="/compendium/pah" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonary Arterial Hypertension</a></div><div><a href="/compendium/raredisease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Disease</a><a href="/compendium/sma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Spinal Muscular Atrophy</a></div><div><a href="/compendium/respiratory" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Respiratory</a><a href="/compendium/asthma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Asthma</a><a href="/compendium/ipf" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Idiopathic Pulmonary Fibrosis</a></div><div><a href="/compendium/rheumatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rheumatology</a></div><div><a href="/compendium/womens-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Women&#x27;s Health</a></div></nav></div></div></div></div></div></div><div class="z-1 relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Topics<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Topics" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><a href="/topic/center-on-health-equity-and-access" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Center on Health Equity &amp; Access</a></div><div><a href="/compendium/digital-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Digital Health</a></div><div><a href="/formulary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Formulary</a></div><div><a href="/compendium/gene-therapy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Gene Therapy</a></div><div><a href="/guidelines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Guidelines</a></div><div><a href="/topic/healthcare-cost" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Cost</a></div><div><a href="/topic/healthcare-delivery" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Delivery</a></div><div><a href="/topic/insurance" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Insurance</a></div><div><a href="/topic/policy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Policy</a></div><div><a href="/compendium/population" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Population Health</a></div><div><a href="/approvals-launches" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Product Approvals and Launches</a></div><div><a href="/topic/technology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Technology</a></div><div><a href="/topic/value-based-care" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Value-Based Care</a></div></nav></div></div></div></div></div></div></div></div></div></div></div><div class="fixed top-0 w-[85vw] h-full transform -translate-x-full z-40 transition duration-300 lg:hidden min-h-screen bg-primary shadow-lg" id="mobile-nav"><div class="w-full h-full shadow-lg z-40 fixed overflow-y-auto top-0 flex-col justify-between xl:hidden pb-4 transition duration-500 ease-in-out"><div class="px-5 h-full"><div class="flex flex-col justify-between h-full w-full"><div><div class="mt-6 flex w-full items-center justify-between"><div class="border-b border-gray-200 pb-2 flex items-center justify-between w-full"><div aria-label="logo" role="img" tabindex="0" class="focus:outline-none relative h-16 w-40 "><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left"/><noscript><img sizes="100vw" srcSet="/_next/image?url=%2Fajmc_logo_inverted.png&amp;w=640&amp;q=75 640w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=750&amp;q=75 750w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=828&amp;q=75 828w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=%2Fajmc_logo_inverted.png&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=%2Fajmc_logo_inverted.png&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left" loading="lazy"/></noscript></span></div><button aria-label="close menu" class="focus:outline-none focus:ring-2 rounded-md text-white pl-8 font-bold"><svg width="18" height="18" viewBox="0 0 14 14" fill="#fff" xmlns="http://www.w3.org/2000/svg"><path d="M13 1L1 13" stroke="#fff" stroke-linecap="round" stroke-width="2" stroke-linejoin="round"></path><path d="M1 1L13 13" stroke="#fff" stroke-linecap="round" stroke-width="2" stroke-linejoin="round"></path></svg></button></div></div><ul role="list" class="flex flex-1 flex-col gap-y-7 mt-6"><li><ul role="list" class="-mx-2 space-y-1"><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Spotlight</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>News</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Video</button></div></li><li><a class="hover:bg-gray-500 block rounded-md py-2 pr-2 pl-10 text-sm leading-6 font-semibold text-gray-50" href="/podcasts"><span>Podcasts</span></a></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Conferences</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Journals</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Events</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Resources</button></div></li><li><a class="hover:bg-gray-500 block rounded-md py-2 pr-2 pl-10 text-sm leading-6 font-semibold text-gray-50" href="/continuing-education"><span>CE</span></a></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>About AJMC</button></div></li><li><a class="hover:bg-gray-500 block rounded-md py-2 pr-2 pl-10 text-sm leading-6 font-semibold text-gray-50" href="https://one.ajmc.com/subscribe"><span>Subscribe</span></a></li></ul></li></ul><div class="flex md:hidden mt-4 items-center gap-2 mt-6 pt-6 border-t"><a rel="noreferrer noopener" target="_blank" href="https://www.facebook.com/TheAmericanJournalOfManagedCare"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 448 512" color="#fff" style="color:#fff" height="24" width="24" xmlns="http://www.w3.org/2000/svg"><path d="M400 32H48A48 48 0 0 0 0 80v352a48 48 0 0 0 48 48h137.25V327.69h-63V256h63v-54.64c0-62.15 37-96.48 93.67-96.48 27.14 0 55.52 4.84 55.52 4.84v61h-31.27c-30.81 0-40.42 19.12-40.42 38.73V256h68.78l-11 71.69h-57.78V480H400a48 48 0 0 0 48-48V80a48 48 0 0 0-48-48z"></path></svg></a><a rel="noreferrer noopener" target="_blank" href="https://twitter.com/AJMC_Journal"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" width="21" height="21" viewBox="12.65 12.65 118.02 118.02"><g transform="translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)"><path d="M 11 4 C 7.134 4 4 7.134 4 11 L 4 39 C 4 42.866 7.134 46 11 46 L 39 46 C 42.866 46 46 42.866 46 39 L 46 11 C 46 7.134 42.866 4 39 4 L 11 4 z M 13.085938 13 L 21.023438 13 L 26.660156 21.009766 L 33.5 13 L 36 13 L 27.789062 22.613281 L 37.914062 37 L 29.978516 37 L 23.4375 27.707031 L 15.5 37 L 13 37 L 22.308594 26.103516 L 13.085938 13 z M 16.914062 15 L 31.021484 35 L 34.085938 35 L 19.978516 15 L 16.914062 15 z" fill="#FFFFFF"></path></g></svg></a><a rel="noreferrer noopener" target="_blank" href="https://www.linkedin.com/company/american-journal-of-managed-care/"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 448 512" color="#fff" style="color:#fff" height="27" width="27" xmlns="http://www.w3.org/2000/svg"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"></path></svg></a><a rel="noreferrer noopener" target="_blank" href="https://www.instagram.com/ajmcjournal/"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 448 512" color="#fff" style="color:#fff" height="24" width="24" xmlns="http://www.w3.org/2000/svg"><path d="M224,202.66A53.34,53.34,0,1,0,277.36,256,53.38,53.38,0,0,0,224,202.66Zm124.71-41a54,54,0,0,0-30.41-30.41c-21-8.29-71-6.43-94.3-6.43s-73.25-1.93-94.31,6.43a54,54,0,0,0-30.41,30.41c-8.28,21-6.43,71.05-6.43,94.33S91,329.26,99.32,350.33a54,54,0,0,0,30.41,30.41c21,8.29,71,6.43,94.31,6.43s73.24,1.93,94.3-6.43a54,54,0,0,0,30.41-30.41c8.35-21,6.43-71.05,6.43-94.33S357.1,182.74,348.75,161.67ZM224,338a82,82,0,1,1,82-82A81.9,81.9,0,0,1,224,338Zm85.38-148.3a19.14,19.14,0,1,1,19.13-19.14A19.1,19.1,0,0,1,309.42,189.74ZM400,32H48A48,48,0,0,0,0,80V432a48,48,0,0,0,48,48H400a48,48,0,0,0,48-48V80A48,48,0,0,0,400,32ZM382.88,322c-1.29,25.63-7.14,48.34-25.85,67s-41.4,24.63-67,25.85c-26.41,1.49-105.59,1.49-132,0-25.63-1.29-48.26-7.15-67-25.85s-24.63-41.42-25.85-67c-1.49-26.42-1.49-105.61,0-132,1.29-25.63,7.07-48.34,25.85-67s41.47-24.56,67-25.78c26.41-1.49,105.59-1.49,132,0,25.63,1.29,48.33,7.15,67,25.85s24.63,41.42,25.85,67.05C384.37,216.44,384.37,295.56,382.88,322Z"></path></svg></a><a rel="noreferrer noopener" target="_blank" href="/rss"></a></div></div></div></div></div></div></nav></div></div><div class="container px-4 mx-auto pl-2 pr-2 sm:h-[98px] sm:w-[728px]"><div id="leaderboardWrapper" class="jsx-1661e6713d4eb9b5 leaderboardAdWrapper mx-auto mt-1 flex min-h-0 md:min-h-[90px] justify-center items-center flex-col relative z-[99999] "><div class="jsx-1661e6713d4eb9b5 bg-white md:-translate-x-4"><div class="jsx-1661e6713d4eb9b5 text-[8px] text-center text-gray-600 hidden relative">Advertisement</div><div id="div-gpt-ad-top" class="jsx-1661e6713d4eb9b5 AD728x90 mx-auto text-center x"></div></div></div></div><hr class="mt-8 pt-8 -mb-4 pb-0"/><div id="atopic-dermatitis" class="container mx-auto flex m-1 min-h-[57vh] px-4"><div class="flex-auto w-[calc(100%-300px)] pr-0 md:pr-6 mt-16 sm:mt-0"><div class="pb-24 my-2"><div class="flex"><h1 class="text-[19px] mt-1 md:mt-0 md:text-3xl mb-2">Atopic Dermatitis</h1><div class="flex justify-center px-0 -mt-1 sm:-mt-2 align-center"></div></div><div class="w-full mb-2 border border-secondary"></div><div id="description-summary" class="text-sm text-gray-500"><div class="blockText_blockContent__TbCXh"><p class="pb-2">The <em>AJMC</em><sup class="text-inherit">®</sup> Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.</p></div><div class="clear-both"></div></div><div class="border-b-[2px] border-[#EEE] "><div class="m-2"><div class="hidden xs:flex justify-between items-center"><h2 class="text-3xl">Latest News</h2></div><div class="xs:my-6 my-4 xs:block hidden"><div class="flex"><div class="flex sm:pr-[35px] pr-[20px] flex-col w-[40%] border-r-[2px] border-[#EEE]"><div class="lg:h-[220px] h-[170px] relative bg-default-logo-background "><a class="0 w-full" href="/view/study-finds-increased-impaired-mobility-by-sex-age-in-atopic-dermatitis"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-contain" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-contain" loading="lazy"/></noscript></span></a></div><div class="border-t-gray-100 border-t-2 flex-auto py-2 "><span class="text-sm text-gray-500 py-2">June 30th 2024</span><div class="py-3"><a class="lg:text-[20px] text-[19px] font-[500]" href="/view/study-finds-increased-impaired-mobility-by-sex-age-in-atopic-dermatitis">Study Finds Increased Impaired Mobility by Sex, Age in Atopic Dermatitis</a></div><div class="pb-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div><a href="/view/study-finds-increased-impaired-mobility-by-sex-age-in-atopic-dermatitis"><a href="/view/study-finds-increased-impaired-mobility-by-sex-age-in-atopic-dermatitis"><p class="mt-1 text-gray-800 text-[13px] line-clamp-6 text-hidden">Patients with atopic dermatitis, particularly males and those aged 40 to 59 years, have significantly higher rates of impaired mobility.</p></a></a></div></div><div class="flex-wrap w-[60%] flex "><a class="flex w-[50%] flex-col sm:pl-[35px] pl-[20px] pb-[35px] " href="/view/parental-e-cigarette-use-may-increase-pediatric-ad-risk"><div class="w-full lg:h-[134px] h-[100px] relative bg-default-logo-background "><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="lg:object-cover object-contain " style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="lg:object-cover object-contain " loading="lazy"/></noscript></span></div><div class="border-t-gray-100 border-t-2 pt-2 pb-2 flex-auto "><a href="/view/parental-e-cigarette-use-may-increase-pediatric-ad-risk"><span class="text-sm text-gray-500">May 22nd 2024</span></a><div><a class="text-[14px]" href="/view/parental-e-cigarette-use-may-increase-pediatric-ad-risk"><p class="line-clamp-4 text-hidden font-[500]">Parental e-Cigarette Use May Increase Pediatric AD Risk</p></a></div><div class="py-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></a><a class="flex w-[50%] flex-col sm:pl-[35px] pl-[20px] pb-[35px] " href="/view/study-visible-ad-impacts-romantic-relationships-occupation-sexual-health-of-french-female-patients"><div class="w-full lg:h-[134px] h-[100px] relative bg-default-logo-background "><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="lg:object-cover object-contain " style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="lg:object-cover object-contain " loading="lazy"/></noscript></span></div><div class="border-t-gray-100 border-t-2 pt-2 pb-2 flex-auto "><a href="/view/study-visible-ad-impacts-romantic-relationships-occupation-sexual-health-of-french-female-patients"><span class="text-sm text-gray-500">May 19th 2024</span></a><div><a class="text-[14px]" href="/view/study-visible-ad-impacts-romantic-relationships-occupation-sexual-health-of-french-female-patients"><p class="line-clamp-4 text-hidden font-[500]">Study: Visible AD Impacts Romantic Relationships, Occupation, Sexual Health of French Female Patients </p></a></div><div class="py-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></a><a class="flex w-[50%] flex-col sm:pl-[35px] pl-[20px] pb-[35px] " href="/view/patients-with-ad-prioritize-itch-control-in-treatment-preferences"><div class="w-full lg:h-[134px] h-[100px] relative bg-default-logo-background "><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="lg:object-cover object-contain " style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="lg:object-cover object-contain " loading="lazy"/></noscript></span></div><div class="border-t-gray-100 border-t-2 pt-2 pb-2 flex-auto "><a href="/view/patients-with-ad-prioritize-itch-control-in-treatment-preferences"><span class="text-sm text-gray-500">May 14th 2024</span></a><div><a class="text-[14px]" href="/view/patients-with-ad-prioritize-itch-control-in-treatment-preferences"><p class="line-clamp-4 text-hidden font-[500]">Patients With AD Prioritize Itch Control in Treatment Preferences</p></a></div><div class="py-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></a><a class="flex w-[50%] flex-col sm:pl-[35px] pl-[20px] pb-[35px] " href="/view/study-educational-interventions-substantially-reduce-ad-severity"><div class="w-full lg:h-[134px] h-[100px] relative bg-default-logo-background "><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="lg:object-cover object-contain " style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="lg:object-cover object-contain " loading="lazy"/></noscript></span></div><div class="border-t-gray-100 border-t-2 pt-2 pb-2 flex-auto "><a href="/view/study-educational-interventions-substantially-reduce-ad-severity"><span class="text-sm text-gray-500">May 10th 2024</span></a><div><a class="text-[14px]" href="/view/study-educational-interventions-substantially-reduce-ad-severity"><p class="line-clamp-4 text-hidden font-[500]">Study: Educational Interventions Substantially Reduce AD Severity</p></a></div><div class="py-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></a></div></div></div><div class="xs:hidden block"><div class="jsx-19ede9f0a5a45918 py-4 relative px-0"><div class="flex justify-between items-center py-1 space-x-4 border-0 select-none"><div class="w-full xs:my-6 my-4 #000 text-3xl">Latest News</div></div><div style="scroll-snap-type:none" class="jsx-19ede9f0a5a45918 flex items-start overflow-x-auto space-x-4 py-4 relative mx-auto w-[calc(100%-64px)]"><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-1215160397 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/study-finds-increased-impaired-mobility-by-sex-age-in-atopic-dermatitis"><div class="jsx-1215160397 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-1215160397 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-1215160397 content-wrap"><span class="jsx-1215160397 py-3 text-sm text-gray-500 text-left"><i class="jsx-1215160397">June 30th 2024</i></span><div class="jsx-1215160397 w-full h-fit mb-4"><p class="jsx-1215160397 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Study Finds Increased Impaired Mobility by Sex, Age in Atopic Dermatitis</p></div><div class="jsx-1215160397 pb-2 text-left ]"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-1637274924 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/parental-e-cigarette-use-may-increase-pediatric-ad-risk"><div class="jsx-1637274924 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-1637274924 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Ff6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-1637274924 content-wrap"><span class="jsx-1637274924 py-3 text-sm text-gray-500 text-left"><i class="jsx-1637274924">May 22nd 2024</i></span><div class="jsx-1637274924 w-full h-fit mb-4"><p class="jsx-1637274924 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Parental e-Cigarette Use May Increase Pediatric AD Risk</p></div><div class="jsx-1637274924 pb-2 text-left ]"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-286612495 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/study-visible-ad-impacts-romantic-relationships-occupation-sexual-health-of-french-female-patients"><div class="jsx-286612495 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-286612495 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fbb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-286612495 content-wrap"><span class="jsx-286612495 py-3 text-sm text-gray-500 text-left"><i class="jsx-286612495">May 19th 2024</i></span><div class="jsx-286612495 w-full h-fit mb-4"><p class="jsx-286612495 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Study: Visible AD Impacts Romantic Relationships, Occupation, Sexual Health of French Female Patients </p></div><div class="jsx-286612495 pb-2 text-left ]"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-2915913710 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/patients-with-ad-prioritize-itch-control-in-treatment-preferences"><div class="jsx-2915913710 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-2915913710 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-2915913710 content-wrap"><span class="jsx-2915913710 py-3 text-sm text-gray-500 text-left"><i class="jsx-2915913710">May 14th 2024</i></span><div class="jsx-2915913710 w-full h-fit mb-4"><p class="jsx-2915913710 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Patients With AD Prioritize Itch Control in Treatment Preferences</p></div><div class="jsx-2915913710 pb-2 text-left ]"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-2363373513 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/study-educational-interventions-substantially-reduce-ad-severity"><div class="jsx-2363373513 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-2363373513 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-2363373513 content-wrap"><span class="jsx-2363373513 py-3 text-sm text-gray-500 text-left"><i class="jsx-2363373513">May 10th 2024</i></span><div class="jsx-2363373513 w-full h-fit mb-4"><p class="jsx-2363373513 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Study: Educational Interventions Substantially Reduce AD Severity</p></div><div class="jsx-2363373513 pb-2 text-left ]"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/brooke-mccormick"><i>Brooke McCormick</i></a></span></div></div></div></div></a></div></div></div></div></div><div class="py-8 border-b-[2px] border-[#EEE]"><div class="relative w-full h-full max-w-[984px] rounded-md mx-auto"><div class="flex flex-col-reverse lg:flex-row items-center justify-center mx-auto rounded-md"><div class="w-full lg:w-[610px] xl:w-3/4 h-[280px] xs:h-[260px] sm:h-[250px] lg:h-[243px] xl:h-[311px] pb-[90px] pt-2 sm:pt-4 lg:pt-3 xl:pt-4 pl-3 xs:pl-4 sm:pl-6 pr-3 rounded-tl-none lg:rounded-tl-md rounded-bl-md rounded-br-md lg:rounded-br-none" style="background:var(--primary)"><h2 class="text-md sm:text-lg xl:text-xl leading-tight lg:leading-none xl:sleading-tight text-white font-bold font-lora my-2">Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access</h2><p class="line-clamp-5 lg:line-clamp-4 font-light font-rubik text-white text-xs xl:text-sm">Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies. </p><div style="color:var(--primary)"><a class="font-bold font-rubik text-xs flex items-center gap-2 mt-2.5 xs:mt-4 lg:mt-2.5 xl:mt-3.5 py-2 px-3 cursor-pointer max-w-fit bg-white hover:bg-gray-300 rounded-md" href="https://www.ajmc.com/payer-perspectives/topical-therapies-for-the-treatment-of-atopic-dermatitis-balancing-safety-efficacy-and-access">Visit Now</a></div></div><div class="w-full max-h-[385px] lg:max-h-[243px] xl:max-h-[311px] overflow-hidden flex justify-center items-center rounded-br-none rounded-tr-md rounded-tl-md lg:rounded-r-md lg:rounded-tl-none pointer-events-none"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27959%27%20height=%27539.5%27/%3e"/></span><img alt="Atopic Dermatitis Payer Perspectives" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Atopic Dermatitis Payer Perspectives" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F3752f89404f2f63f6cf870dedac919c4371f881f-492x300.png&amp;w=1080&amp;q=75 1x, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F3752f89404f2f63f6cf870dedac919c4371f881f-492x300.png&amp;w=1920&amp;q=75 2x" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F3752f89404f2f63f6cf870dedac919c4371f881f-492x300.png&amp;w=1920&amp;q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="absolute bottom-0 left-0 flex justify-between lg:justify-start gap-2 w-full lg:w-[22rem] xl:w-[27rem] px-3 xs:px-4 sm:px-6 pb-3 xs:pb-6 lg:pb-3 xl:pb-6"><button class="w-8 h-8 rounded-2xl flex items-center justify-center"><svg fill="none" height="32" viewBox="0 0 24 24" width="32" xmlns="http://www.w3.org/2000/svg"><g stroke="#fff" stroke-width="2"><circle cx="12" cy="12" r="10"></circle><path d="m13.5 8-4 4 4 4" stroke-linecap="round" stroke-linejoin="round"></path></g></svg></button><div class="flex items-center justify-around w-full gap-[3px]"><button class="flex-1 h-[3px] rounded-full bg-white"></button></div><button class="w-8 h-8 rounded-2xl flex items-center justify-center"><svg fill="none" height="32" viewBox="0 0 24 24" width="32" xmlns="http://www.w3.org/2000/svg"><g stroke="#fff" stroke-width="2"><circle cx="12" cy="12" r="10"></circle><path d="m10.5 8 4 4-4 4" stroke-linecap="round" stroke-linejoin="round"></path></g></svg></button></div></div></div><div class="border-b-[2px] border-[#EEE] "><div class="jsx-19ede9f0a5a45918 py-4 relative px-0"><div class="flex justify-between items-center py-1 space-x-4 border-0 select-none"><div class="w-[70%] mr-3 xs:my-6 my-4 #000 text-3xl">Video Interviews</div><a href="/interviews" class="w-[30%] text-right text-[#0AA2BE] text-[16px] underline"><span>View All</span></a></div><div style="scroll-snap-type:none" class="jsx-19ede9f0a5a45918 flex items-start overflow-x-auto space-x-4 py-4 relative mx-auto w-[calc(100%-64px)]"><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-1215160397 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-martin-dahl-summarizes-findings-limitations-of-study-analyzing-anb032-use-in-patients-with-ad"><div class="jsx-1215160397 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-1215160397 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png%2FScreenshot%25202024-04-29%2520at%252011.12.07%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-1215160397 content-wrap"><span class="jsx-1215160397 py-3 text-sm text-gray-500 text-left"><i class="jsx-1215160397">May 1st 2024</i></span><div class="jsx-1215160397 w-full h-fit mb-4"><p class="jsx-1215160397 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Martin Dahl Summarizes Findings, Limitations of Study Analyzing ANB032 Use in Patients With AD</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-1637274924 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-lawrence-eichenfield-hopeful-for-new-pediatric-ad-treatment-option"><div class="jsx-1637274924 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-1637274924 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-1637274924 content-wrap"><span class="jsx-1637274924 py-3 text-sm text-gray-500 text-left"><i class="jsx-1637274924">April 16th 2024</i></span><div class="jsx-1637274924 w-full h-fit mb-4"><p class="jsx-1637274924 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Lawrence Eichenfield Hopeful for New Pediatric AD Treatment Option</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-286612495 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-lawerence-eichenfield-discusses-positive-results-of-roflumilast-cream-0-05-in-pediatric-patients-with-ad"><div class="jsx-286612495 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-286612495 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fb5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png%2FLawrence%2520Eichenfeld.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-286612495 content-wrap"><span class="jsx-286612495 py-3 text-sm text-gray-500 text-left"><i class="jsx-286612495">April 8th 2024</i></span><div class="jsx-286612495 w-full h-fit mb-4"><p class="jsx-286612495 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Lawrence Eichenfield Discusses Positive Results of Roflumilast Cream 0.05% in Pediatric Patients With AD</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-2915913710 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-jonathan-silverberg-describes-ad-diagnosis-treatment-in-children-vs-adults"><div class="jsx-2915913710 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-2915913710 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fc604364841a910a2075536c659ada17f2fcbdc43-658x352.png%2FScreenshot%25202024-03-26%2520at%25202.54.33%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-2915913710 content-wrap"><span class="jsx-2915913710 py-3 text-sm text-gray-500 text-left"><i class="jsx-2915913710">April 2nd 2024</i></span><div class="jsx-2915913710 w-full h-fit mb-4"><p class="jsx-2915913710 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Jonathan Silverberg Describes AD Diagnosis, Treatment in Children vs Adults</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-2363373513 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-raj-chovatiya-describes-oral-jak-inhibitor-monitoring-protocols-for-ad-treatment"><div class="jsx-2363373513 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-2363373513 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-2363373513 content-wrap"><span class="jsx-2363373513 py-3 text-sm text-gray-500 text-left"><i class="jsx-2363373513">April 1st 2024</i></span><div class="jsx-2363373513 w-full h-fit mb-4"><p class="jsx-2363373513 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-2785488040 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-raj-chovatiya-provides-evidence-supporting-oral-jak-inhibitor-use-to-treat-ad"><div class="jsx-2785488040 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-2785488040 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png%2FScreenshot%25202024-03-15%2520at%25204.07.46%25E2%2580%25AFPM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-2785488040 content-wrap"><span class="jsx-2785488040 py-3 text-sm text-gray-500 text-left"><i class="jsx-2785488040">March 24th 2024</i></span><div class="jsx-2785488040 w-full h-fit mb-4"><p class="jsx-2785488040 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-1434825611 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-amy-paller-safety-is-of-paramount-importance-when-choosing-systemic-therapies-for-children-with-ad"><div class="jsx-1434825611 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-1434825611 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-1434825611 content-wrap"><span class="jsx-1434825611 py-3 text-sm text-gray-500 text-left"><i class="jsx-1434825611">March 17th 2024</i></span><div class="jsx-1434825611 w-full h-fit mb-4"><p class="jsx-1434825611 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Amy Paller: Safety Is of Paramount Importance When Choosing Systemic Therapies for Children With AD</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-4064126826 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-amy-paller-discusses-using-systemic-therapies-to-treat-children-with-ad"><div class="jsx-4064126826 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-4064126826 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png%2FScreenshot%25202024-03-11%2520at%252010.54.43%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-4064126826 content-wrap"><span class="jsx-4064126826 py-3 text-sm text-gray-500 text-left"><i class="jsx-4064126826">March 12th 2024</i></span><div class="jsx-4064126826 w-full h-fit mb-4"><p class="jsx-4064126826 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Amy Paller Discusses Using Systemic Therapies to Treat Children With AD</p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-187450181 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-elaine-siegfried-summarizes-ad-treatment-guideline-update"><div class="jsx-187450181 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-187450181 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fdb081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png%2FScreenshot%25202023-12-12%2520at%252010.11.28%25E2%2580%25AFAM.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-187450181 content-wrap"><span class="jsx-187450181 py-3 text-sm text-gray-500 text-left"><i class="jsx-187450181">January 10th 2024</i></span><div class="jsx-187450181 w-full h-fit mb-4"><p class="jsx-187450181 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Elaine Siegfried Summarizes AD Treatment Guideline Update </p></div></div></div></a><a target="" style="scroll-snap-align:center;text-decoration:none" class="jsx-609564708 sm:w-[280px] xs:w-[240px] w-[65%] h-auto flex flex-col space-y-3 flex-none select-none no-underline" href="/view/dr-jonathan-silverberg-lists-which-patients-with-ad-benefit-most-from-jak-inhibitors"><div class="jsx-609564708 w-full h-full flex flex-col overflow-hidden relative bg-white text-center"><div class="jsx-609564708 relative w-full shadow-md shadow-grey-800 aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fa1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg%2FSilverbergTN3.jpg%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="object-cover" loading="lazy"/></noscript></span></div><div class="jsx-609564708 content-wrap"><span class="jsx-609564708 py-3 text-sm text-gray-500 text-left"><i class="jsx-609564708">January 4th 2024</i></span><div class="jsx-609564708 w-full h-fit mb-4"><p class="jsx-609564708 text-[18px] font-bold text-[#000000] text-left line-clamp-3 text-hidden">Dr Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors</p></div></div></div></a></div></div></div><div class="flex items-center space-x-4 border-0 border-b border-secondary select-none py-1"><h2 class="text-3xl text-primary">More News</h2></div><div class="flex flex-wrap w-full pb-4"><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-1"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/study-ad-identified-as-potential-risk-factor-for-headache-disorder"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/20889be9c8c12dc41a85d9e54ca3d9942207c31d-5616x3744.jpg?fit=crop&amp;auto=format" alt="Female patient with headache pain | Image Credit: Artem Furman - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">April 16th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/study-ad-identified-as-potential-risk-factor-for-headache-disorder">Study: AD Identified as Potential Risk Factor for Headache Disorder</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/study-ad-identified-as-potential-risk-factor-for-headache-disorder"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Patients with atopic dermatitis (AD) may have an increased risk of headache disorder and migraines.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/children-born-to-mothers-with-stress-mental-health-conditions-during-pregnancy-at-higher-ad-risk"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/fbab2b19d55aa46e81db8af632893b82be2bde47-6000x4000.jpg?fit=crop&amp;auto=format" alt="sleeping infant holding mother&#x27;s finger | Image Credit: Bostan Natalia - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">April 2nd 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/children-born-to-mothers-with-stress-mental-health-conditions-during-pregnancy-at-higher-ad-risk">Children Born to Mothers With Stress, Mental Health Conditions During Pregnancy at Higher AD Risk</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/children-born-to-mothers-with-stress-mental-health-conditions-during-pregnancy-at-higher-ad-risk"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">A meta-analysis found significant associations between maternal stress, anxiety, depression, and adverse life events during pregnancy with increased atopic dermatitis (AD) risk in offspring.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/children-with-ad-neurodevelopmental-comorbidities-at-greater-odds-of-learning-memory-difficulties"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/73291959f906333046db4310a9d050f6e67ed450-6240x3801.jpg?fit=crop&amp;auto=format" alt="child scratching atopic dermatitis | Image Credit: Марина Терехова - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">March 18th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/children-with-ad-neurodevelopmental-comorbidities-at-greater-odds-of-learning-memory-difficulties">Children With AD, Neurodevelopmental Comorbidities at Greater Odds of Learning, Memory Difficulties</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/children-with-ad-neurodevelopmental-comorbidities-at-greater-odds-of-learning-memory-difficulties"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Children with atopic dermatitis (AD) face higher chances of learning and memory difficulties, particularly when they have neurodevelopmental comorbidities, like attention-deficit/hyperactivity disorder.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/study-patients-with-ad-limited-health-literacy-face-impaired-quality-of-life"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/134521fd8c460ed94dcc712d4c0a88ab6fa97963-3301x2395.jpg?fit=crop&amp;auto=format" alt="Quality of life | Image Credit: gustavofrazao - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">March 10th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/study-patients-with-ad-limited-health-literacy-face-impaired-quality-of-life">Study: Patients With AD, Limited Health Literacy Face Impaired Quality of Life</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/study-patients-with-ad-limited-health-literacy-face-impaired-quality-of-life"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">A considerable number of patients with atopic dermatitis (AD) and limited health literacy, especially older individuals, experienced impaired health-related quality of life.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dupilumab-considered-safe-effective-for-ad-in-real-life-settings"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/a30f8534226e504e1f369b1f64da0261d00e909f-6240x4160.jpg?fit=crop&amp;auto=format" alt="Adult scratching atopic dermatitis on arm | Image Credit: ltyuan - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">March 4th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dupilumab-considered-safe-effective-for-ad-in-real-life-settings">Dupilumab Considered Safe, Effective for AD in Real-Life Settings</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dupilumab-considered-safe-effective-for-ad-in-real-life-settings"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">This study enhances current understandings of dupilumab use in patients with atopic dermatitis (AD) by showing its real-world effectiveness and safety.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/upadacitinib-effective-in-treating-patients-with-moderate-to-severe-ad-study-says"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/2f234603bd7f97415e1893931f8dbaf82d713242-7952x5304.jpg?fit=crop&amp;auto=format" alt="Upadacitinib | Image Credit: luchschenF - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 14th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/upadacitinib-effective-in-treating-patients-with-moderate-to-severe-ad-study-says">Upadacitinib Effective in Treating Patients With Moderate to Severe AD, Study Says</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/upadacitinib-effective-in-treating-patients-with-moderate-to-severe-ad-study-says"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Adult patients with moderate to severe atopic dermatitis (AD) had a 1-year and 1.5-year upadacitinib drug survival of 91.5% and 80.2%, respectively.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-7"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/telemedicine-considered-equivalent-to-in-person-care-for-ad-follow-up"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912.jpg?fit=crop&amp;auto=format" alt="female patient speaking with physician on video call | Image Credit: rh2010 - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 8th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/telemedicine-considered-equivalent-to-in-person-care-for-ad-follow-up">Telemedicine Considered Equivalent to In-Person Care for AD Follow-Up</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/telemedicine-considered-equivalent-to-in-person-care-for-ad-follow-up"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">This systemic review determined telemedicine to be as effective as in-person appointments for the follow-up of patients with atopic dermatitis (AD).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/study-tralokinumab-caused-more-frequent-injection-site-reactions-than-dupilumab-in-patients-with-ad"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/cfde0828443f149997a7a2086456ee374f7a9d34-4141x2761.jpg?fit=crop&amp;auto=format" alt="Injection site reaction | Image Credit: Irina Schmidt - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 7th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/study-tralokinumab-caused-more-frequent-injection-site-reactions-than-dupilumab-in-patients-with-ad">Study: Tralokinumab Shows More Frequent Injection Site Reactions Than Dupilumab in Patients With AD</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/study-tralokinumab-caused-more-frequent-injection-site-reactions-than-dupilumab-in-patients-with-ad"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Although injection site reactions were common occurrences in both the tralokinumab and dupilumab groups, tralokinumab caused ISRs more frequently.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/combination-dupilumab-topical-corticosteroids-treatment-demonstrated-efficacy-in-children-with-ad"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/04bfbda193785ce69eaabd6ae5b01bb50ead4248-5351x3567.jpg?fit=crop&amp;auto=format" alt="Child with atopic dermatitis (AD) | Image Credit: Юля Шевцова - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 2nd 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/combination-dupilumab-topical-corticosteroids-treatment-demonstrated-efficacy-in-children-with-ad">Combination Dupilumab, Topical Corticosteroids Treatment Demonstrated Efficacy in Children With AD</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/combination-dupilumab-topical-corticosteroids-treatment-demonstrated-efficacy-in-children-with-ad"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Dupilumab and topical corticosteroids can be used to treat symptoms in children with atopic dermatitis (AD).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/climatic-hazards-directly-impact-patients-with-ad-review-says"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b41a82faddae95bdd8d4209b107c61a707625a21-7768x4000.jpg?fit=crop&amp;auto=format" alt="climate change | Image Credit: jozsitoeroe - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 24th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/climatic-hazards-directly-impact-patients-with-ad-review-says">Climatic Hazards Directly Impact Patients With AD, Review Says</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/climatic-hazards-directly-impact-patients-with-ad-review-says"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Global warming, wildfires, precipitation, floods, and storms impact patients with atopic dermatitis (AD).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/ad-patients-caregivers-prioritize-symptom-control-minimizing-adverse-effects-during-treatment"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/851684487922df1e6e0de47826946729a90c0d4a-5951x3967.jpg?fit=crop&amp;auto=format" alt="Atopic dermatitis treatment | Image Credit: Ladanifer - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 19th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/ad-patients-caregivers-prioritize-symptom-control-minimizing-adverse-effects-during-treatment">AD Patients, Caregivers Prioritize Symptom Control, Minimizing Adverse Effects During Treatment</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/ad-patients-caregivers-prioritize-symptom-control-minimizing-adverse-effects-during-treatment"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The researchers suggested that physicians consider age-relevant atopic dermatitis (AD) treatment preferences in discussions with patients and caregivers.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/weekend-catch-up-sleep-prevents-suicidal-ideation-in-adolescent-patients-with-ad-study-says"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/66d9a98c5a3fc8dcd9ac21c82ed26ff73451d6a7-5760x3840.jpg?fit=crop&amp;auto=format" alt="Adolescent sleeping | Image Credit: digitalskillet1 - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 11th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/weekend-catch-up-sleep-prevents-suicidal-ideation-in-adolescent-patients-with-ad-study-says">Weekend Catch-Up Sleep Prevents Suicidal Ideation in Adolescent Patients With AD, Study Says </a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/weekend-catch-up-sleep-prevents-suicidal-ideation-in-adolescent-patients-with-ad-study-says"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">This study suggests that adolescents with atopic dermatitis (AD) sleep less, have greater sleep dissatisfaction, and longer weekend catch-up sleep (WCUS) than those without AD.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-13"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-andy-blauvelt-recommends-new-novel-ad-treatments"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/d0b6ca281cb1bd4dd15d50f8f1378632ed396b40-2880x1537.png?fit=crop&amp;auto=format" alt="dr andy blauvelt" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 2nd 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-andy-blauvelt-recommends-new-novel-ad-treatments">Dr Andy Blauvelt Recommends New Novel AD Treatments</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/pearl-steinzor">Pearl Steinzor</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-andy-blauvelt-recommends-new-novel-ad-treatments"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, recommends new novel topical therapies over topical steroids for patients with atopic dermatitis (AD).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-elaine-siegfried-describes-how-aad-guideline-update-impacts-ad-treatment"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b156aa69b8e4268b42d4b096d87eaadd7e027450-2665x1531.png?fit=crop&amp;auto=format" alt="dr elaine siegfried" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 1st 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-elaine-siegfried-describes-how-aad-guideline-update-impacts-ad-treatment">Dr Elaine Siegfried Describes How AAD Guideline Update Impacts AD Treatment</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-elaine-siegfried-describes-how-aad-guideline-update-impacts-ad-treatment"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Elaine Siegfried, MD, of Saint Louis University School of Medicine, discusses how the recent guideline update by the American Academy of Dermatology (AAD) affects dermatologists&#x27; atopic dermatitis (AD) treatment decisions.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/top-5-most-read-ad-content-of-2023"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/6a45cb4b9431c2845646a6ca5a058dddda29d27e-1020x520.png?fit=crop&amp;auto=format" alt="top 5 AD articles " width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 28th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/top-5-most-read-ad-content-of-2023">Top 5 Most-Read AD Content of 2023</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/top-5-most-read-ad-content-of-2023"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">This year’s most-read articles on atopic dermatitis (AD) explored different treatment and education methods.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/exploring-the-relationship-between-ad-psychological-stress-sleep-disturbances-salivary-biomarkers"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832.jpg?fit=crop&amp;auto=format" alt="atopic dermatitis" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 20th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/exploring-the-relationship-between-ad-psychological-stress-sleep-disturbances-salivary-biomarkers">Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, Salivary Biomarkers</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/lauren-buchanan-ma-managing-editor">Lauren Buchanan, MA</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/exploring-the-relationship-between-ad-psychological-stress-sleep-disturbances-salivary-biomarkers"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Understanding these relationships is crucial for developing effective clinical management strategies for patients with AD, according to a recent literature review.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/icymi-highlights-from-rad-2023"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/263c6d1bcbe64c6d016036ee243011fbbbec2c05-3187x1625.png?fit=crop&amp;auto=format" alt="ICYMI: Highlights From RAD 2023" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 17th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/icymi-highlights-from-rad-2023">ICYMI: Highlights From RAD 2023</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/pearl-steinzor">Pearl Steinzor</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/icymi-highlights-from-rad-2023"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Our top coverage from this year’s Revolutionizing Atopic Dermatitis (RAD) conference highlighted the evolving therapy landscape for patients with AD. </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-elaine-siegfried-discusses-using-biologics-to-treat-ad"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b156aa69b8e4268b42d4b096d87eaadd7e027450-2665x1531.png?fit=crop&amp;auto=format" alt="dr elaine siegfried" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 12th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-elaine-siegfried-discusses-using-biologics-to-treat-ad">Dr Elaine Siegfried Discusses Using Biologics to Treat AD</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-elaine-siegfried-discusses-using-biologics-to-treat-ad"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Elaine Siegfried, MD, of Saint Louis University School of Medicine discusses the use of biologics to treat atopic dermatitis (AD) and how they differ from other treatments.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-19"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/worsening-severity-of-ad-in-children-associated-with-increased-comorbidity-onset-risk"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/618023f2e60041d285c98320303dd0edbc2b23eb-5760x3840.jpg?fit=crop&amp;auto=format" alt="child with AD" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 10th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/worsening-severity-of-ad-in-children-associated-with-increased-comorbidity-onset-risk">Worsening Severity of AD in Children Associated With Increased Comorbidity Onset Risk</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/joshua-fitch">Joshua Fitch</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/worsening-severity-of-ad-in-children-associated-with-increased-comorbidity-onset-risk"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/most-patients-with-ad-satisfied-with-baricitinib-treatment-study-says"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/690165cc12a8154f8ce3951a41de04f986e84123-5341x3560.jpg?fit=crop&amp;auto=format" alt="Baricitinib" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 5th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/most-patients-with-ad-satisfied-with-baricitinib-treatment-study-says">Most Patients With AD Satisfied With Baricitinib Treatment, Study Says</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/most-patients-with-ad-satisfied-with-baricitinib-treatment-study-says"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Based on the Likert scale, most patients with atopic dermatitis (AD) using baricitinib reported being either “satisfied” (76%) or “very satisfied” (18%).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/mental-health-concerns-prevalent-in-patients-with-ad-poster-says"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/e926faf39a0b61879b4fd879bf5ce1ff514ca867-8305x5304.jpg?fit=crop&amp;auto=format" alt="patient with mental health issues" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">November 24th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/mental-health-concerns-prevalent-in-patients-with-ad-poster-says">Mental Health Concerns Prevalent in Patients With AD, Poster Says</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/heidi-anne-duerr-mph">Heidi Anne Duerr, MPH</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/mental-health-concerns-prevalent-in-patients-with-ad-poster-says"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis (AD).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/aad-updates-guidelines-for-ad-treatment-using-phototherapy-systemic-therapies"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/f4bb8db60db72afc836851f5efacf1358e4e0649-6497x4331.jpg?fit=crop&amp;auto=format" alt="doctor speaking with patient" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">November 21st 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/aad-updates-guidelines-for-ad-treatment-using-phototherapy-systemic-therapies">AAD Updates Guidelines for AD Treatment Using Phototherapy, Systemic Therapies</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/aad-updates-guidelines-for-ad-treatment-using-phototherapy-systemic-therapies"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">These new atopic dermatitis (AD) treatment guidelines from the American Academy of Dermatology (AAD) update their 2014 recommendations for the management of AD with phototherapy and systemic therapies.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-proposes-new-ad-treatment-standards"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615.png?fit=crop&amp;auto=format" alt="dr april armstrong" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">November 14th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-proposes-new-ad-treatment-standards">Dr April Armstrong Proposes New AD Treatment Standards</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-proposes-new-ad-treatment-standards"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">With the recent development of various new treatments, April Armstrong, MD, MPH, discusses the new standards she and other dermatologists hope to set for treating patients with atopic dermatitis (AD). </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/long-term-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic-dermatitis"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/77c2c84d9048d107cc226b88c416df6c7d4ebfad-6240x4160.jpg?fit=crop&amp;auto=format" alt="adult patient with atopic dermatitis (AD)" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">November 9th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/long-term-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic-dermatitis">Long-Term Safety of Dupilumab in Adults With Moderate to Severe Atopic Dermatitis</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/lauren-buchanan-ma-managing-editor">Lauren Buchanan, MA</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/long-term-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic-dermatitis"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The results from this 5-year, open-label extension trial affirm the safety of dupilumab in adults with moderate to severe AD.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-25"></div></div></div><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-peter-lio-describes-the-ad-treatment-toolkit"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/33d6ae51e99089b0a522cb66b24dc01f917b0230-2880x1613.png?fit=crop&amp;auto=format" alt="dr peter lio" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">November 6th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-peter-lio-describes-the-ad-treatment-toolkit">Dr Peter Lio Describes the AD Treatment Toolbox</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-peter-lio-describes-the-ad-treatment-toolkit"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University&#x27;s Feinberg School of Medicine, describes different methods dermatologists can use to treat atopic dermatitis (AD). </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/middle-aged-older-adults-with-ad-at-increased-risk-of-cognitive-dysfunction"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/40872453de9916931451a20765bdfb9e5d8efc2a-6720x4480.jpg?fit=crop&amp;auto=format" alt="middle aged patient with atopic dermatitis" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">November 3rd 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/middle-aged-older-adults-with-ad-at-increased-risk-of-cognitive-dysfunction">Middle-Aged, Older Adults With AD at Increased Risk of Cognitive Dysfunction</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/middle-aged-older-adults-with-ad-at-increased-risk-of-cognitive-dysfunction"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Because of their study&#x27;s findings, the researchers urged clinicians to screen patients with atopic dermatitis (AD) for cognitive dysfunction.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-how-recent-biologics-advancements-improved-ad-treatment"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615.png?fit=crop&amp;auto=format" alt="dr april armstrong" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">October 30th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-how-recent-biologics-advancements-improved-ad-treatment">Dr April Armstrong: How Recent Biologics Advancements Improved AD Treatment</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-how-recent-biologics-advancements-improved-ad-treatment"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">April Armstrong, MD, MPH, of University of California, Los Angeles, discussed how recent biologics advancements improved moderate-to-severe atopic dermatitis (AD) treatment. </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/more-than-half-of-adults-with-moderate-to-severe-ad-report-conditions-that-may-influence-selection-of-jak-inhibitors"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/6d34edecb4f7a1affdcf52e756ae5e81497c471f-5472x3648.jpg?fit=crop&amp;auto=format" alt="Atopic dermatitis | Image credit: Ольга Тернавская - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">October 27th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/more-than-half-of-adults-with-moderate-to-severe-ad-report-conditions-that-may-influence-selection-of-jak-inhibitors">More Than Half of Adults With Moderate to Severe AD Report Conditions That May Influence Selection of JAK Inhibitors</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/emma-andrus">Emma Andrus</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/more-than-half-of-adults-with-moderate-to-severe-ad-report-conditions-that-may-influence-selection-of-jak-inhibitors"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The most common conditions or concerns patients with atopic dermatitis (AD) reported having that may influence their selection of a JAK inhibitor included an increased risk of MACE and an age above 65 years.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-clinician-education-needed-to-overcome-ad-treatment-barriers"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615.png?fit=crop&amp;auto=format" alt="dr april armstrong" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">October 26th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-clinician-education-needed-to-overcome-ad-treatment-barriers">Dr April Armstrong: Clinician Education Needed to Overcome AD Treatment Barriers</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-clinician-education-needed-to-overcome-ad-treatment-barriers"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">April Armstrong, MD, MPH, of University of California, Los Angeles, gave an overview of her Fall Clinical Dermatology session on treating atopic dermatitis (AD) in patients with diverse skin tones and weighed in on how to address related treatment barriers.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-identifies-main-ad-health-care-gaps"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615.png?fit=crop&amp;auto=format" alt="dr april armstrong" width="288" class="jsx-ad50481d5ee26850 w-full xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 font-bold article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">October 24th 2023</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-identifies-main-ad-health-care-gaps">Dr April Armstrong Identifies Main AD Health Care Gaps</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/brooke-mccormick">Brooke McCormick</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#000] text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-april-armstrong-identifies-main-ad-health-care-gaps"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">April Armstrong, MD, MPH, of University of California, Los Angeles, explained that the main health care gap within the atopic dermatitis (AD) realm is that many clinicians are not comfortable prescribing systemic medications.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div></div><div class="w-full text-center flex justify-center pb-24"><a class="px-4 py-2 border-y border-r bg-primary text-white" href="/compendium/atopic-dermatitis?page=1">1</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=2">2</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=3">3</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=4">4</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=5">5</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=6">6</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=7">7</a><a class="px-4 py-2 border-y border-r " href="/compendium/atopic-dermatitis?page=8">8</a><a class="px-4 py-2 border-y border-r" href="/compendium/atopic-dermatitis?page=2">&gt;</a></div></div></div><div class="flex-none w-[300px] z-[9999] relative hidden md:block"><div style="top:5rem" class="sticky custom-spacing"><div class="collapse-container " style="overflow:hidden;max-height:900px;transition:max-height .4s ease-in-out"></div></div></div></div><div id="div-gpt-ad-pixel" style="width:1px;height:1px" class=""></div><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NK5KQXS" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><div id="footerOuterWrap" class=" mx-auto flex"><div class="bg-[#00598D] xl:w-[70%] w-[70%] py-12 pl-auto"><div class="xxl:w-[75%] w-[90%] ml-auto"><div><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27300%27%20height=%2744%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" srcSet="/_next/image?url=%2Fan_mjhls_brand_ko.png&amp;w=384&amp;q=75 1x, /_next/image?url=%2Fan_mjhls_brand_ko.png&amp;w=640&amp;q=75 2x" src="/_next/image?url=%2Fan_mjhls_brand_ko.png&amp;w=640&amp;q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div><div class="flex"><div class="flex justify-between pt-6"><div class="w-[40%]"><div class="text-footer-text-color text-xs"><p>2 Commerce Drive<br/>Suite 100<br/>Cranbury, NJ 08512</p></div><div class="self-start py-6" style="display:flex;flex-wrap:wrap"><a rel="noreferrer noopener" class="pr-1" target="_blank" href="https://www.facebook.com/TheAmericanJournalOfManagedCare"><p> <svg width='25px' height='25px' viewBox='0 0 512 512' version='1.1' xmlns='http://www.w3.org/2000/svg'> <g id='Page-1' stroke='none' strokeWidth='1' fill='none' fillRule='evenodd'> <g id='facebook' fill='#FFFFFF' fillRule='nonzero'> <path d='M512,256 C512,114.6 397.4,0 256,0 C114.6,0 0,114.6 0,256 C0,397.4 114.6,512 256,512 C257.5,512 259,512 260.5,511.9 L260.5,312.7 L205.5,312.7 L205.5,248.6 L260.5,248.6 L260.5,201.4 C260.5,146.7 293.9,116.9 342.7,116.9 C366.1,116.9 386.2,118.6 392,119.4 L392,176.6 L358.4,176.6 C331.9,176.6 326.7,189.2 326.7,207.7 L326.7,248.5 L390.2,248.5 L381.9,312.6 L326.7,312.6 L326.7,502.1 C433.7,471.4 512,372.9 512,256 Z' id='Path' /> </g> </g> </svg> </p></a><a rel="noreferrer noopener" class="pr-1" href="https://twitter.com/AJMC_Journal"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" width="25" height="25" viewBox="1.41 1.41 252.9 252.9"><g transform="translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)"><polygon points="24.89,23.01 57.79,66.99 65.24,66.99 32.34,23.01" fill="#FFFFFF" transform="matrix(1 0 0 1 0 0)"></polygon><path d="M 45 0 L 45 0 C 20.147 0 0 20.147 0 45 v 0 c 0 24.853 20.147 45 45 45 h 0 c 24.853 0 45 -20.147 45 -45 v 0 C 90 20.147 69.853 0 45 0 z M 56.032 70.504 L 41.054 50.477 L 22.516 70.504 h -4.765 L 38.925 47.63 L 17.884 19.496 h 16.217 L 47.895 37.94 l 17.072 -18.444 h 4.765 L 50.024 40.788 l 22.225 29.716 H 56.032 z" fill="#FFFFFF" transform="matrix(1 0 0 1 0 0)" stroke-linecap="round"></path></g></svg></a><a rel="noreferrer noopener" class="pr-1" target="_blank" href="https://www.linkedin.com/company/american-journal-of-managed-care/"><p> <svg width='25px' height='25px' viewBox='0 0 512 512' version='1.1' xmlns='http://www.w3.org/2000/svg'> <g id='Page-1' stroke='none' strokeWidth='1' fill='none' fillRule='evenodd'> <g id='linkedin' fill='#FFFFFF' fillRule='nonzero'> <path d='M256,0 C114.636719,0 0,114.636719 0,256 C0,397.363281 114.636719,512 256,512 C397.363281,512 512,397.363281 512,256 C512,114.636719 397.363281,0 256,0 Z M181.609375,387 L119.261719,387 L119.261719,199.425781 L181.609375,199.425781 L181.609375,387 Z M150.4375,173.8125 L150.03125,173.8125 C129.109375,173.8125 115.578125,159.410156 115.578125,141.410156 C115.578125,123.003906 129.523438,109 150.851562,109 C172.179688,109 185.304688,123.003906 185.710938,141.410156 C185.710938,159.410156 172.179688,173.8125 150.4375,173.8125 Z M406.421875,387 L344.082031,387 L344.082031,286.652344 C344.082031,261.433594 335.054688,244.234375 312.496094,244.234375 C295.273438,244.234375 285.015625,255.835938 280.507812,267.035156 C278.859375,271.042969 278.457031,276.644531 278.457031,282.25 L278.457031,387 L216.113281,387 C216.113281,387 216.929688,217.023438 216.113281,199.425781 L278.457031,199.425781 L278.457031,225.984375 C286.742188,213.203125 301.566406,195.023438 334.644531,195.023438 C375.664062,195.023438 406.421875,221.832031 406.421875,279.445312 L406.421875,387 Z' id='Shape' /> </g> </g> </svg> </p></a><a rel="noreferrer noopener" class="pr-1" target="_blank" href="https://www.instagram.com/ajmcjournal/"><p> <svg width='25px' height='25px' viewBox='0 0 512 512' version='1.1' xmlns='http://www.w3.org/2000/svg'> <g id='Page-1' stroke='none' strokeWidth='1' fill='none' fillRule='evenodd'> <g id='instagram' fill='#FFFFFF' fillRule='nonzero'> <path d='M305,256 C305,283.0625 283.0625,305 256,305 C228.9375,305 207,283.0625 207,256 C207,228.9375 228.9375,207 256,207 C283.0625,207 305,228.9375 305,256 Z' id='Path' /> <path d='M370.59375,169.304688 C368.238281,162.921875 364.480469,157.144531 359.597656,152.402344 C354.855469,147.519531 349.082031,143.761719 342.695312,141.40625 C337.515625,139.394531 329.734375,137 315.402344,136.347656 C299.898438,135.640625 295.25,135.488281 256,135.488281 C216.746094,135.488281 212.097656,135.636719 196.597656,136.34375 C182.265625,137 174.480469,139.394531 169.304688,141.40625 C162.917969,143.761719 157.140625,147.519531 152.402344,152.402344 C147.519531,157.144531 143.761719,162.917969 141.402344,169.304688 C139.390625,174.484375 136.996094,182.269531 136.34375,196.601562 C135.636719,212.101562 135.484375,216.75 135.484375,256.003906 C135.484375,295.253906 135.636719,299.902344 136.34375,315.40625 C136.996094,329.738281 139.390625,337.519531 141.402344,342.699219 C143.761719,349.085938 147.515625,354.859375 152.398438,359.601562 C157.140625,364.484375 162.914062,368.242188 169.300781,370.597656 C174.480469,372.613281 182.265625,375.007812 196.597656,375.660156 C212.097656,376.367188 216.742188,376.515625 255.996094,376.515625 C295.253906,376.515625 299.902344,376.367188 315.398438,375.660156 C329.730469,375.007812 337.515625,372.613281 342.695312,370.597656 C355.515625,365.652344 365.648438,355.519531 370.59375,342.699219 C372.605469,337.519531 375,329.738281 375.65625,315.40625 C376.363281,299.902344 376.511719,295.253906 376.511719,256.003906 C376.511719,216.75 376.363281,212.101562 375.65625,196.601562 C375.003906,182.269531 372.609375,174.484375 370.59375,169.304688 L370.59375,169.304688 Z M256,331.484375 C214.308594,331.484375 180.511719,297.691406 180.511719,256 C180.511719,214.308594 214.308594,180.515625 256,180.515625 C297.6875,180.515625 331.484375,214.308594 331.484375,256 C331.484375,297.691406 297.6875,331.484375 256,331.484375 Z M334.46875,195.171875 C324.726562,195.171875 316.828125,187.273438 316.828125,177.53125 C316.828125,167.789062 324.726562,159.890625 334.46875,159.890625 C344.210938,159.890625 352.109375,167.789062 352.109375,177.53125 C352.105469,187.273438 344.210938,195.171875 334.46875,195.171875 Z' id='Shape' /> <path d='M256,0 C114.636719,0 0,114.636719 0,256 C0,397.363281 114.636719,512 256,512 C397.363281,512 512,397.363281 512,256 C512,114.636719 397.363281,0 256,0 Z M402.113281,316.605469 C401.402344,332.253906 398.914062,342.9375 395.28125,352.289062 C387.644531,372.035156 372.035156,387.644531 352.289062,395.28125 C342.941406,398.914062 332.253906,401.398438 316.609375,402.113281 C300.933594,402.828125 295.925781,403 256.003906,403 C216.078125,403 211.074219,402.828125 195.394531,402.113281 C179.75,401.398438 169.0625,398.914062 159.714844,395.28125 C149.902344,391.589844 141.019531,385.804688 133.675781,378.324219 C126.199219,370.984375 120.414062,362.097656 116.722656,352.289062 C113.089844,342.941406 110.601562,332.253906 109.890625,316.609375 C109.167969,300.929688 109,295.921875 109,256 C109,216.078125 109.167969,211.070312 109.886719,195.394531 C110.597656,179.746094 113.082031,169.0625 116.714844,159.710938 C120.40625,149.902344 126.195312,141.015625 133.675781,133.675781 C141.015625,126.195312 149.902344,120.410156 159.710938,116.71875 C169.0625,113.085938 179.746094,110.601562 195.394531,109.886719 C211.070312,109.171875 216.078125,109 256,109 C295.921875,109 300.929688,109.171875 316.605469,109.890625 C332.253906,110.601562 342.9375,113.085938 352.289062,116.714844 C362.097656,120.40625 370.984375,126.195312 378.328125,133.675781 C385.804688,141.019531 391.59375,149.902344 395.28125,159.710938 C398.917969,169.0625 401.402344,179.746094 402.117188,195.394531 C402.832031,211.070312 403,216.078125 403,256 C403,295.921875 402.832031,300.929688 402.113281,316.605469 L402.113281,316.605469 Z' id='Shape' /> </g> </g> </svg> </p></a><a rel="noreferrer noopener" class="pr-1" target="_blank" href="/rss"><p><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svgjs="http://svgjs.com/svgjs" version="1.1" width="25px" height="25px" x="0" y="0" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512" xml:space="preserve"> <g> <path xmlns="http://www.w3.org/2000/svg" d="m437.019531 74.980469c-48.351562-48.351563-112.640625-74.980469-181.019531-74.980469s-132.667969 26.628906-181.019531 74.980469c-48.351563 48.351562-74.980469 112.640625-74.980469 181.019531s26.628906 132.667969 74.980469 181.019531c48.351562 48.351563 112.640625 74.980469 181.019531 74.980469s132.667969-26.628906 181.019531-74.980469c48.351563-48.351562 74.980469-112.640625 74.980469-181.019531s-26.628906-132.667969-74.980469-181.019531zm-267.757812 292.957031c-13.730469 0-24.90625-11.171875-24.90625-24.90625s11.175781-24.90625 24.90625-24.90625c13.734375 0 24.90625 11.171875 24.90625 24.90625s-11.171875 24.90625-24.90625 24.90625zm80.277343 4.925781c-8.28125 0-15-6.714843-15-15 0-44.171875-35.9375-80.109375-80.109374-80.109375-8.285157 0-15-6.71875-15-15 0-8.285156 6.714843-15 15-15 60.714843 0 110.109374 49.394532 110.109374 110.109375 0 8.285157-6.714843 15-15 15zm67.09375 0c-8.285156 0-15-6.714843-15-15 0-81.167969-66.035156-147.203125-147.203124-147.203125-8.285157 0-15-6.714844-15-15s6.714843-15 15-15c97.710937 0 177.203124 79.492188 177.203124 177.203125 0 8.285157-6.714843 15-15 15zm66.292969 0c-8.28125 0-15-6.714843-15-15 0-117.722656-95.773437-213.496093-213.496093-213.496093-8.285157 0-15-6.714844-15-15 0-8.285157 6.714843-15 15-15 65.039062 0 126.1875 25.328124 172.179687 71.316406 45.988281 45.992187 71.316406 107.140625 71.316406 172.179687 0 8.285157-6.714843 15-15 15zm0 0" fill="#ffffff" data-original="#000000" style=""/> </g> </svg></p></a></div><div class="text-footer-text-color text-xs"><p>© <!-- -->2024<!-- --> MJH Life Sciences<sup>®</sup> and<!-- --> <!-- -->AJMC®<!-- -->.<br/> All rights reserved.</p></div></div><div class="flex flex-row flex-wrap self-start w-[60%]"><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/about-us">About</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/contactus">Contact</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/editorial-boards">Editorial Boards</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/advertise">Advertise</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_blank" href="https://www.mjhlifesciences.com/ccpa?domain=www.ajmc.com">Do Not Sell My Information</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/terms">Terms &amp; Conditions</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/privacy">Privacy Policy</a></div></div><div class="flex items-start mr-6 lg:mr-10"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27251%27%20height=%2768%27/%3e"/></span><img alt="AJMC Managed Markets Network Logo" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="AJMC Managed Markets Network Logo" srcSet="/_next/image?url=%2FAJMC_MMN_logo_light.png&amp;w=256&amp;q=75 1x, /_next/image?url=%2FAJMC_MMN_logo_light.png&amp;w=640&amp;q=75 2x" src="/_next/image?url=%2FAJMC_MMN_logo_light.png&amp;w=640&amp;q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div></div></div></div><div class="w-[30%] bg-[#003767] flex items-center justify-center "><div class="flex flex-col justify-between "><a target="_self" rel="noopener noreferrer" class="my-2 px-8" href="/topic/center-on-health-equity-and-access"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27315%27%20height=%2777%27/%3e"/></span><img alt="CH Logo" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="CH Logo" srcSet="/_next/image?url=%2FCHA_Logo.png&amp;w=384&amp;q=75 1x, /_next/image?url=%2FCHA_Logo.png&amp;w=640&amp;q=75 2x" src="/_next/image?url=%2FCHA_Logo.png&amp;w=640&amp;q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></a><a target="_blank" rel="noopener noreferrer" class="my-2 px-8" href="https://www.centerforbiosimilars.com/"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27315%27%20height=%2777%27/%3e"/></span><img alt="Center for Biosimilars Logo" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Center for Biosimilars Logo" srcSet="/_next/image?url=%2FCB.png&amp;w=384&amp;q=75 1x, /_next/image?url=%2FCB.png&amp;w=640&amp;q=75 2x" src="/_next/image?url=%2FCB.png&amp;w=640&amp;q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></a></div></div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"pageProps":{},"cache":{"main_menu":[{"_id":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_updatedAt":"2020-04-14T13:26:21Z","subQuery":[{"children":[],"_updatedAt":"2020-04-14T13:30:35Z","name":"All News","is_active":true,"_rev":"sBk7YzjWMuBuhiatU3YIhQ","navParent":{"_ref":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_type":"reference"},"_createdAt":"2020-04-14T13:30:35Z","url":"/news","_type":"mainNavigation","_id":"1376963d-32e8-4647-bb5e-59c984e35893"},{"_rev":"QxOJBWa4XErmibN6Cb5OcA","_id":"2af5da5e-78c2-42c8-90b8-3900f8c89889","children":[],"name":"Press Releases","_updatedAt":"2020-04-14T13:30:57Z","_type":"mainNavigation","url":"/press-release","is_active":true,"navParent":{"_ref":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_type":"reference"},"_createdAt":"2020-04-14T13:30:57Z"},{"_id":"854a1ad1-9831-4387-bda9-ffb93a074ace","navParent":{"_ref":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_type":"reference"},"_rev":"jvOgZ3KZdbRHfWlt9ePmOA","children":[],"is_active":true,"_type":"mainNavigation","name":"Product Approvals and Launches","_updatedAt":"2022-01-07T20:44:44Z","url":"/approvals-launches","_createdAt":"2021-07-29T12:15:49Z"}],"name":"News","_rev":"Yw6MEKZDMdk6hC2JCRdGN7","_type":"mainNavigation","is_active":true,"_createdAt":"2020-04-14T13:26:14Z","navParent":null,"sortOrder":1},{"_updatedAt":"2024-05-24T16:36:15Z","_createdAt":"2020-04-14T13:26:30Z","sortOrder":2,"_rev":"rcwwj6TiN2Q0ymhqDzIFjO","_type":"mainNavigation","name":"Video","navParent":null,"is_active":true,"_id":"821e259a-db55-4862-985a-5cd089bbf894","subQuery":[{"_updatedAt":"2024-05-24T16:52:54Z","is_active":true,"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDzJ8ty","_type":"mainNavigation","name":"All Video Types","children":[],"url":"/video-hub","sortOrder":1,"_createdAt":"2024-05-24T16:37:06Z","_id":"f51d85fa-cabc-4c7d-85d0-11301088b7f6"},{"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_rev":"LJrwYxwtzLC9JsOYMk8TBr","_updatedAt":"2024-05-28T19:38:54Z","_id":"a99a3683-5173-46b3-94b0-21b7d6b06a24","_createdAt":"2024-05-24T16:38:14Z","_type":"mainNavigation","children":[],"url":"/interviews","name":"AJMC TV","is_active":true},{"_updatedAt":"2020-04-14T13:43:45Z","_type":"mainNavigation","children":[],"_rev":"Yw6MEKZDMdk6hC2JCRda8Z","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_id":"b03ccbf6-6387-48de-8edc-4f1f23debe40","is_active":true,"_createdAt":"2020-04-14T13:43:45Z","name":"Insights","url":"/insights"},{"_type":"mainNavigation","_id":"f3d69d10-636b-4927-8ff4-4f54fabc940a","navParent":{"_type":"reference","_ref":"821e259a-db55-4862-985a-5cd089bbf894"},"_updatedAt":"2020-04-14T13:44:19Z","children":[],"_createdAt":"2020-04-14T13:44:19Z","name":"OnLocation","is_active":true,"url":"/onlocation","_rev":"k6N5FycA5UhVnvpzSEa3Rp"},{"_rev":"37PW14Mg02p9z7FTF1SGE9","url":"/payer-perspectives","is_active":true,"_updatedAt":"2022-10-05T15:29:11Z","children":[],"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"name":"Payer Perspectives","_id":"d4e3d69c-8a07-4191-af89-27d7e838af08","_type":"mainNavigation","_createdAt":"2022-10-05T15:29:11Z"},{"name":"Peer Exchange","_updatedAt":"2020-04-14T13:44:43Z","url":"/peer-exchange","_createdAt":"2020-04-14T13:44:43Z","_id":"8f602f1e-1840-4c32-8cdb-9a26d6c0e873","is_active":true,"_rev":"VdTcsTJkAuZveXGf2i9Pes","children":[],"_type":"mainNavigation","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"}},{"_createdAt":"2024-05-24T18:27:43Z","_type":"mainNavigation","name":"Post Conference Perspectives","children":[],"_updatedAt":"2024-05-24T18:27:43Z","url":"/post-conference-perspectives","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHgA51N","_id":"0f532685-cd4c-4350-89cd-b8a388e6495b","is_active":true},{"_createdAt":"2020-12-01T22:43:10Z","_updatedAt":"2020-12-01T22:43:26Z","_type":"mainNavigation","name":"Stakeholder Summit","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_rev":"y3lsbm3yQTliOnC9CU5TiR","url":"/stakeholder-summit","children":[],"_id":"bbc55ff8-1532-475e-9f51-f9d5eb39e369","is_active":true}]},{"is_active":true,"sortOrder":3,"_rev":"rcwwj6TiN2Q0ymhqDzIUb7","url":"/podcasts","subQuery":[],"_id":"4939ee15-ae6f-4aba-8481-9ee27ce729d3","_updatedAt":"2024-05-24T16:41:18Z","_createdAt":"2024-05-24T16:40:58Z","_type":"mainNavigation","navParent":null,"name":"Podcasts"},{"_createdAt":"2020-04-14T13:27:01Z","subQuery":[{"name":"Conference Coverage","_updatedAt":"2020-08-21T22:11:23Z","_type":"mainNavigation","_id":"f45b532b-23e3-4b44-8d7f-2f3c13c9ae81","navParent":{"_ref":"6841664a-93f2-4f56-8760-836ec9c7b483","_type":"reference"},"sortOrder":1,"children":[],"is_active":true,"_createdAt":"2020-06-12T15:17:29Z","url":"/latest-conference","_rev":"pI9SawGKsTP14Lioy589Kx"},{"_id":"004461ae-46cb-45ef-916e-f03c6d99d6d3","navParent":{"_ref":"6841664a-93f2-4f56-8760-836ec9c7b483","_type":"reference"},"children":[],"url":"/conference","sortOrder":2,"_rev":"FxFuWbqTkFGbPWgBBSR6xp","_type":"mainNavigation","_updatedAt":"2020-06-12T15:19:26Z","name":"Conference Listing","is_active":true,"_createdAt":"2020-06-12T15:18:28Z"},{"_id":"a006d0df-0cc9-4386-abfb-b1931a3918d4","sortOrder":3,"_updatedAt":"2024-07-03T19:00:13Z","url":"/post-conference-perspectives","name":"Post Conference Perspectives","is_active":true,"navParent":{"_ref":"6841664a-93f2-4f56-8760-836ec9c7b483","_type":"reference"},"children":[],"_createdAt":"2024-07-03T19:00:13Z","_type":"mainNavigation","_rev":"ZU3dXbR1BZtBbbPuRGxz53"}],"name":"Conferences","_updatedAt":"2024-05-24T16:41:40Z","is_active":true,"sortOrder":4,"_rev":"rcwwj6TiN2Q0ymhqDzIVAU","navParent":null,"_type":"mainNavigation","_id":"6841664a-93f2-4f56-8760-836ec9c7b483"},{"_type":"mainNavigation","name":"Journals","_id":"94f13109-c3cc-47b5-bf49-96ed727c8150","_updatedAt":"2024-05-24T16:41:49Z","_createdAt":"2020-04-14T13:27:20Z","_rev":"uJbbwQWkLESsncBrcLL0hr","is_active":true,"sortOrder":5,"navParent":null,"subQuery":[{"url":"/publications","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDzIVyQ","children":[],"_createdAt":"2020-05-04T21:06:00Z","sortOrder":1,"_type":"mainNavigation","_id":"48193abd-ecf4-4c90-b0ae-984ca2be88c9","navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"name":"All Journals","_updatedAt":"2024-05-24T16:42:23Z"},{"sortOrder":2,"is_active":true,"navParent":{"_type":"reference","_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150"},"_createdAt":"2020-04-14T13:55:29Z","_updatedAt":"2024-05-24T16:42:39Z","children":[],"_rev":"rcwwj6TiN2Q0ymhqDzIWug","_type":"mainNavigation","name":"The American Journal of Managed Care","url":"/publications/issue","_id":"08081ddf-ffd8-4b17-a2ff-dfe6a0ac64a3"},{"navParent":{"_type":"reference","_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150"},"_createdAt":"2020-04-14T13:56:01Z","_rev":"4fso9RuTzczLhlxmnMQ1bu","_type":"mainNavigation","_id":"47782239-2714-4bd1-99e6-750443bd39ea","is_active":true,"name":"Population Health, Equity \u0026 Outcomes","_updatedAt":"2024-09-16T13:23:11Z","url":"/publications/ajac","children":[],"sortOrder":3},{"name":"Evidence-Based Oncology","is_active":true,"navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"_id":"b99cc54f-5801-46e9-bd20-e690623ed12c","_updatedAt":"2024-05-24T16:43:12Z","_createdAt":"2020-04-14T13:56:21Z","_type":"mainNavigation","sortOrder":4,"_rev":"uJbbwQWkLESsncBrcLL4uf","url":"/publications/evidence-based-oncology","children":[]},{"_id":"6e7e3485-ef8b-40e3-8320-3c434df6bbb5","url":"/supplement","_updatedAt":"2024-05-24T16:43:26Z","_createdAt":"2024-05-23T20:59:41Z","sortOrder":5,"is_active":true,"navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"children":[],"_rev":"rcwwj6TiN2Q0ymhqDzIY1L","_type":"mainNavigation","name":"About Supplements and Featured Publications"},{"_createdAt":"2020-04-14T13:56:51Z","url":"/publications/supplement","_rev":"uJbbwQWkLESsncBrcLL5w0","children":[],"is_active":true,"navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"sortOrder":6,"_type":"mainNavigation","name":"Supplements and Featured Publications Issues","_id":"a2112c87-8e92-4b64-b42d-3117117f67a3","_updatedAt":"2024-05-24T16:43:32Z"},{"url":"/submit-a-manuscript","navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"_createdAt":"2023-03-14T13:29:11Z","sortOrder":7,"_rev":"rcwwj6TiN2Q0ymhqDzIYDp","_id":"fa8c9edc-3d32-4e9e-b68b-47d5c15694a5","_updatedAt":"2024-05-24T16:43:38Z","_type":"mainNavigation","children":[],"is_active":true,"name":"Submit a Manuscript"}]},{"_createdAt":"2020-04-14T13:27:17Z","_id":"ad5c19be-040c-4ea8-b639-807f54c9a1aa","_updatedAt":"2020-05-08T20:03:10Z","url":"/events","_rev":"8ZvheBjSwe5Dc4gCmgsR0M","_type":"mainNavigation","is_active":true,"name":"Events","sortOrder":6,"navParent":null,"subQuery":[{"_updatedAt":"2024-05-24T18:26:23Z","_createdAt":"2024-05-24T16:44:43Z","_id":"de4fe195-3db9-4d12-842d-f26100fbea5b","url":"/ivbmevents","_rev":"Jz2W7keLhiw1UYkGHgA4Yf","name":"Institute for Value-Based Medicine","navParent":{"_ref":"ad5c19be-040c-4ea8-b639-807f54c9a1aa","_type":"reference"},"_type":"mainNavigation","is_active":true,"children":[]},{"_createdAt":"2024-05-24T16:45:02Z","_rev":"Jz2W7keLhiw1UYkGHgA4eP","_type":"mainNavigation","url":"https://pcoc.ajmc.com/","navParent":{"_ref":"ad5c19be-040c-4ea8-b639-807f54c9a1aa","_type":"reference"},"name":"Patient-Centered Oncology Care","_id":"dddfc37d-8958-4e0a-91e3-0634bb6502a3","is_active":true,"_updatedAt":"2024-05-24T18:26:42Z","children":[]}]},{"_updatedAt":"2024-05-24T16:45:37Z","is_active":true,"_createdAt":"2020-04-14T13:29:34Z","subQuery":[{"sortOrder":1,"_type":"mainNavigation","children":[],"name":"Interactive Tools","_id":"4a08b5fc-379c-4952-bec1-0d9dacb11170","_updatedAt":"2024-05-24T16:46:13Z","is_active":true,"_createdAt":"2020-04-14T13:51:39Z","navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"url":"/interactive-tools","_rev":"rcwwj6TiN2Q0ymhqDzIfXP"},{"name":"Clinical Spotlight","children":[],"_updatedAt":"2024-05-23T20:32:07Z","is_active":true,"navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyFVrf","_type":"mainNavigation","_createdAt":"2020-10-16T13:03:47Z","_id":"43960f88-0c8d-404b-b9d9-d90432c2c516","url":"/clinical-spotlight"},{"_createdAt":"2024-05-24T16:46:44Z","children":[],"_updatedAt":"2024-05-24T16:46:44Z","url":"/custom-email","navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"_type":"mainNavigation","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDzIhDR","name":"Microsites","_id":"38aa3af0-8a34-4ae6-898c-37214580d384"},{"_type":"mainNavigation","_id":"d0b0683f-18e1-4e75-89fd-fb4e578a562f","_updatedAt":"2024-05-24T16:47:05Z","url":"/sponsored","_createdAt":"2024-05-24T16:47:05Z","navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"name":"Sponsored Content","_rev":"rcwwj6TiN2Q0ymhqDzIiDr","children":[],"is_active":true}],"_rev":"rcwwj6TiN2Q0ymhqDzIdco","name":"Resources","sortOrder":7,"navParent":null,"_type":"mainNavigation","_id":"86b03e38-f3d2-41d1-89e7-c3175c571a55"},{"name":"CE","_createdAt":"2020-04-14T14:00:08Z","_id":"621fccf5-dcdb-40a9-af70-9bf3ccf79278","is_active":true,"_type":"mainNavigation","sortOrder":8,"_rev":"LtkInV1jlQdtEIFjVpi9sG","_updatedAt":"2024-08-27T15:31:04Z","url":"/continuing-education","navParent":null,"subQuery":[]},{"navParent":null,"subQuery":[{"_updatedAt":"2024-05-24T19:05:57Z","_type":"mainNavigation","_rev":"Jz2W7keLhiw1UYkGHgBp6D","url":"/editorial","children":[],"_id":"be637b3b-f72a-4049-91b8-409809b2d815","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"},"_createdAt":"2024-05-24T19:05:57Z","name":"AJMC Staff","is_active":true},{"_rev":"rcwwj6TiN2Q0ymhqDzIn5Y","children":[],"_type":"mainNavigation","is_active":true,"_createdAt":"2024-05-24T16:48:30Z","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"},"_id":"5298152f-5135-4c2c-a46e-a14ad0300bf4","url":"/anniversary","name":"Anniversary","_updatedAt":"2024-05-24T16:48:30Z"},{"_updatedAt":"2024-07-23T13:38:48Z","is_active":true,"_rev":"AGf4LvcO2r7q1La1cjR7dD","url":"/about/seema-sonnad-nomination","name":"Seema Sonnad Award","_id":"28d33143-d9a9-45bd-af63-bed8d2198118","_createdAt":"2024-05-24T18:24:23Z","children":[],"_type":"mainNavigation","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"}},{"name":"Strategic Alliance Partners","_rev":"uJbbwQWkLESsncBrcLLVEZ","_createdAt":"2024-05-24T16:49:00Z","_id":"acb7dc53-dfab-462a-b2e9-b0cfc8675da4","_updatedAt":"2024-05-24T16:49:00Z","is_active":true,"children":[],"_type":"mainNavigation","url":"/partners","navParent":{"_type":"reference","_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352"}}],"name":"About AJMC","_createdAt":"2024-05-24T16:48:11Z","_updatedAt":"2024-05-24T16:48:11Z","is_active":true,"sortOrder":9,"_rev":"rcwwj6TiN2Q0ymhqDzIlc0","_type":"mainNavigation","_id":"c14e4637-909c-4bf6-bf81-64eeb6005352"},{"name":"Subscribe","_updatedAt":"2024-03-11T14:58:15Z","_id":"1e279576-0b33-4e57-8782-b6b1edbf68da","navParent":null,"is_active":true,"_type":"mainNavigation","_rev":"gFXie0Ldruy1o91XppbLLd","url":"https://one.ajmc.com/subscribe","blank":true,"subQuery":[],"_createdAt":"2020-06-22T20:56:33Z","sortOrder":9}],"sub_menu":[{"url":"/compendium","_createdAt":"2020-04-14T14:04:25Z","navParent":null,"_type":"subNavigation","_id":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_updatedAt":"2024-05-24T05:08:37Z","name":"Specialty Area","subQuery":[{"is_active":true,"_id":"aa3904f3-c0d8-495d-a77f-afcc41f27045","_updatedAt":"2024-05-24T05:06:44Z","url":"/compendium/biosimilars","name":"Biosimilars","_type":"subNavigation","_createdAt":"2024-05-24T05:06:44Z","_rev":"Jz2W7keLhiw1UYkGHfbM3A","children":[],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"}},{"_createdAt":"2024-05-24T05:30:27Z","children":[{"url":"/compendium/cardiovascular","is_active":true,"_rev":"Jz2W7keLhiw1UYkGHfbquf","_id":"c3566f20-e7c6-4b38-bf9f-7d52055698b1","name":"Cardiovascular","_updatedAt":"2024-05-24T05:30:54Z","navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_createdAt":"2024-05-24T05:30:54Z","_type":"subNavigation"},{"_createdAt":"2024-05-24T05:32:42Z","_type":"subNavigation","_updatedAt":"2024-05-24T05:32:42Z","url":"/compendium/ckd","is_active":true,"navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbumO","name":"Chronic Kidney Disease","_id":"f3a69e16-dc38-4135-886e-d70e18532bf4"},{"_id":"79c02dc8-3c2d-451b-9797-008b25d61d4d","_updatedAt":"2024-05-24T05:31:14Z","is_active":true,"navParent":{"_type":"reference","_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab"},"_type":"subNavigation","name":"Diabetes","_createdAt":"2024-05-24T05:31:14Z","_rev":"Jz2W7keLhiw1UYkGHfbrEl","url":"/compendium/diabetes"},{"is_active":true,"navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbrQF","_type":"subNavigation","name":"Heart Failure","_updatedAt":"2024-05-24T05:31:38Z","url":"/compendium/heart-failure","_createdAt":"2024-05-24T05:31:38Z","_id":"84c7dd54-fb21-4bc5-86bc-9bbf39a7f836"},{"name":"Type 1 Diabetes","_id":"aadd9bdc-4dd1-4ac1-be4f-2afb4315b6cb","_createdAt":"2024-05-24T05:32:00Z","_rev":"Jz2W7keLhiw1UYkGHfbsbS","_type":"subNavigation","url":"/compendium/type1diabetes","is_active":true,"navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_updatedAt":"2024-05-24T05:32:00Z"}],"_updatedAt":"2024-06-11T20:17:38Z","is_active":true,"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"name":"Cardiorenalmetabolic","_id":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_rev":"G7uWgc8ggxb5zBvm8zNQqB","_type":"subNavigation"},{"_rev":"Jz2W7keLhiw1UYkGHfbSVf","_id":"7599f50b-36ff-42a5-8d72-82814db9b988","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"name":"Dermatology","is_active":true,"_updatedAt":"2024-05-24T05:10:35Z","url":"/compendium/dermatology","children":[{"is_active":true,"navParent":{"_ref":"7599f50b-36ff-42a5-8d72-82814db9b988","_type":"reference"},"_createdAt":"2024-05-23T21:42:49Z","_type":"subNavigation","_rev":"Jz2W7keLhiw1UYkGHfbTPe","name":"Alopecia","_id":"04523862-a8a1-4626-b288-95b3d4114267","_updatedAt":"2024-05-24T05:12:43Z","url":"/compendium/alopecia"},{"_createdAt":"2024-05-24T05:12:02Z","_type":"subNavigation","name":"Atopic Dermatitis","_id":"637a0b1e-1b12-42bf-81a3-e6db5a997021","is_active":true,"navParent":{"_ref":"7599f50b-36ff-42a5-8d72-82814db9b988","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbSvV","_updatedAt":"2024-05-24T05:12:02Z","url":"/compendium/atopic-dermatitis"},{"is_active":true,"_createdAt":"2024-05-24T05:12:30Z","_rev":"Jz2W7keLhiw1UYkGHfbTJu","_type":"subNavigation","name":"Psoriasis","_id":"a9dcce80-4f29-488e-b7ef-51f0fb562a5a","navParent":{"_ref":"7599f50b-36ff-42a5-8d72-82814db9b988","_type":"reference"},"_updatedAt":"2024-05-24T05:12:36Z","url":"/compendium/psoriasis"}],"_createdAt":"2024-05-24T05:10:35Z","_type":"subNavigation"},{"children":[{"_updatedAt":"2024-05-29T15:28:26Z","is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-29T15:28:26Z","_rev":"Iat2IZiT321TmGHwkF66wB","_type":"subNavigation","name":"ALL/AML","_id":"d79f2b30-e7f2-4915-bef8-1a73a9190a91","url":"/compendium/all"},{"name":"CLL/SLL","url":"/compendium/cll","navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-29T15:26:57Z","_rev":"Iat2IZiT321TmGHwkF65Md","_type":"subNavigation","_id":"664a6ece-64dd-41f8-87a0-7f5a47323c3b","_updatedAt":"2024-05-29T15:27:46Z","is_active":true},{"is_active":true,"_createdAt":"2024-05-29T15:28:51Z","name":"GVHD","_id":"32cf626c-1ce6-4fb5-9dd7-088522dc46e6","navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_rev":"Iat2IZiT321TmGHwkF67tn","_type":"subNavigation","_updatedAt":"2024-05-29T15:28:51Z","url":"/compendium/gvhd"},{"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_id":"4dd2ce64-8f4d-4285-bc1a-ec40ffc99b51","_updatedAt":"2024-05-24T05:14:15Z","url":"/compendium/hemophilia","is_active":true,"_rev":"Jz2W7keLhiw1UYkGHfbUDt","_type":"subNavigation","name":"Hemophilia","_createdAt":"2024-05-24T05:14:15Z"},{"is_active":true,"navParent":{"_type":"reference","_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4"},"_createdAt":"2024-05-24T05:45:17Z","name":"Multiple Myeloma","_id":"84e2d674-0fe1-4bd1-9d97-2f8bc8589ba0","url":"/compendium/multiple-myeloma","_rev":"Iat2IZiT321TmGHwkF6NtX","_type":"subNavigation","_updatedAt":"2024-05-29T15:35:07Z"},{"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_rev":"Iat2IZiT321TmGHwkF6a5X","name":"Myelodysplastic Syndromes","_updatedAt":"2024-05-29T15:35:22Z","url":"/compendium/myelodysplastic-syndromes","is_active":true,"_type":"subNavigation","_id":"3a327f90-a5fc-4d87-9a18-02f54cb40b8e","_createdAt":"2024-05-24T05:45:36Z"},{"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-29T15:29:21Z","_rev":"Up1TL5YPo1fhI8V2tpNnMb","_type":"subNavigation","is_active":true,"name":"Myeloproliferative Neoplasms","_id":"a6003c4f-e7f0-422a-8129-49a2d78eb113","_updatedAt":"2024-06-05T20:02:27Z","url":"/compendium/mpn"},{"_createdAt":"2024-05-24T05:43:54Z","name":"Non-Hodgkin Lymphoma","url":"/compendium/nhl","_updatedAt":"2024-06-25T17:42:12Z","is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_rev":"rmdpbbz4U7GL9ExaGp96DY","_type":"subNavigation","_id":"fc247a6b-0b33-4e18-ae78-56e677c6bb18"},{"_rev":"Jz2W7keLhiw1UYkGHfbUPN","name":"Rare Blood","_updatedAt":"2024-05-24T05:14:40Z","url":"/compendium/rareblood","is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-24T05:14:40Z","_type":"subNavigation","_id":"85e2fc3e-ac5c-4b47-8b14-411d730d20d9"}],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","is_active":true,"_rev":"Jz2W7keLhiw1UYkGHfbU3q","name":"Hematology","_type":"subNavigation","_updatedAt":"2024-05-24T05:13:48Z","url":"/compendium/hematology","_createdAt":"2024-05-24T05:13:48Z"},{"_rev":"N7mKycgLbGtEq6btkLqjkf","name":"Hepatology","_updatedAt":"2024-06-11T20:17:54Z","is_active":true,"_createdAt":"2024-05-24T05:34:29Z","_type":"subNavigation","_id":"a96e7dbc-b037-41f4-bd5e-d96abf8f3c7d","children":[{"is_active":true,"navParent":{"_ref":"a96e7dbc-b037-41f4-bd5e-d96abf8f3c7d","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbwkP","_type":"subNavigation","name":"Liver","url":"/compendium/liver-cancer","_createdAt":"2024-05-24T05:34:54Z","_id":"2aefee8c-db97-4e7d-b600-efb48e6bcb6c","_updatedAt":"2024-05-24T05:34:54Z"}],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"}},{"_createdAt":"2024-05-24T05:23:19Z","_id":"1b1e3727-8b82-42da-9a62-b20472b9c797","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbkam","children":[{"_type":"subNavigation","name":"Autoimmune","_id":"b3daefd0-0ac3-4be2-ad23-f9c3fa37cf37","url":"/compendium/autoimmune","_createdAt":"2024-05-24T05:23:39Z","navParent":{"_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbkp8","_updatedAt":"2024-05-24T05:23:39Z","is_active":true},{"is_active":true,"_createdAt":"2024-05-24T05:23:59Z","_type":"subNavigation","name":"Inflammation","url":"/compendium/Inflammation","navParent":{"_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbkzB","_id":"6016d41d-9d43-49fa-99b6-7caca304f30d","_updatedAt":"2024-05-24T05:23:59Z"},{"_id":"b537fcea-aea3-40ca-83c1-0907fdc9ccb5","_updatedAt":"2024-05-24T05:24:47Z","url":"/compendium/lupus","navParent":{"_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbmd6","name":"Lupus","is_active":true,"_createdAt":"2024-05-24T05:24:47Z","_type":"subNavigation"},{"_updatedAt":"2024-05-24T05:25:23Z","_createdAt":"2024-05-24T05:25:23Z","_type":"subNavigation","_id":"ef6c4efc-5932-4148-b626-cbf42e1c49c3","name":"Myasthenia Gravis","url":"/compendium/myasthenia-gravis","is_active":true,"navParent":{"_type":"reference","_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797"},"_rev":"Jz2W7keLhiw1UYkGHfbn7F"}],"_updatedAt":"2024-05-24T05:23:19Z","url":"/compendium/immunology","is_active":true,"_type":"subNavigation","name":"Immunology"},{"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfcA9Y","_type":"subNavigation","name":"Infectious Disease","url":"/compendium/infectious-disease","is_active":true,"children":[{"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_createdAt":"2024-05-24T05:36:03Z","_rev":"rcwwj6TiN2Q0ymhqDyeyP3","_updatedAt":"2024-05-24T05:36:03Z","url":"/compendium/covid-19","is_active":true,"_type":"subNavigation","name":"COVID-19","_id":"ffcd30d0-169f-4a8f-9f01-616142f33712"},{"_createdAt":"2024-05-24T05:36:22Z","_rev":"Jz2W7keLhiw1UYkGHfcAxn","_type":"subNavigation","name":"HIV","_updatedAt":"2024-05-24T05:36:29Z","url":"/compendium/hiv","is_active":true,"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_id":"a53004c6-9fe2-4b9c-a86a-ad74f9204b3a"},{"is_active":true,"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_createdAt":"2024-05-24T05:37:06Z","_updatedAt":"2024-05-24T05:37:06Z","_rev":"rcwwj6TiN2Q0ymhqDyezNO","_type":"subNavigation","name":"RSV","_id":"ca70e9ab-a981-4629-a766-81f7890b3977","url":"/compendium/rsv"},{"name":"Vaccines","_updatedAt":"2024-05-24T05:37:53Z","is_active":true,"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_createdAt":"2024-05-24T05:37:53Z","_rev":"Jz2W7keLhiw1UYkGHfcFFM","_type":"subNavigation","_id":"a0ec0591-b4a1-4723-b984-b681c957523f","url":"/compendium/vaccines"}],"_id":"b62af616-818b-4bda-b606-bd64287f9a85","_createdAt":"2024-05-24T05:35:38Z","_updatedAt":"2024-05-24T05:35:38Z"},{"_rev":"rcwwj6TiN2Q0ymhqDyf4PU","_type":"subNavigation","_updatedAt":"2024-05-24T05:38:33Z","is_active":true,"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"db67ff69-2c58-4931-ad3d-767a636e38b0","_createdAt":"2024-05-24T05:38:33Z","name":"Mental Health","children":[{"name":"Major Depressive Disorder","url":"/compendium/mdd","navParent":{"_ref":"db67ff69-2c58-4931-ad3d-767a636e38b0","_type":"reference"},"_createdAt":"2024-05-24T05:38:58Z","_rev":"rcwwj6TiN2Q0ymhqDyf7Qk","_updatedAt":"2024-05-24T05:38:58Z","is_active":true,"_type":"subNavigation","_id":"efcab5a8-97d8-4f5a-ba99-0a0555531f5a"},{"name":"Sleep","url":"/compendium/sleep","is_active":true,"navParent":{"_ref":"db67ff69-2c58-4931-ad3d-767a636e38b0","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyf96m","_type":"subNavigation","_createdAt":"2024-05-24T05:39:18Z","_id":"f52dbfa9-aefe-4d21-b432-7052a136ae98","_updatedAt":"2024-05-24T05:39:18Z"}],"url":"/compendium/mental-health"},{"_type":"subNavigation","name":"Neurology","_updatedAt":"2024-06-11T20:18:36Z","_createdAt":"2024-05-24T05:39:38Z","_rev":"G7uWgc8ggxb5zBvm8zNRmt","is_active":true,"children":[{"is_active":true,"_createdAt":"2024-05-24T05:40:18Z","_updatedAt":"2024-05-24T05:40:18Z","navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyfERb","_type":"subNavigation","name":"Duchenne Muscular Dystrophy","_id":"3e24f5af-027e-4f0b-a7e2-a3ffaf756a35","url":"/compendium/dmd"},{"navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_createdAt":"2024-05-24T05:40:30Z","_rev":"rcwwj6TiN2Q0ymhqDyfIhq","name":"Epilepsy","_id":"d4e270df-2a59-4109-a7be-9c10f80722a7","is_active":true,"_type":"subNavigation","_updatedAt":"2024-05-24T05:40:38Z","url":"/compendium/epilepsy"},{"_createdAt":"2024-05-24T05:41:07Z","_rev":"rcwwj6TiN2Q0ymhqDyfJRc","_updatedAt":"2024-05-24T05:41:07Z","is_active":true,"navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_type":"subNavigation","name":"Multiple Sclerosis","_id":"7539f9b5-8f2a-4e1b-a10f-8cc748cd1489","url":"/compendium/multiple-sclerosis"},{"is_active":true,"_createdAt":"2024-05-24T05:41:29Z","_type":"subNavigation","_id":"90ebd8e7-e6d1-4128-8010-0b205fedb430","navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyfJiG","name":"Parkinson Disease","_updatedAt":"2024-05-24T05:41:29Z","url":"/compendium/parkinson"}],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"bafe1c52-a8b5-4786-bcee-668409d14a11"},{"_type":"subNavigation","_id":"fe48de19-78d2-4ed0-83fa-8884fb340de2","children":[],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"url":"/compendium/obesity","is_active":true,"_rev":"B2kOGngERQtEUh1WG5WXvd","name":"Obesity","_updatedAt":"2024-09-04T14:25:34Z","_createdAt":"2024-09-04T14:25:34Z"},{"name":"Oncology","_updatedAt":"2024-05-24T05:41:55Z","_rev":"rcwwj6TiN2Q0ymhqDyfKov","_id":"90b398eb-3349-4b6a-b205-780a34cb4717","children":[{"url":"/compendium/breast-cancer","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyfMpl","_id":"03ea9371-55cd-42e2-b300-7078b94ff467","name":"Breast Cancer","_updatedAt":"2024-05-24T05:42:17Z","is_active":true,"_createdAt":"2024-05-24T05:42:17Z","_type":"subNavigation"},{"_createdAt":"2024-05-24T05:42:35Z","_rev":"rcwwj6TiN2Q0ymhqDyfatY","_type":"subNavigation","_id":"8b57fc91-4191-420c-a224-cb869f8fa0d7","_updatedAt":"2024-05-24T05:42:35Z","is_active":true,"name":"Cholangiocarcinoma","url":"/compendium/cholangiocarcinoma","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"}},{"name":"Colorectal Cancer","_id":"e45ff858-e1bc-4b4a-9398-e12877b61607","_updatedAt":"2024-05-24T05:43:23Z","url":"/compendium/colorectal-cancer","is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_type":"subNavigation","_createdAt":"2024-05-24T05:43:23Z","_rev":"Jz2W7keLhiw1UYkGHfcTh6"},{"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:44:17Z","_type":"subNavigation","_id":"289f747b-dffd-4006-a27d-4933a46fd7c1","_updatedAt":"2024-05-24T13:25:09Z","url":"/compendium/immuno-oncology","is_active":true,"_rev":"Jz2W7keLhiw1UYkGHfsKT5","name":"Immuno-Oncology"},{"url":"/compendium/liver-cancer","is_active":true,"_createdAt":"2024-05-29T15:32:02Z","_rev":"Iat2IZiT321TmGHwkF6F4B","_id":"9d17bccc-3f33-4793-90e3-0adecfa71fa1","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_type":"subNavigation","name":"Liver Cancer","_updatedAt":"2024-05-29T15:32:02Z"},{"_updatedAt":"2024-05-24T05:44:58Z","url":"/compendium/lung-cancer","is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:44:58Z","_type":"subNavigation","_id":"89f99f56-72a9-4dcd-9d8c-3d717d66a5f0","_rev":"rcwwj6TiN2Q0ymhqDyfff0","name":"Lung Cancer"},{"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:45:56Z","_rev":"Jz2W7keLhiw1UYkGHfsIwL","_type":"subNavigation","_updatedAt":"2024-05-24T13:24:22Z","is_active":true,"name":"Non–Small Cell Lung Cancer","_id":"85d30c37-d6a1-4028-9c0f-ecdf36de220d","url":"/compendium/nsclc"},{"_createdAt":"2024-05-24T05:46:17Z","_type":"subNavigation","name":"Ovarian Cancer","is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfcbF4","_id":"5a67adcb-11d8-48a6-8c39-b2956f5f3e86","_updatedAt":"2024-05-24T05:46:17Z","url":"/compendium/ovarian-cancer"},{"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:47:42Z","_updatedAt":"2024-05-24T05:47:42Z","_id":"bcfe0d88-7498-4268-95e6-875c94a2dab5","url":"/compendium/prostate-cancer","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDyfmoB","_type":"subNavigation","name":"Prostate Cancer"},{"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_type":"subNavigation","name":"Skin Cancer","_updatedAt":"2024-05-24T05:48:18Z","is_active":true,"_createdAt":"2024-05-24T05:48:18Z","_rev":"rcwwj6TiN2Q0ymhqDyfpKE","_id":"a3a04e72-c707-450d-b9d3-f9ebacc9f997","url":"/compendium/skincancer"},{"is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-29T15:30:06Z","_type":"subNavigation","name":"Soft Tissue Sarcoma","_id":"6d1dc4b4-1be8-41ee-9bba-90ad4ce546b3","_rev":"Iat2IZiT321TmGHwkF69Qd","_updatedAt":"2024-05-29T15:30:06Z","url":"/compendium/soft-tissue-sarcoma"}],"is_active":true,"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"url":"/compendium/oncology","_createdAt":"2024-05-24T05:41:55Z","_type":"subNavigation"},{"_rev":"Jz2W7keLhiw1UYkGHfcePj","is_active":true,"_createdAt":"2024-05-24T05:48:54Z","name":"Ophthalmology","_updatedAt":"2024-05-24T05:48:54Z","url":"/compendium/ophthalmology","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_type":"subNavigation","_id":"eee19078-eb50-46e7-a97c-8f16d79eea97","children":[]},{"_type":"subNavigation","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"name":"Pulmonology","_id":"e6c5e55f-7a5a-4f23-add2-fbf91df76400","_updatedAt":"2024-06-03T20:54:07Z","is_active":true,"_createdAt":"2024-05-24T05:49:11Z","_rev":"5DUHcaiKRKj5c8wHOPlDws","children":[{"_type":"subNavigation","_updatedAt":"2024-05-24T05:49:28Z","navParent":{"_ref":"e6c5e55f-7a5a-4f23-add2-fbf91df76400","_type":"reference"},"_createdAt":"2024-05-24T05:49:28Z","name":"COPD","_id":"3a19d535-d61e-43b1-bf6a-d6ced486a0b9","url":"/compendium/copd","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDyfrwW"},{"is_active":true,"navParent":{"_ref":"e6c5e55f-7a5a-4f23-add2-fbf91df76400","_type":"reference"},"_createdAt":"2024-05-24T05:49:52Z","_rev":"rcwwj6TiN2Q0ymhqDyfuBv","name":"Pulmonary Arterial Hypertension","_id":"474080cd-4295-4a70-907d-e1fc93c435cc","url":"/compendium/pah","_type":"subNavigation","_updatedAt":"2024-05-24T05:49:52Z"}]},{"_createdAt":"2024-05-24T05:50:50Z","_id":"de690920-3cdc-4c43-a27e-ba4e38a62059","name":"Rare Disease","url":"/compendium/raredisease","children":[{"navParent":{"_ref":"de690920-3cdc-4c43-a27e-ba4e38a62059","_type":"reference"},"_createdAt":"2024-05-24T05:51:19Z","_rev":"rcwwj6TiN2Q0ymhqDyg1k4","_updatedAt":"2024-05-24T05:51:19Z","is_active":true,"_type":"subNavigation","name":"Spinal Muscular Atrophy","_id":"9e780f76-2008-441b-ab5f-00d3a6d1a5b0","url":"/compendium/sma"}],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyg1Ah","_updatedAt":"2024-05-24T05:50:50Z","is_active":true,"_type":"subNavigation"},{"_type":"subNavigation","url":"/compendium/respiratory","is_active":true,"name":"Respiratory","_createdAt":"2024-05-24T05:50:22Z","_rev":"Jz2W7keLhiw1UYkGHfcjSf","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"f2a34114-0396-44cb-b241-11ef7b175500","_updatedAt":"2024-05-24T05:50:22Z","children":[{"is_active":true,"_updatedAt":"2024-05-24T05:52:02Z","_rev":"rcwwj6TiN2Q0ymhqDyg2wy","_type":"subNavigation","name":"Asthma","_id":"b2b2802f-2918-4431-8f4f-3bc7e6e6042f","url":"/compendium/asthma","navParent":{"_type":"reference","_ref":"f2a34114-0396-44cb-b241-11ef7b175500"},"_createdAt":"2024-05-24T05:52:02Z"},{"_type":"subNavigation","_id":"4dac47d5-8dd1-4e90-b4be-b6b5e605f6f5","is_active":true,"_createdAt":"2024-06-03T18:31:07Z","name":"Idiopathic Pulmonary Fibrosis","_updatedAt":"2024-06-03T18:31:07Z","url":"/compendium/ipf","navParent":{"_ref":"f2a34114-0396-44cb-b241-11ef7b175500","_type":"reference"},"_rev":"5DUHcaiKRKj5c8wHOPKtuf"}]},{"url":"/compendium/rheumatology","_createdAt":"2024-05-24T05:52:28Z","_rev":"Jz2W7keLhiw1UYkGHfcm6J","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"name":"Rheumatology","children":[],"_id":"3ecb2952-6710-46b1-ab05-36997bfb4a33","_updatedAt":"2024-05-24T05:52:28Z","is_active":true,"_type":"subNavigation"},{"url":"/compendium/womens-health","_createdAt":"2024-05-24T05:52:51Z","_type":"subNavigation","name":"Women's Health","children":[],"_updatedAt":"2024-05-24T05:52:51Z","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfcmDU","_id":"ead467ba-7c17-4a1b-9deb-a7af56a7366e","is_active":true}],"is_active":true,"sortOrder":1,"_rev":"Jz2W7keLhiw1UYkGHfbRHa"},{"_updatedAt":"2024-05-23T21:04:52Z","_rev":"rcwwj6TiN2Q0ymhqDyHDJ3","name":"Spotlight","_id":"db56b0e2-ad58-4407-aff2-5c27cb3145c1","navParent":null,"is_active":true,"_createdAt":"2024-05-23T20:47:34Z","sortOrder":2,"_type":"subNavigation","subQuery":[{"name":"Free In-Person Regional Events Focused on Oncology and Population Health","_id":"f5b2c97b-d6d4-468b-8a9a-4814364994c8","is_active":true,"navParent":{"_ref":"db56b0e2-ad58-4407-aff2-5c27cb3145c1","_type":"reference"},"_createdAt":"2024-05-23T21:04:56Z","_type":"subNavigation","_rev":"uJbbwQWkLESsncBrcJSd1N","_updatedAt":"2024-05-23T21:05:49Z","url":"/ivbmevents?display=home","children":[]}]},{"sortOrder":2,"subQuery":[{"_id":"43207521-4e5f-42d2-b013-34763a4d964c","_updatedAt":"2024-05-24T05:05:19Z","url":"/compendium/biosimilars","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbHQ4","sortOrder":1,"name":"Biosimilars","is_active":true,"_createdAt":"2024-05-24T05:05:19Z","_type":"subNavigation","children":[]},{"_updatedAt":"2024-06-12T13:58:35Z","_createdAt":"2022-12-23T21:04:41Z","_rev":"N7mKycgLbGtEq6btkPIW3d","url":"/topic/center-on-health-equity-and-access","name":"Center on Health Equity \u0026 Access","_id":"4161ff97-2901-4526-80ee-3749b6dc6345","is_active":true,"_type":"subNavigation","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"children":[]},{"_createdAt":"2024-05-24T05:56:42Z","name":"Digital Health","is_active":true,"_id":"232e30a0-2f7d-4ce1-9e4d-cc0cee73b20a","_updatedAt":"2024-05-24T05:56:42Z","children":[],"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDygl51","_type":"subNavigation","url":"/compendium/digital-health"},{"name":"Formulary","_id":"3887cee2-5461-4cb3-b54f-297fcceb11ee","navParent":{"_type":"reference","_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},"is_active":true,"_updatedAt":"2024-05-24T05:57:01Z","url":"/formulary","_createdAt":"2024-05-24T05:57:01Z","_rev":"Jz2W7keLhiw1UYkGHfdAmX","_type":"subNavigation","children":[]},{"_createdAt":"2024-05-24T05:57:41Z","url":"/compendium/gene-therapy","_id":"56aff93b-4f24-48fc-9dda-2d394397f956","_rev":"rcwwj6TiN2Q0ymhqDygmDl","name":"Gene Therapy","_updatedAt":"2024-05-24T05:57:41Z","is_active":true,"children":[],"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_type":"subNavigation"},{"_createdAt":"2024-05-24T06:00:55Z","_rev":"rcwwj6TiN2Q0ymhqDygv9D","_updatedAt":"2024-05-24T06:00:55Z","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_id":"69723346-76b2-4896-b2d9-2db53ed5da96","url":"/guidelines","_type":"subNavigation","children":[],"is_active":true,"name":"Guidelines"},{"_createdAt":"2024-05-24T13:53:24Z","_id":"cd6edcff-faa3-4bee-9071-042f8186052d","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_type":"subNavigation","name":"Health Care Administration","_updatedAt":"2024-05-24T14:10:39Z","url":"/","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDz7eaC","children":[{"name":"Employers","_id":"83fca4ec-4ff0-4766-9e49-0376d44179e8","_updatedAt":"2024-05-24T13:53:42Z","_rev":"rcwwj6TiN2Q0ymhqDz6EMB","_type":"subNavigation","_createdAt":"2024-05-24T05:58:26Z","url":"/compendium/employers","is_active":true,"navParent":{"_ref":"cd6edcff-faa3-4bee-9071-042f8186052d","_type":"reference"}},{"navParent":{"_ref":"cd6edcff-faa3-4bee-9071-042f8186052d","_type":"reference"},"_createdAt":"2024-05-24T05:58:44Z","name":"Medicare","_id":"5647b438-aca9-4b57-9d4d-2df660b5a6ce","_updatedAt":"2024-05-24T13:53:53Z","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDz6F3s","_type":"subNavigation","url":"/compendium/medicare"},{"navParent":{"_ref":"cd6edcff-faa3-4bee-9071-042f8186052d","_type":"reference"},"_type":"subNavigation","url":"/compendium/reimbursement","_id":"2c8ff713-9c43-4afc-aaca-e33ceb98f00c","_updatedAt":"2024-05-24T13:54:23Z","is_active":true,"_createdAt":"2024-05-24T05:59:16Z","_rev":"rcwwj6TiN2Q0ymhqDz6G8S","name":"Reimbursement"}]},{"_createdAt":"2020-04-14T14:06:29Z","name":"Health Care Cost","_id":"c9a8f6fd-0ad0-4a82-a385-13c03fe688d0","_rev":"wx7I38TXtYeZdHCfn60Syn","_type":"subNavigation","is_active":true,"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"children":[],"_updatedAt":"2021-02-25T17:30:59Z","url":"/topic/healthcare-cost"},{"name":"Health Care Delivery","_updatedAt":"2021-02-25T17:29:58Z","url":"/topic/healthcare-delivery","is_active":true,"_createdAt":"2020-04-14T14:06:43Z","_id":"d01b9875-6e51-42d1-bdf5-93fd8771855c","children":[],"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_type":"subNavigation","_rev":"YN5IiYQkhJ3hq0R7jM8DQW"},{"_updatedAt":"2022-12-21T19:05:52Z","_createdAt":"2020-04-14T14:07:01Z","_rev":"lslStCipHxtG437RQOGJ7p","_id":"d8eab058-f5ec-4c42-a95a-941c0a506543","is_active":true,"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"children":[],"name":"Insurance","_type":"subNavigation","url":"/topic/insurance"},{"_updatedAt":"2020-04-14T14:07:15Z","is_active":true,"url":"/topic/policy","children":[],"_type":"subNavigation","_id":"fd066f36-78ee-4112-a121-4e02f8e45b0b","_createdAt":"2020-04-14T14:07:15Z","name":"Policy","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_rev":"T035zdq5xruIFPyK3OzgdQ"},{"is_active":true,"name":"Population Health","url":"/compendium/population","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_updatedAt":"2024-05-24T06:01:29Z","_createdAt":"2024-05-24T05:59:24Z","_rev":"rcwwj6TiN2Q0ymhqDygvgV","_id":"d7893fef-5eb0-4b2d-b13d-a0bec73b2c14","_type":"subNavigation","children":[]},{"_createdAt":"2024-05-24T06:01:51Z","_type":"subNavigation","_id":"6188ac2f-7ec8-4cbb-a154-5822f606f3fa","is_active":true,"_updatedAt":"2024-05-24T13:24:58Z","_rev":"Jz2W7keLhiw1UYkGHfsKLu","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"url":"/approvals-launches","name":"Product Approvals and Launches","children":[]},{"url":"/topic/technology","children":[],"_rev":"QxOJBWa4XErmibN6Cb5bN0","name":"Technology","_id":"4e2fe99b-3ac4-4b48-89ed-774dd51675df","_createdAt":"2020-04-14T14:07:28Z","_type":"subNavigation","is_active":true,"navParent":{"_type":"reference","_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},"_updatedAt":"2020-04-14T14:07:28Z"},{"_createdAt":"2020-04-14T14:07:42Z","url":"/topic/value-based-care","_updatedAt":"2020-04-14T14:07:42Z","_rev":"T035zdq5xruIFPyK3OzhkC","name":"Value-Based Care","children":[],"is_active":true,"_id":"22bd1bd6-88a6-4278-a846-e086cf30b141","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_type":"subNavigation"}],"url":"/topic","_type":"subNavigation","_updatedAt":"2020-08-21T22:11:57Z","_createdAt":"2020-04-14T14:05:54Z","_rev":"iEeBpgQLYwZXMeCflboLMu","navParent":null,"is_active":true,"name":"Topics","_id":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},{"subQuery":[{"_type":"subNavigation","children":[],"is_active":true,"navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"},"_createdAt":"2020-05-06T13:11:16Z","_rev":"cyKVTGb2fpu5E4X0UMrv4p","_updatedAt":"2020-05-06T13:11:16Z","name":"All Coverage","_id":"f7379c68-40be-45e4-9747-484dcec584d3","url":"/ivbm"},{"navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"},"_createdAt":"2020-04-27T18:49:41Z","_rev":"k2D4PisPM2pBS5NIl95QbN","children":[],"_type":"subNavigation","_id":"cc8a827f-3e94-413a-aa0c-0d8b40eb5f18","_updatedAt":"2020-04-27T18:49:41Z","is_active":true,"name":"Event Coverage","url":"/ivbm/event-coverage"},{"url":"/ivbm/interviews","navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"},"name":"Interviews","_updatedAt":"2020-04-27T18:50:03Z","is_active":true,"_id":"aa3f3bb8-9e8c-457d-aeb6-7b94b968395a","_rev":"k2D4PisPM2pBS5NIl95RlO","children":[],"_type":"subNavigation","_createdAt":"2020-04-27T18:50:03Z"},{"url":"/ivbm/news","name":"News","_createdAt":"2020-04-27T18:50:34Z","children":[],"_rev":"XtnP0djhkej33kSTbdUgmN","_type":"subNavigation","_id":"1be7e99c-8d37-4d70-a009-67eb03fae5ba","_updatedAt":"2020-04-27T18:50:34Z","is_active":true,"navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"}}],"_type":"subNavigation","name":"Institute for Value-Based Medicine","is_active":true,"_createdAt":"2020-04-27T18:48:09Z","_rev":"N0LuVAjtHhQSyVgQyS0Kyv","_id":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","navParent":null,"sortOrder":3,"_updatedAt":"2020-04-27T18:48:23Z","url":"/ivbm"},{"_updatedAt":"2020-04-27T18:48:27Z","_rev":"lsW1cEPdRFwwIdupAS8Stb","navParent":null,"subQuery":[{"name":"AJMC Journals","is_active":true,"_rev":"NGYpFwzJghlKjBIAt48VzS","_id":"4e10ead3-6a42-43df-b251-b93b912a24cb","children":[],"_updatedAt":"2020-05-07T17:05:52Z","url":"/about","_createdAt":"2020-05-07T17:05:52Z","navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"_type":"subNavigation"},{"_createdAt":"2020-04-14T14:09:38Z","children":[],"_type":"subNavigation","_id":"4451f4fa-a919-45b4-b6e5-282668cd792e","url":"/anniversary","_rev":"rHX8vIEJKWyjgUO02y82fe","name":"Anniversary","_updatedAt":"2020-04-14T14:09:38Z","navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"is_active":true},{"_updatedAt":"2020-06-09T11:44:06Z","_type":"subNavigation","is_active":true,"_createdAt":"2020-04-14T14:10:37Z","name":"Author Forms","_id":"99bccc8e-9329-496f-b588-ec3d080f0859","children":[],"_rev":"VmKMEDy0rHs5jzhO3eZVVM","url":"/authorshipforms","navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"}},{"_updatedAt":"2020-05-06T12:53:11Z","_createdAt":"2020-04-14T14:10:19Z","_type":"subNavigation","name":"Authors","children":[],"_id":"518317a5-297f-4c4f-9d2a-6da7b8c98d9c","_rev":"0JTsteyxJPdyCvciQ9yBPv","url":"/authors","is_active":true,"navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"}},{"is_active":true,"children":[],"name":"Nominate a Rising Leader","navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"url":"/seema-sonnad-nomination","_createdAt":"2020-06-15T17:13:51Z","_updatedAt":"2020-06-15T17:13:51Z","_type":"subNavigation","_id":"a96a44c9-4d51-47c6-8f81-4263bd2f58b4","_rev":"m6BzyPIGe9IGx2bV3pSCbq"},{"is_active":true,"_updatedAt":"2023-03-14T13:29:28Z","_id":"4420e458-acb4-4edb-9f33-c4fc4504ff41","url":"/submit-a-manuscript","name":"Submit a Manuscript","_createdAt":"2023-03-14T13:29:28Z","_type":"subNavigation","children":[],"navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"_rev":"TctAtfg0qER1kILh39bPC4"}],"is_active":true,"_createdAt":"2020-04-14T14:09:11Z","sortOrder":4,"_type":"subNavigation","name":"About AJMC","_id":"9a07b754-3383-43ac-9d2d-a370d44406d1"}],"site_setting":{"keywords":["American Journal of Managed Care","AJMC"],"_rev":"4ivhMQjTvj4eF8IoNFokPn","name":"AJMC - Managed Care News, Research, and Expert Insights","creativeLayoutLatestNews":null,"socialLinks":[{"_key":"5a09ae68c48c","title":"Facebook","url":"https://www.facebook.com/TheAmericanJournalOfManagedCare","blank":true,"_type":"urlArray"},{"blank":true,"_type":"urlArray","_key":"ad6b3d250e0b","title":"Twitter","url":"https://twitter.com/AJMC_Journal"},{"_type":"urlArray","_key":"7d1e53fa7d09","title":"LinkedIn","url":"https://www.linkedin.com/company/american-journal-of-managed-care/","blank":true},{"_key":"2478204aa05c","title":"Instagram","url":"https://www.instagram.com/ajmcjournal/","blank":true,"_type":"urlArray"},{"title":"RSS","url":"/rss","blank":true,"_type":"urlArray","_key":"0ba4cf990c2f"}],"gaID":"UA-155582410-5,UA-11140057-3","_id":"siteSettings","_updatedAt":"2024-06-04T19:08:40Z","footerLinks":[{"_type":"urlArray","_key":"6170fdefc8129a5a7ef9dfdd78a2573e","title":"About","url":"/about-us"},{"_key":"281c240875d5","title":"Contact","url":"/contactus","_type":"urlArray"},{"_key":"25e9e6fb7b4422cd0ac20e1a1d993228","title":"Editorial Boards","url":"/editorial-boards","_type":"urlArray"},{"_type":"urlArray","_key":"20a44c137e8d","title":"Advertise","url":"/advertise"},{"url":"https://www.mjhlifesciences.com/ccpa?domain=www.ajmc.com","blank":true,"_type":"urlArray","_key":"21b84fcc9b6e","title":"Do Not Sell My Information"},{"_key":"2f35307aab1f","title":"Terms \u0026 Conditions","url":"/terms","_type":"urlArray"},{"_type":"urlArray","_key":"50ecd8627d01","title":"Privacy Policy","url":"/privacy"}],"siteURL":"www.ajmc.com","copyRightText":"AJMC®","_type":"siteSettings","description":"The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.","enableSanity2":true,"creativeLayout":null,"salesforceDMPId":"tr3xsudox","_createdAt":"2020-04-14T14:14:32Z"},"clinicalData":[{"_id":"4ee49086-e720-4a65-883e-4efc24de53bb","name":"Center on Health Equity \u0026 Access","identifier":"center-on-health-equity-and-access","sortOrder":null,"children":[]},{"identifier":"clinical","sortOrder":null,"children":[],"_id":"topic_clinical","name":"Clinical"},{"_id":"topic_healthcare-cost","name":"Health Care Cost","identifier":"healthcare-cost","sortOrder":null,"children":[]},{"sortOrder":null,"children":[],"_id":"topic_healthcare-delivery","name":"Health Care Delivery","identifier":"healthcare-delivery"},{"name":"Insurance","identifier":"insurance","sortOrder":null,"children":[],"_id":"topic_insurance"},{"identifier":"policy","sortOrder":null,"children":[],"_id":"topic_policy","name":"Policy"},{"_id":"topic_technology","name":"Technology","identifier":"technology","sortOrder":null,"children":[]},{"name":"Value-Based Care","identifier":"value-based-care","sortOrder":null,"children":[],"_id":"topic_value-based-care"}],"seo_data":[],"recent_news":[{"url":{"current":"viltolarsen-slows-dmd-progression-in-small-study","_type":"slug"},"published":"2024-11-23T18:00:00.000Z","factCheckAuthorMapping":null,"thumbnail":{"_type":"mainImage","alt":"Boy with DMD using walker | Image credit: Svitlana – stock.adobe.com","asset":{"_ref":"image-7e20ff65b7abea493e84dace957fb80991ce7bb1-6048x4024-jpg","_type":"reference"}},"authorMapping":{"_type":"author","biography":[{"style":"normal","_key":"038a30bd95f3","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/hayden-e-klein-40b8b1173/","_key":"b0bea7fd1873"}],"children":[{"marks":[],"text":"Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.","_key":"607fdc2dfcbb0","_type":"span"}],"_type":"block"},{"_type":"block","style":"normal","_key":"0c154c4abedd","markDefs":[{"href":"https://www.linkedin.com/in/hayden-e-klein-40b8b1173/","_key":"b0bea7fd1873","nofollow":true,"blank":true,"_type":"link"}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism \u0026 media studies from Rutgers University. You can connect with Hayden on ","_key":"3c55bddd8456"},{"text":"LinkedIn","_key":"607fdc2dfcbb1","_type":"span","marks":["b0bea7fd1873"]},{"text":".","_key":"607fdc2dfcbb2","_type":"span","marks":[]}]}],"profileImage":{"_type":"mainImage","alt":"Hayden E. Klein","asset":{"_ref":"image-9a2a017c03e16e188b88d86afed2b268b4b00214-430x430-png","_type":"reference"}},"url":{"_type":"slug","current":"hayden-e-klein"},"displayName":"Hayden E. Klein","_createdAt":"2021-07-07T19:05:23Z","_rev":"sgy4yN0CjmArmRDnE2KbUN","_id":"d4608bc5-b145-4495-9c67-41163578c9f2","_updatedAt":"2024-05-20T19:26:45Z","firstName":"Hayden","lastName":"Klein"},"contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"},"_id":"86d3362c-b948-469e-80be-ca1af7693cbe","title":"Viltolarsen Slows DMD Progression in Small Study","summary":"Further research is needed to determine how once-weekly viltolarsen can slow disease progression and preserve motor function in boys and young men with Duchenne muscular dystrophy (DMD)."},{"authorMapping":{"_type":"author","_id":"232836b2-a7d6-4cdd-8d7e-65ab104eaf06","biography":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Cameron Santoro is an associate editor for ","_key":"93662c5c4cfd"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"213c257c1eca"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f546acb0aa91"},{"_type":"span","marks":[],"text":" (","_key":"acd931edd707"},{"text":"AJMC","_key":"843f7d4e787d","_type":"span","marks":["em"]},{"marks":["superscript"],"text":"®","_key":"7c809e803edb","_type":"span"},{"_type":"span","marks":[],"text":"), AJMC.com, and The Center for Biosimilars","_key":"35b69a01dbbe"},{"_type":"span","marks":["superscript"],"text":"®","_key":"8ddca200bc46"},{"_key":"ba3cca6122e3","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal","_key":"3da8fced8696"}],"lastName":"Santoro","displayName":"Cameron Santoro","_rev":"sgy4yN0CjmArmRDnE2KiNm","_updatedAt":"2024-05-20T19:28:22Z","url":{"current":"cameron-santoro","_type":"slug"},"firstName":"Cameron","_createdAt":"2023-11-22T18:35:06Z","profileImage":{"_type":"mainImage","alt":"Cameron Santoro","asset":{"_ref":"image-6ae51a61642a5ecba7cf4085fe97e68814e3c917-430x430-png","_type":"reference"}}},"factCheckAuthorMapping":null,"_id":"9de436c7-b93c-4acd-82fc-20d1f27bec02","summary":"Younger women with estrogen receptor (ER)–positive, HER2-negative breast cancer have significantly worse long-term outcomes, including higher rates of recurrence and metastasis, compared with older women. ","thumbnail":{"_type":"mainImage","alt":"Young woman receiving breast screening | Image Credit: My Ocean studio - stock.adobe.com","caption":"Younger women with HR-positive, HER2-negative breast cancer have significantly worse long-term outcomes, including higher rates of recurrence and metastasis, compared with older women. | Image Credit: My Ocean studio - stock.adobe.com","asset":{"_ref":"image-f6dde86a347fe1814dcaa933db7ea64e27db3add-8995x5997-jpg","_type":"reference"}},"published":"2024-11-23T17:30:00.000Z","title":"Age-Related Disparities in Long-Term Outcomes for ER+, HER2– Breast Cancer","url":{"current":"age-related-disparities-in-long-term-outcomes-for-er-her2-breast-cancer","_type":"slug"},"contentCategory":{"_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2"}},{"thumbnail":{"alt":"Tooth loss | Image Credit: © valiantsin-stock.adobe.com","asset":{"_ref":"image-d8405a2a194a2c5f871d2c521ca31d0ec29d29bc-1200x738-jpg","_type":"reference"},"_type":"mainImage"},"authorMapping":{"biography":[{"_key":"75ff381b2d42","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/jaredkalt/","_key":"30c8f5445624"}],"children":[{"text":"Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.","_key":"e9f80bd7687c0","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"children":[{"marks":[],"text":"He has an MA from University of Sioux Falls. You can connect with Jared on ","_key":"95b8dd3e29db","_type":"span"},{"text":"LinkedIn","_key":"e9f80bd7687c1","_type":"span","marks":["30c8f5445624"]},{"_type":"span","marks":[],"text":".","_key":"e9f80bd7687c2"}],"_type":"block","style":"normal","_key":"a90d9599d615","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/jaredkalt/","_key":"30c8f5445624","nofollow":true,"blank":true}]}],"_updatedAt":"2022-08-30T13:26:44Z","url":{"current":"jared-kaltwasser","_type":"slug"},"displayName":"Jared Kaltwasser","_createdAt":"2020-05-05T10:50:04Z","_rev":"0TowddpnSMVYA5OKF42uAM","_type":"author","_id":"author_18c68a1fd690db471eba0e0da3b8e979"},"factCheckAuthorMapping":null,"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"_id":"809dec58-4f3c-49a1-8c2b-53878dc5e0c3","summary":"A systematic review has found a potential link between edentulism and sleep apnea risk, although the authors said differences in study designs prohibited a meta-analysis.","url":{"current":"edentulism-may-heighten-sleep-apnea-risk","_type":"slug"},"published":"2024-11-23T15:00:00.000Z","title":"Edentulism May Heighten Sleep Apnea Risk"},{"title":"Novel Relapsed/Refractory CLL Therapies Have Similar Safety Profiles","summary":"The new report is an attempt to provide comprehensive safety data on the rapidly changing treatment landscape for relapsed or refractory chronic lymphocytic leukemia (CLL).","thumbnail":{"_type":"mainImage","alt":"Older woman taking out dose of pills from glass bottle | Image Credit: © fizkes - stock.adobe.com","asset":{"_ref":"image-b276506cb9fe42e52165074a6e038a4b99789dcb-5622x3622-jpg","_type":"reference"}},"url":{"_type":"slug","current":"novel-relapsed-refractory-cll-therapies-have-similar-safety-profiles"},"published":"2024-11-23T13:16:00.000Z","factCheckAuthorMapping":null,"_id":"1fdd2f09-9d9d-4679-8c5c-64fee40e632c","authorMapping":{"_type":"author","_id":"author_18c68a1fd690db471eba0e0da3b8e979","biography":[{"_key":"75ff381b2d42","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/jaredkalt/","_key":"30c8f5445624"}],"children":[{"text":"Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.","_key":"e9f80bd7687c0","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"children":[{"marks":[],"text":"He has an MA from University of Sioux Falls. You can connect with Jared on ","_key":"95b8dd3e29db","_type":"span"},{"text":"LinkedIn","_key":"e9f80bd7687c1","_type":"span","marks":["30c8f5445624"]},{"_type":"span","marks":[],"text":".","_key":"e9f80bd7687c2"}],"_type":"block","style":"normal","_key":"a90d9599d615","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/jaredkalt/","_key":"30c8f5445624","nofollow":true,"blank":true}]}],"_updatedAt":"2022-08-30T13:26:44Z","url":{"current":"jared-kaltwasser","_type":"slug"},"displayName":"Jared Kaltwasser","_createdAt":"2020-05-05T10:50:04Z","_rev":"0TowddpnSMVYA5OKF42uAM"},"contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"}}],"latest_publications":[{"authorDetails":[{"showSocialShare":null,"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"current":"mary-caffrey","_type":"slug"},"profileImage":null,"biography":[{"style":"normal","_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc","_type":"span"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"text":"AJMC","_key":"953d8c643cce","_type":"span","marks":["em"]},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block"},{"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"_key":"4f88673cb2c4","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/"}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"text":".","_key":"9737335da1ed2","_type":"span","marks":[]}]}]}],"factCheckBy":[{"biography":[{"_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_key":"b8dda18bb0dc","_type":"span","marks":["em"],"text":"AJMC"},{"marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08","_type":"span"},{"marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962","_type":"span"},{"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4","nofollow":true,"blank":true}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_type":"span","marks":[],"text":".","_key":"9737335da1ed2"}]}],"showSocialShare":null,"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"_type":"slug","current":"mary-caffrey"},"profileImage":null}],"url":"to-improve-clinical-trial-equity-in-multiple-myeloma-just-ask","published":"2024-11-22T12:37:00.000Z","_id":"5877a6f2-9fdc-47af-8a5c-89e09960f92a","issueGroup":{"_ref":"477f9888-ea5b-4621-bb40-41487563b322","_type":"reference"},"title":"To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask","summary":null,"thumbnail":{"_type":"mainImage","asset":{"extension":"jpg","assetId":"3e665a0c15a17fc3c7ade987a36f77617f865715","_id":"image-3e665a0c15a17fc3c7ade987a36f77617f865715-437x115-jpg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/3e665a0c15a17fc3c7ade987a36f77617f865715-437x115.jpg","originalFilename":"CHEA LOGO.jpg","metadata":{"_type":"sanity.imageMetadata","palette":{"lightMuted":{"background":"#c5cdd0","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":1.36},"vibrant":{"title":"#fff","population":0.07,"background":"#678db6","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"background":"#c5cdd0","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":1.36},"_type":"sanity.imagePalette","darkMuted":{"background":"#383838","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.41},"muted":{"title":"#fff","population":0.66,"background":"#60829c","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.02,"background":"#a4daec"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.5,"background":"#15445f","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAFABQDASIAAhEBAxEB/8QAFwABAAMAAAAAAAAAAAAAAAAAAAIFCP/EAB0QAAICAwADAAAAAAAAAAAAAAECAAMEERITITP/xAAVAQEBAAAAAAAAAAAAAAAAAAABAv/EABcRAQEBAQAAAAAAAAAAAAAAAAAxAQL/2gAMAwEAAhEDEQA/ANFmtqktPkY7IEjis1mQlfRHXvYiI7U8xcLjtr7OYiIKf//Z","dimensions":{"width":437,"aspectRatio":3.8,"height":115,"_type":"sanity.imageDimensions"},"isOpaque":true,"blurHash":"DARW3j9v?vR.IV~qWXM{ayof"},"_type":"sanity.imageAsset","mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/3e665a0c15a17fc3c7ade987a36f77617f865715-437x115.jpg","size":8393,"_createdAt":"2024-11-22T12:47:16Z","_updatedAt":"2024-11-22T12:47:16Z","uploadId":"S6qsHDgdYFzzPaJkPMiq04qdRlFigqm8","_rev":"qMZkEXqBAV3IRERLM7zYaX","sha1hash":"3e665a0c15a17fc3c7ade987a36f77617f865715"}}},{"authorDetails":[{"displayName":"Maggie L. Shaw","firstName":null,"lastName":null,"url":{"current":"maggie-l-shaw","_type":"slug"},"profileImage":{"asset":{"_type":"reference","_ref":"image-7219c501186d8cbe6d25614b5b22645ea1c6fe2c-600x619-jpg"},"_type":"mainImage","alt":"Maggie L. Shaw"},"biography":[{"markDefs":[],"children":[{"marks":[],"text":"Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.","_key":"abc0e18a29ce0","_type":"span"}],"_type":"block","style":"normal","_key":"643be033259e"},{"_key":"f4070c315fab","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/maggielshaw/","_key":"159c764717fb","nofollow":true}],"children":[{"_type":"span","marks":[],"text":"She has a BA in English from Penn State University. You can connect with Maggie on ","_key":"8e1abe71bcd2"},{"_type":"span","marks":["159c764717fb"],"text":"LinkedIn","_key":"abc0e18a29ce1"},{"_type":"span","marks":[],"text":".","_key":"abc0e18a29ce2"}],"_type":"block","style":"normal"}],"showSocialShare":null}],"factCheckBy":[{"showSocialShare":null,"displayName":"Maggie L. Shaw","firstName":null,"lastName":null,"url":{"current":"maggie-l-shaw","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Maggie L. Shaw","asset":{"_ref":"image-7219c501186d8cbe6d25614b5b22645ea1c6fe2c-600x619-jpg","_type":"reference"}},"biography":[{"children":[{"_type":"span","marks":[],"text":"Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.","_key":"abc0e18a29ce0"}],"_type":"block","style":"normal","_key":"643be033259e","markDefs":[]},{"_type":"block","style":"normal","_key":"f4070c315fab","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/maggielshaw/","_key":"159c764717fb","nofollow":true}],"children":[{"_type":"span","marks":[],"text":"She has a BA in English from Penn State University. You can connect with Maggie on ","_key":"8e1abe71bcd2"},{"_type":"span","marks":["159c764717fb"],"text":"LinkedIn","_key":"abc0e18a29ce1"},{"_type":"span","marks":[],"text":".","_key":"abc0e18a29ce2"}]}]}],"_id":"e122e007-e3bd-49b9-982a-29e287e95906","issueGroup":{"_ref":"477f9888-ea5b-4621-bb40-41487563b322","_type":"reference"},"summary":"Coverage from the recent Institute for Value-Based Medicine event with NYU Langone Health.","url":"collaborating-for-cancer-care-equity-community-and-academic-insights","published":"2024-11-21T18:30:00.000Z","title":"Collaborating for Cancer Care Equity: Community and Academic Insights","thumbnail":{"_type":"mainImage","asset":{"uploadId":"TBdykeEPkoVIc4yGVg1aMDXZqoY4mmnp","_rev":"EbkpNMUbiIwDU1ASliP5Sw","_createdAt":"2024-11-21T18:37:58Z","_id":"image-54f2a4431fd4ea73ec6c2ec625fd0d107129c22d-285x121-png","metadata":{"_type":"sanity.imageMetadata","palette":{"dominant":{"background":"#510684","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":5.11},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":1.1,"background":"#663881","_type":"sanity.imagePaletteSwatch"},"muted":{"foreground":"#fff","title":"#fff","population":0.66,"background":"#7a5f8f","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"population":1.44,"background":"#deb7ee","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"darkVibrant":{"title":"#fff","population":5.11,"background":"#510684","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"population":0.23,"background":"#b6aac4","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"population":3.6,"background":"#5a0696","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":false,"lqip":"data:image/png;base64,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","dimensions":{"aspectRatio":2.355371900826446,"height":121,"_type":"sanity.imageDimensions","width":285},"isOpaque":true,"blurHash":"MQQ9ycah-:Rkx[~pM|D*%Lt7_2IVt6a{ay"},"_type":"sanity.imageAsset","mimeType":"image/png","size":3589,"assetId":"54f2a4431fd4ea73ec6c2ec625fd0d107129c22d","extension":"png","sha1hash":"54f2a4431fd4ea73ec6c2ec625fd0d107129c22d","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/54f2a4431fd4ea73ec6c2ec625fd0d107129c22d-285x121.png","path":"images/0vv8moc6/ajmc/54f2a4431fd4ea73ec6c2ec625fd0d107129c22d-285x121.png","_updatedAt":"2024-11-21T18:37:58Z","originalFilename":"NYU Lang Health.png"}}},{"title":"Elevating Value in Cancer Care With Innovations, Accessibility, Equity","authorDetails":[{"biography":[{"children":[{"_type":"span","marks":[],"text":"Cameron Santoro is an associate editor for ","_key":"93662c5c4cfd"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"213c257c1eca"},{"marks":["superscript"],"text":"®","_key":"f546acb0aa91","_type":"span"},{"_type":"span","marks":[],"text":" (","_key":"acd931edd707"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"843f7d4e787d"},{"text":"®","_key":"7c809e803edb","_type":"span","marks":["superscript"]},{"_type":"span","marks":[],"text":"), AJMC.com, and The Center for Biosimilars","_key":"35b69a01dbbe"},{"_type":"span","marks":["superscript"],"text":"®","_key":"8ddca200bc46"},{"_type":"span","marks":[],"text":".","_key":"ba3cca6122e3"}],"_type":"block","style":"normal","_key":"3da8fced8696","markDefs":[]}],"showSocialShare":null,"displayName":"Cameron Santoro","firstName":"Cameron","lastName":"Santoro","url":{"current":"cameron-santoro","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Cameron Santoro","asset":{"_ref":"image-6ae51a61642a5ecba7cf4085fe97e68814e3c917-430x430-png","_type":"reference"}}}],"factCheckBy":[{"url":{"current":"cameron-santoro","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Cameron Santoro","asset":{"_ref":"image-6ae51a61642a5ecba7cf4085fe97e68814e3c917-430x430-png","_type":"reference"}},"biography":[{"_key":"3da8fced8696","markDefs":[],"children":[{"_key":"93662c5c4cfd","_type":"span","marks":[],"text":"Cameron Santoro is an associate editor for "},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"213c257c1eca"},{"text":"®","_key":"f546acb0aa91","_type":"span","marks":["superscript"]},{"_type":"span","marks":[],"text":" (","_key":"acd931edd707"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"843f7d4e787d"},{"_type":"span","marks":["superscript"],"text":"®","_key":"7c809e803edb"},{"_type":"span","marks":[],"text":"), AJMC.com, and The Center for Biosimilars","_key":"35b69a01dbbe"},{"_type":"span","marks":["superscript"],"text":"®","_key":"8ddca200bc46"},{"_type":"span","marks":[],"text":".","_key":"ba3cca6122e3"}],"_type":"block","style":"normal"}],"showSocialShare":null,"displayName":"Cameron Santoro","firstName":"Cameron","lastName":"Santoro"}],"published":"2024-11-21T17:23:00.000Z","_id":"3ab0a249-35da-4929-895b-bc3bc50fe93c","issueGroup":{"_type":"reference","_ref":"477f9888-ea5b-4621-bb40-41487563b322"},"summary":"Coverage from the IVBM Regional event in Denver, Colorado.","thumbnail":{"_type":"mainImage","asset":{"uploadId":"gJzaHcTHR9p1SOaC0U8krFjLzNeOH32L","_rev":"AGf4LvcO2r7q1La1cjaXrz","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/c93bf646d31467af3bf1146ded1ddb1b32755d08-2022x645.png","_createdAt":"2024-07-23T15:37:52Z","metadata":{"_type":"sanity.imageMetadata","palette":{"lightMuted":{"foreground":"#000","title":"#fff","population":0.04,"background":"#d5bec1","_type":"sanity.imagePaletteSwatch"},"vibrant":{"title":"#fff","population":1.07,"background":"#18a3d3","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.07,"background":"#18a3d3"},"_type":"sanity.imagePalette","darkMuted":{"background":"#28374c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.24},"muted":{"foreground":"#fff","title":"#fff","population":0.19,"background":"#61739a","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"background":"#5ce4fc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01},"darkVibrant":{"title":"#fff","population":0.04,"background":"#064487","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2022,"aspectRatio":3.1348837209302327,"height":645},"isOpaque":false,"blurHash":"D85Zzn4T?^H;oI.ADg%MM_j="},"_type":"sanity.imageAsset","mimeType":"image/png","path":"images/0vv8moc6/ajmc/c93bf646d31467af3bf1146ded1ddb1b32755d08-2022x645.png","_id":"image-c93bf646d31467af3bf1146ded1ddb1b32755d08-2022x645-png","originalFilename":"AJMC_Denver_Final 1.png","extension":"png","size":266092,"assetId":"c93bf646d31467af3bf1146ded1ddb1b32755d08","_updatedAt":"2024-07-23T15:37:52Z","sha1hash":"c93bf646d31467af3bf1146ded1ddb1b32755d08"}},"url":"elevating-value-in-cancer-care-with-innovations-accessibility-equity"},{"url":"recent-cohorts-aging-into-medicare-use-more-counseling-and-psychotherapy-than-past-cohorts","_id":"f5657fbb-1a24-4a40-b7dd-55b0c5bd2234","title":"Recent Cohorts Aging Into Medicare Use More Counseling and Psychotherapy Than Past Cohorts","summary":"Adults currently aging into Medicare utilized counseling and psychotherapy services at higher rates than those in prior cohorts at the same age.","authorDetails":[{"firstName":"Grace","lastName":"McCormack","url":{"current":"grace-mccormack-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Grace McCormack, PhD"},{"firstName":"Erin","lastName":"Duffy","url":{"current":"erin-l-duffy-phd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Erin L. Duffy, PhD, MPH"},{"biography":null,"showSocialShare":null,"displayName":"Adam Biener, PhD","firstName":"Adam","lastName":"Biener","url":{"current":"adam-biener-phd","_type":"slug"},"profileImage":null}],"factCheckBy":[{"lastName":"McCormack","url":{"current":"grace-mccormack-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Grace McCormack, PhD","firstName":"Grace"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Erin L. Duffy, PhD, MPH","firstName":"Erin","lastName":"Duffy","url":{"_type":"slug","current":"erin-l-duffy-phd-mph"}},{"biography":null,"showSocialShare":null,"displayName":"Adam Biener, PhD","firstName":"Adam","lastName":"Biener","url":{"current":"adam-biener-phd","_type":"slug"},"profileImage":null}],"issueGroup":{"_ref":"3b0140fe-ebe5-450c-b4e4-9f7b3e0f41d3","_type":"reference"},"thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"_updatedAt":"2023-07-11T20:45:56Z","_rev":"hiKH9HIKxNVM35TxYdonKh","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"originalFilename":"AJMC_logo_NEW.png","extension":"png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","mimeType":"image/png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"muted":{"population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"title":"#fff","population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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"}}},"published":"2024-11-14T14:00:00.000Z"},{"_id":"d99dde01-66cf-4191-8bad-05d431132d9f","summary":"Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.","url":"how-english--and-spanish-preferring-patients-with-cancer-decide-on-emergency-care","published":"2024-11-13T14:00:00.000Z","authorDetails":[{"biography":null,"showSocialShare":null,"displayName":"Arthur S. Hong, MD, MPH","firstName":"Arthur","lastName":"Hong","url":{"current":"arthur-s-hong-md-mph","_type":"slug"},"profileImage":null},{"displayName":"Beverly Kyalwazi, MD","firstName":"Beverly","lastName":"Kyalwazi","url":{"current":"beverly-kyalwazi-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"Ethan A. Halm, MD, MPH, MBA","firstName":"Ethan","lastName":"Halm","url":{"current":"ethan-a-halm-md-mph-mba","_type":"slug"},"profileImage":null,"biography":null},{"showSocialShare":null,"displayName":"D. Mark Courtney, MD, MSCI","firstName":"D.","lastName":"Courtney","url":{"current":"d-mark-courtney-md-msci","_type":"slug"},"profileImage":null,"biography":null},{"displayName":"John W. Sweetenham, MD","firstName":"John","lastName":"Sweetenham","url":{"current":"john-w-sweetenham-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"Navid Sadeghi, MD, MSPH","firstName":"Navid","lastName":"Sadeghi","url":{"current":"navid-sadeghi-md","_type":"slug"},"profileImage":null,"biography":null},{"firstName":"John","lastName":"Cox","url":{"current":"john-v-cox-do-mba","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"John V. Cox, DO, MBA"},{"biography":null,"showSocialShare":null,"displayName":"Simon J. Craddock Lee, PhD, MPH","firstName":"Simon","lastName":"Craddock Lee","url":{"current":"simon-j-craddock-lee-phd-mph","_type":"slug"},"profileImage":null}],"issueGroup":{"_ref":"3b0140fe-ebe5-450c-b4e4-9f7b3e0f41d3","_type":"reference"},"title":"How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care ","thumbnail":{"alt":"AJMC","asset":{"extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"originalFilename":"AJMC_logo_NEW.png","mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"foreground":"#fff","title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"title":"#000","population":0.93,"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc"}},"hasAlpha":true},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z"},"_type":"mainImage"},"factCheckBy":[{"lastName":"Hong","url":{"current":"arthur-s-hong-md-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Arthur S. Hong, MD, MPH","firstName":"Arthur"},{"lastName":"Kyalwazi","url":{"current":"beverly-kyalwazi-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Beverly Kyalwazi, MD","firstName":"Beverly"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Ethan A. Halm, MD, MPH, MBA","firstName":"Ethan","lastName":"Halm","url":{"current":"ethan-a-halm-md-mph-mba","_type":"slug"}},{"showSocialShare":null,"displayName":"D. Mark Courtney, MD, MSCI","firstName":"D.","lastName":"Courtney","url":{"current":"d-mark-courtney-md-msci","_type":"slug"},"profileImage":null,"biography":null},{"displayName":"John W. Sweetenham, MD","firstName":"John","lastName":"Sweetenham","url":{"current":"john-w-sweetenham-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"url":{"current":"navid-sadeghi-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Navid Sadeghi, MD, MSPH","firstName":"Navid","lastName":"Sadeghi"},{"displayName":"John V. Cox, DO, MBA","firstName":"John","lastName":"Cox","url":{"current":"john-v-cox-do-mba","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Simon J. Craddock Lee, PhD, MPH","firstName":"Simon","lastName":"Craddock Lee","url":{"current":"simon-j-craddock-lee-phd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}]},{"thumbnail":{"alt":"AJMC","asset":{"mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","metadata":{"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52,"background":"#18568d"},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09},"lightMuted":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z","size":203185,"originalFilename":"AJMC_logo_NEW.png","extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png"},"_type":"mainImage"},"url":"geographic-variations-and-facility-determinants-of-acute-care-utilization-and-spending-for-acscs","title":"Geographic Variations and Facility Determinants of Acute Care Utilization and Spending for ACSCs","summary":"Emergency department (ED) visits and hospitalizations for ambulatory care–sensitive conditions (ACSCs) among Medicaid patients constitute almost 40% of all ED visits and hospitalizations, with lower rates observed in areas with greater proximity to urgent care facilities and density of rural health clinics.","published":"2024-11-12T14:00:00.000Z","authorDetails":[{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Sadiq Y. Patel, PhD, MS","firstName":"Sadiq","lastName":"Patel","url":{"current":"sadiq-y-patel-phd-ms","_type":"slug"}},{"biography":null,"showSocialShare":null,"displayName":"Aaron Baum, PhD","firstName":"Aaron","lastName":"Baum","url":{"current":"aaron-baum-phd","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"Sanjay Basu, MD, PhD","firstName":"Sanjay","lastName":"Basu","url":{"current":"sanjay-basu-md-phd","_type":"slug"},"profileImage":null}],"factCheckBy":[{"displayName":"Sadiq Y. Patel, PhD, MS","firstName":"Sadiq","lastName":"Patel","url":{"current":"sadiq-y-patel-phd-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"Aaron Baum, PhD","firstName":"Aaron","lastName":"Baum","url":{"current":"aaron-baum-phd","_type":"slug"},"profileImage":null,"biography":null},{"biography":null,"showSocialShare":null,"displayName":"Sanjay Basu, MD, PhD","firstName":"Sanjay","lastName":"Basu","url":{"current":"sanjay-basu-md-phd","_type":"slug"},"profileImage":null}],"_id":"404b320c-f480-4fc3-b080-8fa1dd562551","issueGroup":{"_ref":"3b0140fe-ebe5-450c-b4e4-9f7b3e0f41d3","_type":"reference"}},{"authorDetails":[{"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"current":"mary-caffrey","_type":"slug"},"profileImage":null,"biography":[{"_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc","_type":"span"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"text":"AJMC","_key":"953d8c643cce","_type":"span","marks":["em"]},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"text":".","_key":"9737335da1ed2","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4","nofollow":true,"blank":true,"_type":"link"}]}],"showSocialShare":null}],"_id":"f46ba78f-9e25-4566-a21d-7f2d8013f43b","issueGroup":{"_type":"reference","_ref":"f3dd603a-37be-46c5-a0ed-79c2e9f9a55d"},"url":"beyond-mckesson-and-florida-cancer-specialists-deals-are-reshaping-community-oncology","published":"2024-10-25T13:04:00.000Z","factCheckBy":[{"lastName":null,"url":{"_type":"slug","current":"mary-caffrey"},"profileImage":null,"biography":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_key":"b8dda18bb0dc","_type":"span","marks":["em"],"text":"AJMC"},{"marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08","_type":"span"},{"marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962","_type":"span"},{"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal","_key":"80606b0b2412"},{"style":"normal","_key":"a03d32973d6e","markDefs":[{"href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4","nofollow":true,"blank":true,"_type":"link"}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_type":"span","marks":[],"text":".","_key":"9737335da1ed2"}],"_type":"block"}],"showSocialShare":null,"displayName":"Mary Caffrey","firstName":null}],"title":"Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology ","summary":null,"thumbnail":{"_type":"mainImage","alt":"Orange City ribbon-cutting | Image credit: FCS press release","caption":"Ribbon-cutting at new facility in Orange City for Florida Cancer Specialists \u0026 Research Institute in February 2024. | Image credit: FCS press release","asset":{"path":"images/0vv8moc6/ajmc/4cc5fe49422965d25cd9df088a7f56d3a2de40b1-1200x628.jpg","assetId":"4cc5fe49422965d25cd9df088a7f56d3a2de40b1","_createdAt":"2024-10-25T13:47:39Z","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/4cc5fe49422965d25cd9df088a7f56d3a2de40b1-1200x628.jpg","uploadId":"i9vAHOJP6REIOEUWNlG2EiJ2k2uzm3nO","_rev":"l8hWsBDY1XE7uXNKgKoAse","_type":"sanity.imageAsset","extension":"jpg","metadata":{"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"width":1200,"aspectRatio":1.910828025477707,"height":628,"_type":"sanity.imageDimensions"},"isOpaque":true,"blurHash":"MkL:AbR5tQRPo}~AV@kDi^ozx^oet7WBW=","_type":"sanity.imageMetadata","palette":{"lightMuted":{"background":"#c1a394","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":7.27},"vibrant":{"population":5.37,"background":"#e48c53","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"dominant":{"foreground":"#fff","title":"#fff","population":7.44,"background":"#8e7b63","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"background":"#4c3827","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.59},"muted":{"title":"#fff","population":7.44,"background":"#8e7b63","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"population":0.36,"background":"#f58d57","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"darkVibrant":{"population":0.28,"background":"#714918","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}}},"sha1hash":"4cc5fe49422965d25cd9df088a7f56d3a2de40b1","size":206688,"_id":"image-4cc5fe49422965d25cd9df088a7f56d3a2de40b1-1200x628-jpg","_updatedAt":"2024-10-25T13:47:39Z","originalFilename":"Orange-City-Ribbon-Cutting-022724.jpg","mimeType":"image/jpeg"}}},{"_id":"444a4315-6531-40e0-845b-418d00ed04bb","issueGroup":{"_ref":"f9450ef8-d89e-4aaa-9fac-2b11c3a068fb","_type":"reference"},"title":"Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis","url":"accountable-care-organizations-and-hpv-vaccine-uptake-a-multilevel-analysis","published":"2024-10-24T18:00:00.000Z","summary":"The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.","thumbnail":{"_type":"mainImage","asset":{"size":203185,"originalFilename":"AJMC_logo_NEW.png","extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","metadata":{"_type":"sanity.imageMetadata","palette":{"vibrant":{"population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"title":"#fff","population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38,"background":"#628cad"},"lightVibrant":{"foreground":"#000","title":"#000","population":0.93,"background":"#cae1f2","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09},"lightMuted":{"foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":true,"lqip":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAKCAYAAAC0VX7mAAAACXBIWXMAABYlAAAWJQFJUiTwAAABxklEQVQoka2STW/aQBCG+f/qLZdeqkrpoQqpWiIlCk2BhKCEErAxRXGMnQ8wJoAxGMyX7fX6rWbSpqXnWlrN7M7sszPvOAMAaZrif32Z3zCySSKRSIlYJFhtQgTrLVbbCNsohpQSUqYIY8ErigU2YYxNGPGe7hHjFUiHjutj6C0w8ZfQLAeK0UPTtKF2bEwXK8yCNZ+3LAd6d4iOPcbjYIKB63MBO0BvvkSxYaDctHDvuCg0DJzd3OHsRsd+voaG0UP7YYAP+Rren1RxVGnxfjDxMZousN5GL0CCiSRhSLakIFtU0DT7DL9QTVy1HxiQLan4WtPxNlfBm48FHBQVPHtzloIkIvsLmMIP1tzWafUWh+cqCnUD+e+3KCkd1PQnfC5reHd8zRCye58u+IHucMoaU7ukP7EyJHR/PENd76J173CrhyUVuUsN52oH1fYjyk2TK6b1pazhqPKDH9OsPkx7zPfDKH6ZMpVK+tnjGVw/YGjusoVv9TsYvRG6Q48vTOZL1srqu1wZ+aQfDZKGRbJxhdS3SCSESFiL0TRgsZ+ePRaaziiZ8qgbyqP2yCdLMfIpvjPl139RSkRCcPK/sT/7v/3d+E98j+pE3hWucAAAAABJRU5ErkJggg==","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj"},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z"}},"authorDetails":[{"showSocialShare":null,"displayName":"Eileen J. Carter, PhD, RN","firstName":"Eileen","lastName":"Carter","url":{"_type":"slug","current":"eileen-j-carter-phd-rn"},"profileImage":null,"biography":null},{"url":{"current":"yuen-tsz-abby-lau-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Yuen Tsz Abby Lau, PhD","firstName":"Yuen Tsz","lastName":"Lau"},{"biography":null,"showSocialShare":null,"displayName":"Laurel Buchanan, MA","firstName":"Laurel","lastName":"Buchanan","url":{"current":"laurel-buchanan-ma","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"David M. Krol, MD, MPH","firstName":"David","lastName":"Krol","url":{"current":"david-m-krol-md-mph","_type":"slug"},"profileImage":null},{"firstName":"Jun","lastName":"Yan","url":{"current":"jun-yan-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Jun Yan, PhD"},{"firstName":"Robert","lastName":"Aseltine","url":{"current":"robert-h-aseltine-jr-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Robert H. Aseltine Jr, PhD"}],"factCheckBy":[{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Eileen J. Carter, PhD, RN","firstName":"Eileen","lastName":"Carter","url":{"current":"eileen-j-carter-phd-rn","_type":"slug"}},{"showSocialShare":null,"displayName":"Yuen Tsz Abby Lau, PhD","firstName":"Yuen Tsz","lastName":"Lau","url":{"current":"yuen-tsz-abby-lau-phd","_type":"slug"},"profileImage":null,"biography":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Laurel Buchanan, MA","firstName":"Laurel","lastName":"Buchanan","url":{"current":"laurel-buchanan-ma","_type":"slug"}},{"url":{"_type":"slug","current":"david-m-krol-md-mph"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"David M. Krol, MD, MPH","firstName":"David","lastName":"Krol"},{"biography":null,"showSocialShare":null,"displayName":"Jun Yan, PhD","firstName":"Jun","lastName":"Yan","url":{"current":"jun-yan-phd","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"Robert H. Aseltine Jr, PhD","firstName":"Robert","lastName":"Aseltine","url":{"current":"robert-h-aseltine-jr-phd","_type":"slug"},"profileImage":null}]},{"authorDetails":[{"firstName":"Alexandra","lastName":"Hames","url":{"current":"alexandra-g-hames-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Alexandra G. Hames, PhD"},{"showSocialShare":null,"displayName":"Renuka Tipirneni, MD, MSc","firstName":"Renuka","lastName":"Tipirneni","url":{"_type":"slug","current":"renuka-tipirneni-md-msc"},"profileImage":null,"biography":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Galen E. Switzer, PhD","firstName":"Galen","lastName":"Switzer","url":{"current":"galen-e-switzer-phd","_type":"slug"}},{"showSocialShare":null,"displayName":"John Z. Ayanian, MD, MPP","firstName":"John","lastName":"Ayanian","url":{"current":"john-z-ayanian-md-mpp","_type":"slug"},"profileImage":null,"biography":null},{"firstName":"Jeffrey","lastName":"Kullgren","url":{"current":"jeffrey-t-kullgren-md-ms-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Jeffrey T. Kullgren, MD, MS, MPH"},{"displayName":"Erica Solway, PhD, MPH, MSW","firstName":"Erica","lastName":"Solway","url":{"current":"erica-solway-phd-mph-msw","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Eric T. Roberts, PhD","firstName":"Eric","lastName":"Roberts","url":{"current":"eric-t-roberts-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}],"_id":"c797bf68-6f9e-4d02-9336-14c1800b8a24","title":"Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional Medicare","summary":"Among near-poor Black and Hispanic individuals, Medicare Advantage was associated with increased vision care and some, although not uniform, reductions in access disparities vs traditional Medicare.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09},"lightMuted":{"population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":true},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z","size":203185,"originalFilename":"AJMC_logo_NEW.png","extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png"}},"url":"racial-ethnic-disparities-in-cost-related-barriers-to-care-among-near-poor-beneficiaries-in-medicare-advantage-vs-traditional-medicare","issueGroup":{"_ref":"f9450ef8-d89e-4aaa-9fac-2b11c3a068fb","_type":"reference"},"published":"2024-10-23T14:00:11.540Z","factCheckBy":[{"showSocialShare":null,"displayName":"Alexandra G. Hames, PhD","firstName":"Alexandra","lastName":"Hames","url":{"current":"alexandra-g-hames-phd","_type":"slug"},"profileImage":null,"biography":null},{"firstName":"Renuka","lastName":"Tipirneni","url":{"current":"renuka-tipirneni-md-msc","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Renuka Tipirneni, MD, MSc"},{"displayName":"Galen E. Switzer, PhD","firstName":"Galen","lastName":"Switzer","url":{"current":"galen-e-switzer-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"John Z. Ayanian, MD, MPP","firstName":"John","lastName":"Ayanian","url":{"_type":"slug","current":"john-z-ayanian-md-mpp"}},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Jeffrey T. Kullgren, MD, MS, MPH","firstName":"Jeffrey","lastName":"Kullgren","url":{"current":"jeffrey-t-kullgren-md-ms-mph","_type":"slug"}},{"displayName":"Erica Solway, PhD, MPH, MSW","firstName":"Erica","lastName":"Solway","url":{"_type":"slug","current":"erica-solway-phd-mph-msw"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Eric T. Roberts, PhD","firstName":"Eric","lastName":"Roberts","url":{"current":"eric-t-roberts-phd","_type":"slug"}}]},{"_id":"0f3eca76-cd72-4e5c-b4bc-cdc6fe1cea34","issueGroup":{"_ref":"f9450ef8-d89e-4aaa-9fac-2b11c3a068fb","_type":"reference"},"title":"Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities","factCheckBy":[{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Reza Amini, PhD, MD, MPH","firstName":"Reza","lastName":"Amini","url":{"current":"reza-amini-phd-md-mph","_type":"slug"}},{"displayName":"Azmat Sidhu, MPH","firstName":"Azmat","lastName":"Sidhu","url":{"current":"azmat-sidhu-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}],"summary":"This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.","thumbnail":{"asset":{"mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"darkMuted":{"foreground":"#fff","title":"#fff","population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch"},"muted":{"title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93,"background":"#cae1f2"},"darkVibrant":{"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09},"lightMuted":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"vibrant":{"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette"},"hasAlpha":true},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185},"_type":"mainImage","alt":"AJMC"},"url":"hospital-stays-and-probable-dementia-as-predictors-of-relocation-to-long-term-care-facilities","published":"2024-10-22T13:00:00.000Z","authorDetails":[{"biography":null,"showSocialShare":null,"displayName":"Reza Amini, PhD, MD, MPH","firstName":"Reza","lastName":"Amini","url":{"current":"reza-amini-phd-md-mph","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"Azmat Sidhu, MPH","firstName":"Azmat","lastName":"Sidhu","url":{"current":"azmat-sidhu-mph","_type":"slug"},"profileImage":null}]},{"url":"the-daily-balancing-act-of-value-based-cancer-care","_id":"2fe4c86e-9756-4ef8-ab38-411834bb1a83","title":"The Daily Balancing Act of Value-Based Cancer Care","thumbnail":{"_type":"mainImage","alt":"MinnOncology logo | Image: Minnesota Oncology","caption":"MinnOncology logo | Image: Minnesota Oncology","asset":{"_id":"image-7d70f8513adc70c28ce0e147ba594bb572d73064-540x235-jpg","extension":"jpg","metadata":{"_type":"sanity.imageMetadata","palette":{"muted":{"background":"#8e9559","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.11},"lightVibrant":{"background":"#9be8ee","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.38},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.21,"background":"#24475d"},"lightMuted":{"population":0.1,"background":"#ccd3a1","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"vibrant":{"background":"#0bb6ce","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.2},"dominant":{"title":"#fff","population":0.47,"background":"#3f483a","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"population":0.47,"background":"#3f483a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAJABQDASIAAhEBAxEB/8QAGAAAAwEBAAAAAAAAAAAAAAAAAAQFAwj/xAAhEAABBAEEAwEAAAAAAAAAAAACAAEDBBEFITFxFDNDkf/EABUBAQEAAAAAAAAAAAAAAAAAAAID/8QAFxEAAwEAAAAAAAAAAAAAAAAAAAIRAf/aAAwDAQACEQMRAD8A6ee3kXzFILvtuym6MFmnJY8qUpmkLIYbhlR1H1D2lR5DtPFuEmeNB9rGfmf4hbIQKn//2Q==","dimensions":{"_type":"sanity.imageDimensions","width":540,"aspectRatio":2.297872340425532,"height":235},"isOpaque":true,"blurHash":"MFS6V%t8~Vxu9G^+j[x]j[D*%gofsooft6"},"mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/7d70f8513adc70c28ce0e147ba594bb572d73064-540x235.jpg","assetId":"7d70f8513adc70c28ce0e147ba594bb572d73064","_updatedAt":"2024-10-14T16:43:33Z","uploadId":"KFZplqb0QKaISRQVulrrZEj0ohzt8bwt","_type":"sanity.imageAsset","size":11001,"_createdAt":"2024-10-14T16:43:33Z","originalFilename":"minnesota-oncology.jpg","_rev":"KLVqzQL7KTVccOrMxma2pU","sha1hash":"7d70f8513adc70c28ce0e147ba594bb572d73064","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/7d70f8513adc70c28ce0e147ba594bb572d73064-540x235.jpg"}},"published":"2024-10-14T20:00:00.000Z","authorDetails":[{"displayName":"Laura Joszt, MA","firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00","_type":"span"}],"_type":"block","style":"normal","_key":"4a950aea97b3"},{"style":"normal","_key":"b28d8058b3d8","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d","nofollow":true,"blank":true},{"nofollow":true,"blank":true,"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"_type":"span","marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5"},{"marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01","_type":"span"},{"_key":"67a67d3764f02","_type":"span","marks":[],"text":" or "},{"text":"Twitter","_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"]},{"text":".","_key":"67a67d3764f04","_type":"span","marks":[]}],"_type":"block"}],"showSocialShare":true}],"factCheckBy":[{"firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"},"_type":"mainImage","alt":"Laura Joszt headshot"},"biography":[{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"_type":"span","marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00"}],"_type":"block","style":"normal","_key":"4a950aea97b3"},{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d","nofollow":true,"blank":true},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe","nofollow":true,"blank":true}],"children":[{"marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5","_type":"span"},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"marks":[],"text":" or ","_key":"67a67d3764f02","_type":"span"},{"_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"],"text":"Twitter"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block","style":"normal","_key":"b28d8058b3d8"}],"showSocialShare":true,"displayName":"Laura Joszt, MA"}],"issueGroup":{"_ref":"f3dd603a-37be-46c5-a0ed-79c2e9f9a55d","_type":"reference"},"summary":null},{"_id":"ac700a43-4c32-49dd-81d3-c17f7eb1b5c2","summary":null,"authorDetails":[{"firstName":"Rose","lastName":"McNulty","url":{"current":"rose-mcnulty","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Rose McNulty","asset":{"_type":"reference","_ref":"image-8445b436ab605560bc20c7e9c6f4f60912e914df-430x430-png"}},"biography":[{"style":"normal","_key":"3a2b873558e3","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Rose is an associate editorial director at ","_key":"123612bd9b2b0"},{"_key":"2cd28f20d2b9","_type":"span","marks":["em"],"text":"The American Journal of Managed Care"},{"_type":"span","marks":["superscript"],"text":"®","_key":"032c8e723210"},{"_key":"e2d5625eae03","_type":"span","marks":[],"text":" ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3af109dc927a"},{"_type":"span","marks":["superscript"],"text":"®","_key":"1903cd426eb6"},{"marks":[],"text":").","_key":"688f269c2ad0","_type":"span"}],"_type":"block"},{"style":"normal","_key":"3a18842aed2b","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/rose-mcnulty-652a09126/","_key":"a1a427c7e90e"}],"children":[{"marks":[],"text":"She has a BA in journalism \u0026 media studies and Spanish from Rutgers University. You can connect with Rose on ","_key":"3abc796e3805","_type":"span"},{"_type":"span","marks":["a1a427c7e90e"],"text":"LinkedIn","_key":"123612bd9b2b1"},{"_type":"span","marks":[],"text":".","_key":"123612bd9b2b2"}],"_type":"block"}],"showSocialShare":null,"displayName":"Rose McNulty"}],"factCheckBy":[{"firstName":"Rose","lastName":"McNulty","url":{"current":"rose-mcnulty","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Rose McNulty","asset":{"_type":"reference","_ref":"image-8445b436ab605560bc20c7e9c6f4f60912e914df-430x430-png"}},"biography":[{"style":"normal","_key":"3a2b873558e3","markDefs":[],"children":[{"text":"Rose is an associate editorial director at ","_key":"123612bd9b2b0","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"2cd28f20d2b9"},{"_type":"span","marks":["superscript"],"text":"®","_key":"032c8e723210"},{"_type":"span","marks":[],"text":" (","_key":"e2d5625eae03"},{"marks":["em"],"text":"AJMC","_key":"3af109dc927a","_type":"span"},{"_type":"span","marks":["superscript"],"text":"®","_key":"1903cd426eb6"},{"_type":"span","marks":[],"text":").","_key":"688f269c2ad0"}],"_type":"block"},{"markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/rose-mcnulty-652a09126/","_key":"a1a427c7e90e"}],"children":[{"_key":"3abc796e3805","_type":"span","marks":[],"text":"She has a BA in journalism \u0026 media studies and Spanish from Rutgers University. You can connect with Rose on "},{"text":"LinkedIn","_key":"123612bd9b2b1","_type":"span","marks":["a1a427c7e90e"]},{"_type":"span","marks":[],"text":".","_key":"123612bd9b2b2"}],"_type":"block","style":"normal","_key":"3a18842aed2b"}],"showSocialShare":null,"displayName":"Rose McNulty"}],"published":"2024-10-14T18:00:00.000Z","issueGroup":{"_ref":"f3dd603a-37be-46c5-a0ed-79c2e9f9a55d","_type":"reference"},"title":"Transforming Value-Based Oncology Care in an Evolving Therapeutic Landscape","thumbnail":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/b3c196af748f73352b08b68beb6bd7d1b1becb97-310x163.jpg","size":7531,"_id":"image-b3c196af748f73352b08b68beb6bd7d1b1becb97-310x163-jpg","originalFilename":"fcs logo.jpg","metadata":{"palette":{"lightMuted":{"population":0.17,"background":"#caa7ae","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"background":"#db1b41","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.03},"dominant":{"population":0.2,"background":"#32424f","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#32424f","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.2},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.16,"background":"#886d76"},"lightVibrant":{"foreground":"#000","title":"#000","population":0.1,"background":"#96e0f1","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"background":"#045ca4","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAALABQDASIAAhEBAxEB/8QAGAAAAwEBAAAAAAAAAAAAAAAAAAMGBQj/xAAhEAACAgICAQUAAAAAAAAAAAABAgADBREEEhRBUVNhkf/EABUBAQEAAAAAAAAAAAAAAAAAAAAB/8QAFxEBAQEBAAAAAAAAAAAAAAAAABEhQf/aAAwDAQACEQMRAD8A6FoyOUbirYlIcuOwDKQR9GNGSyCjVlNQfW9bm/oRVlFTv2etS3uRLib1OXZjKK+q6aCuvUwlB4nH+FPyEUj/2Q==","dimensions":{"height":163,"_type":"sanity.imageDimensions","width":310,"aspectRatio":1.901840490797546},"isOpaque":true,"blurHash":"MTRfnKxuWCkCWCt7RjjZoejZ~poJoJjsoK","_type":"sanity.imageMetadata"},"_type":"sanity.imageAsset","sha1hash":"b3c196af748f73352b08b68beb6bd7d1b1becb97","path":"images/0vv8moc6/ajmc/b3c196af748f73352b08b68beb6bd7d1b1becb97-310x163.jpg","assetId":"b3c196af748f73352b08b68beb6bd7d1b1becb97","extension":"jpg","_createdAt":"2024-10-14T12:53:32Z","_updatedAt":"2024-10-14T12:53:32Z","uploadId":"Cn0HwxWFv0Ec8KIymIMyyzBtesHXyLzB","_rev":"tCpUdDwaYfiJObLAq3Mq1j","mimeType":"image/jpeg"},"_type":"mainImage"},"url":"transforming-value-based-oncology-care-in-an-evolving-therapeutic-landscape"},{"summary":"The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"_createdAt":"2023-07-11T20:45:56Z","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"title":"#000","population":0.93,"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09},"lightMuted":{"foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch"},"vibrant":{"title":"#fff","population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z","extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"originalFilename":"AJMC_logo_NEW.png","mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png"}},"url":"systemic-treatments-for-advanced-prostate-cancer-relationship-between-health-insurance-plan-and-treatment-costs","authorDetails":[{"lastName":"Kaye","url":{"current":"deborah-r-kaye-md-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Deborah R. Kaye, MD, MS","firstName":"Deborah"},{"url":{"current":"hui-jie-lee-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Hui-Jie Lee, PhD","firstName":"Hui-Jie","lastName":"Lee"},{"lastName":"Gordee","url":{"current":"alexander-gordee-ma","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Alexander Gordee, MA","firstName":"Alexander"},{"lastName":"George","url":{"_type":"slug","current":"daniel-j-george-md"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Daniel J. George, MD","firstName":"Daniel"},{"url":{"current":"charles-d-scales-jr-md-mshs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Charles D. Scales Jr, MD, MSHS","firstName":"Charles","lastName":"Scales"},{"showSocialShare":null,"displayName":"Peter A. Ubel, MD","firstName":"Peter","lastName":"Ubel","url":{"current":"peter-a-ubel-md","_type":"slug"},"profileImage":null,"biography":null},{"lastName":"Bundorf","url":{"current":"m-kate-bundorf-phd-mba-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"M. Kate Bundorf, PhD, MBA, MPH","firstName":"M."}],"_id":"d8777579-53e5-4e4f-a977-0e8f0c366418","title":"Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs","published":"2024-09-20T13:00:00.000Z","factCheckBy":[{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Deborah R. Kaye, MD, MS","firstName":"Deborah","lastName":"Kaye","url":{"current":"deborah-r-kaye-md-ms","_type":"slug"}},{"firstName":"Hui-Jie","lastName":"Lee","url":{"current":"hui-jie-lee-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Hui-Jie Lee, PhD"},{"displayName":"Alexander Gordee, MA","firstName":"Alexander","lastName":"Gordee","url":{"_type":"slug","current":"alexander-gordee-ma"},"profileImage":null,"biography":null,"showSocialShare":null},{"biography":null,"showSocialShare":null,"displayName":"Daniel J. George, MD","firstName":"Daniel","lastName":"George","url":{"current":"daniel-j-george-md","_type":"slug"},"profileImage":null},{"displayName":"Charles D. Scales Jr, MD, MSHS","firstName":"Charles","lastName":"Scales","url":{"_type":"slug","current":"charles-d-scales-jr-md-mshs"},"profileImage":null,"biography":null,"showSocialShare":null},{"url":{"current":"peter-a-ubel-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Peter A. Ubel, MD","firstName":"Peter","lastName":"Ubel"},{"biography":null,"showSocialShare":null,"displayName":"M. Kate Bundorf, PhD, MBA, MPH","firstName":"M.","lastName":"Bundorf","url":{"current":"m-kate-bundorf-phd-mba-mph","_type":"slug"},"profileImage":null}],"issueGroup":{"_type":"reference","_ref":"b8e3b82c-0452-4c4b-8ec4-c441a3a5bfb8"}},{"published":"2024-09-19T13:00:00.000Z","authorDetails":[{"biography":null,"showSocialShare":null,"displayName":"Mariétou H. Ouayogodé, PhD","firstName":"Mariétou","lastName":"Ouayogodé","url":{"current":"marietou-h-ouayogode-phd","_type":"slug"},"profileImage":null},{"displayName":"Brianna Hardy, BS","firstName":"Brianna","lastName":"Hardy","url":{"current":"brianna-hardy-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"John","lastName":"Mullahy","url":{"current":"john-mullahy-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"John Mullahy, PhD"},{"displayName":"Maureen A. Smith, MD, PhD, MPH","firstName":"Maureen","lastName":"Smith","url":{"current":"maureen-a-smith-md-phd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Ellen Meara, PhD","firstName":"Ellen","lastName":"Meara","url":{"current":"ellen-meara-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}],"_id":"caac8d8b-f8a3-4614-8abe-abe358cfa806","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"extension":"png","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"originalFilename":"AJMC_logo_NEW.png","mimeType":"image/png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","metadata":{"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch"},"vibrant":{"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52},"dominant":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38}}},"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","_rev":"hiKH9HIKxNVM35TxYdonKh","_updatedAt":"2023-07-11T20:45:56Z"}},"summary":"Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.","url":"care-transition-management-and-patient-outcomes-in-hospitalized-medicare-beneficiaries","factCheckBy":[{"firstName":"Mariétou","lastName":"Ouayogodé","url":{"current":"marietou-h-ouayogode-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Mariétou H. Ouayogodé, PhD"},{"showSocialShare":null,"displayName":"Brianna Hardy, BS","firstName":"Brianna","lastName":"Hardy","url":{"current":"brianna-hardy-bs","_type":"slug"},"profileImage":null,"biography":null},{"lastName":"Mullahy","url":{"_type":"slug","current":"john-mullahy-phd"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"John Mullahy, PhD","firstName":"John"},{"displayName":"Maureen A. Smith, MD, PhD, MPH","firstName":"Maureen","lastName":"Smith","url":{"current":"maureen-a-smith-md-phd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"url":{"current":"ellen-meara-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Ellen Meara, PhD","firstName":"Ellen","lastName":"Meara"}],"issueGroup":{"_ref":"b8e3b82c-0452-4c4b-8ec4-c441a3a5bfb8","_type":"reference"},"title":"Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries"},{"factCheckBy":[{"showSocialShare":null,"displayName":"Megha A. Parikh, PhD, MS","firstName":"Megha","lastName":"Parikh","url":{"current":"megha-a-parikh-phd-ms","_type":"slug"},"profileImage":null,"biography":null},{"displayName":"Sabree C. Burbage, PharmD, MPH","firstName":"Sabree","lastName":"Burbage","url":{"current":"sabree-c-burbage-pharmd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Meghan H. Gabriel, PhD","firstName":"Meghan","lastName":"Gabriel","url":{"current":"meghan-h-gabriel-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Ben","lastName":"Shirley","url":{"current":"ben-e-shirley-bsph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Ben E. Shirley, BSPH"},{"showSocialShare":null,"displayName":"Patrick J. Campbell, PharmD, PhD","firstName":"Patrick","lastName":"Campbell","url":{"current":"patrick-j-campbell-pharmd-phd","_type":"slug"},"profileImage":null,"biography":null}],"issueGroup":{"_ref":"b8e3b82c-0452-4c4b-8ec4-c441a3a5bfb8","_type":"reference"},"title":"COPD Treatment Ratio: A Measure for Improving COPD Population Health","summary":"This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_createdAt":"2023-07-11T20:45:56Z","metadata":{"palette":{"darkMuted":{"title":"#fff","population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"muted":{"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93,"background":"#cae1f2"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09,"background":"#044679"},"lightMuted":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette"},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"_type":"sanity.imageExifMetadata","PixelXDimension":778,"PixelYDimension":382},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata"},"_updatedAt":"2023-07-11T20:45:56Z","_rev":"hiKH9HIKxNVM35TxYdonKh","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"originalFilename":"AJMC_logo_NEW.png","extension":"png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","mimeType":"image/png"}},"url":"copd-treatment-ratio-a-measure-for-improving-copd-population-health","published":"2024-09-18T16:00:00.000Z","authorDetails":[{"firstName":"Megha","lastName":"Parikh","url":{"current":"megha-a-parikh-phd-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Megha A. Parikh, PhD, MS"},{"lastName":"Burbage","url":{"current":"sabree-c-burbage-pharmd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Sabree C. Burbage, PharmD, MPH","firstName":"Sabree"},{"lastName":"Gabriel","url":{"_type":"slug","current":"meghan-h-gabriel-phd"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Meghan H. Gabriel, PhD","firstName":"Meghan"},{"displayName":"Ben E. Shirley, BSPH","firstName":"Ben","lastName":"Shirley","url":{"current":"ben-e-shirley-bsph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Patrick J. Campbell, PharmD, PhD","firstName":"Patrick","lastName":"Campbell","url":{"current":"patrick-j-campbell-pharmd-phd","_type":"slug"}}],"_id":"53f2a80a-ab08-4863-9f67-14a3c7903a0d"},{"_id":"04159ba8-44f9-40b5-b25f-0ae627881e39","title":"Healthy State: Practicing What They Preach in Louisiana","summary":"An IVBM event cohosted by The American Journal of Managed Care focused on Healthy State, a multiyear, multistakeholder commitment to moving Louisiana ahead in America’s Health Rankings.","issueGroup":{"_type":"reference","_ref":"73c988a3-a73b-49fa-af49-dce7e755e713"},"thumbnail":{"asset":{"_createdAt":"2024-08-28T16:07:24Z","_id":"image-29b0fbb8f7b48c24276a1a8a300c1168e50e8707-2800x1867-jpg","extension":"jpg","altText":null,"_rev":"LtkInV1jlQdtEIFjVqjDMg","path":"images/0vv8moc6/ajmc/29b0fbb8f7b48c24276a1a8a300c1168e50e8707-2800x1867.jpg","size":4265557,"_type":"sanity.imageAsset","description":null,"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/29b0fbb8f7b48c24276a1a8a300c1168e50e8707-2800x1867.jpg","originalFilename":"New Orleans Bourbon Street - f11photo - AdobeStock_169182961.jpeg","title":null,"_updatedAt":"2024-08-28T16:07:46Z","assetId":"29b0fbb8f7b48c24276a1a8a300c1168e50e8707","metadata":{"exif":{"LightSource":0,"CustomRendered":0,"PixelYDimension":1867,"LensSpecification":[16,35,4,4],"SensitivityType":2,"ColorSpace":1,"FocalPlaneYResolution":2164.4328018223237,"DateTimeOriginal":"2016-11-15T06:32:19.000Z","ExposureProgram":1,"ExposureMode":1,"ISO":100,"Contrast":0,"Sharpness":0,"_type":"sanity.imageExifMetadata","FNumber":5.6,"RecommendedExposureIndex":100,"ApertureValue":4.970853658536585,"FocalPlaneResolutionUnit":3,"FocalLengthIn35mmFormat":42,"BrightnessValue":-0.89296875,"DigitalZoomRatio":1,"ExposureBiasValue":0,"SceneCaptureType":0,"MaxApertureValue":4,"Saturation":2,"LensModel":"16-35mm F4 G SSM OSS","FocalLength":28,"FocalPlaneXResolution":2164.4328018223237,"DateTimeDigitized":null,"WhiteBalance":0,"PixelXDimension":2800,"MeteringMode":5,"ShutterSpeedValue":-1,"ExposureTime":2},"isOpaque":true,"blurHash":"VLKJoRB?^vPDoi765Ev|$*$x~W-poztRR-%#x]SxNyt7","_type":"sanity.imageMetadata","palette":{"_type":"sanity.imagePalette","darkMuted":{"background":"#2e3d58","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.99},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":5.22,"background":"#976e64"},"lightVibrant":{"background":"#f6d770","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":6.13},"darkVibrant":{"background":"#935917","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.13},"lightMuted":{"background":"#b6a9cd","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.06},"vibrant":{"foreground":"#000","title":"#fff","population":5.95,"background":"#efa11f","_type":"sanity.imagePaletteSwatch"},"dominant":{"foreground":"#000","title":"#000","population":6.13,"background":"#f6d770","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2800,"aspectRatio":1.4997321906802357,"height":1867}},"uploadId":"kH1bS8OTS7iWFNmOt3qixxFUDmuSmj11","mimeType":"image/jpeg","sha1hash":"29b0fbb8f7b48c24276a1a8a300c1168e50e8707","opt":{"media":{"tags":null}}},"_type":"mainImage","alt":"New Orleans Bourbon Street | Image Credit: © f11photo - stock.adobe.com"},"url":"healthy-state-practicing-what-they-preach-in-louisiana","published":"2024-09-16T16:31:55.211Z","authorDetails":[{"displayName":"Mary K. Caffrey","firstName":null,"lastName":null,"url":{"current":"mary-k-caffrey","_type":"slug"},"profileImage":{"asset":{"_ref":"image-ed06a2c91900970a850116ba649d9f9b4a954ca5-430x430-png","_type":"reference"},"default":false,"_type":"mainImage","alt":"Mary K. Caffrey"},"biography":null,"showSocialShare":null}],"factCheckBy":[{"biography":null,"showSocialShare":null,"displayName":"Mary K. Caffrey","firstName":null,"lastName":null,"url":{"_type":"slug","current":"mary-k-caffrey"},"profileImage":{"default":false,"_type":"mainImage","alt":"Mary K. Caffrey","asset":{"_ref":"image-ed06a2c91900970a850116ba649d9f9b4a954ca5-430x430-png","_type":"reference"}}}]},{"issueGroup":{"_type":"reference","_ref":"73c988a3-a73b-49fa-af49-dce7e755e713"},"published":"2024-09-16T16:31:18.436Z","authorDetails":[{"firstName":"Christina","lastName":"Mattina","url":{"current":"christina-mattina","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Christina Mattina","asset":{"_ref":"image-6304e08858dcb7b689cd8fa5703c926a96ecdb48-512x492-jpg","_type":"reference"}},"biography":[{"children":[{"_type":"span","marks":[],"text":"Christina is the associate editorial director of ","_key":"ffac76b64934"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"4eac35f29678","_type":"span"},{"_type":"span","marks":["superscript"],"text":"®","_key":"b16316585120"},{"_type":"span","marks":[],"text":" (","_key":"ed200dc9139a"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b773bee92455"},{"_type":"span","marks":["superscript"],"text":"®","_key":"1f9bb13b24fa"},{"_type":"span","marks":[],"text":") and ","_key":"b9461d308bc8"},{"_type":"span","marks":["em"],"text":"The American Journal of Accountable Care","_key":"f235dc7df490"},{"_type":"span","marks":["superscript"],"text":"®","_key":"14118ee858d3"},{"text":" (","_key":"a25757970c62","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJAC","_key":"6353c3a02e0f"},{"_type":"span","marks":[],"text":"), and joined ","_key":"7f777b20be12"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"682a0f2ea0d4"},{"_type":"span","marks":[],"text":" in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.","_key":"8b1f00d70d7f"}],"_type":"block","style":"normal","_key":"9271b97a8f45","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"She has a BS in public health from Rutgers University. You can connect with Christina on ","_key":"6d8dca7834cc"},{"marks":["c281c6aba22d"],"text":"LinkedIn","_key":"e23534b48658","_type":"span"},{"_type":"span","marks":[],"text":".","_key":"83d100c64d0e"}],"_type":"block","style":"normal","_key":"a90d7ab4c801","markDefs":[{"href":"https://www.linkedin.com/in/christinamattina/","_key":"c281c6aba22d","nofollow":true,"blank":true,"_type":"link"}]}],"showSocialShare":null,"displayName":"Christina Mattina"}],"factCheckBy":[{"displayName":"Christina Mattina","firstName":"Christina","lastName":"Mattina","url":{"current":"christina-mattina","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Christina Mattina","asset":{"_ref":"image-6304e08858dcb7b689cd8fa5703c926a96ecdb48-512x492-jpg","_type":"reference"}},"biography":[{"children":[{"_type":"span","marks":[],"text":"Christina is the associate editorial director of ","_key":"ffac76b64934"},{"text":"The American Journal of Managed Care","_key":"4eac35f29678","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"b16316585120"},{"marks":[],"text":" (","_key":"ed200dc9139a","_type":"span"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b773bee92455"},{"_key":"1f9bb13b24fa","_type":"span","marks":["superscript"],"text":"®"},{"_type":"span","marks":[],"text":") and ","_key":"b9461d308bc8"},{"_type":"span","marks":["em"],"text":"The American Journal of Accountable Care","_key":"f235dc7df490"},{"text":"®","_key":"14118ee858d3","_type":"span","marks":["superscript"]},{"text":" (","_key":"a25757970c62","_type":"span","marks":[]},{"marks":["em"],"text":"AJAC","_key":"6353c3a02e0f","_type":"span"},{"_type":"span","marks":[],"text":"), and joined ","_key":"7f777b20be12"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"682a0f2ea0d4"},{"_type":"span","marks":[],"text":" in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.","_key":"8b1f00d70d7f"}],"_type":"block","style":"normal","_key":"9271b97a8f45","markDefs":[]},{"_key":"a90d7ab4c801","markDefs":[{"_key":"c281c6aba22d","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/christinamattina/"}],"children":[{"marks":[],"text":"She has a BS in public health from Rutgers University. You can connect with Christina on ","_key":"6d8dca7834cc","_type":"span"},{"text":"LinkedIn","_key":"e23534b48658","_type":"span","marks":["c281c6aba22d"]},{"_type":"span","marks":[],"text":".","_key":"83d100c64d0e"}],"_type":"block","style":"normal"}],"showSocialShare":null}],"_id":"2a95bae0-0c9f-4bc1-8e7d-3602ac803646","title":"Institute for Value-Based Medicine®: Multifaceted Approach Can Help Patients Benefit From the Expanded Lipid-Lowering Toolbox","summary":"Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that the recent advancements in lipid management are making their way to patients.","thumbnail":{"_type":"mainImage","alt":"Denver Colorado | Image Credit: © f11photo - stock.adobe.com","asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/c2b2ded664a1fbdc0483dd96d0b7deae84831a7b-1200x700.jpg","size":584915,"_id":"image-c2b2ded664a1fbdc0483dd96d0b7deae84831a7b-1200x700-jpg","extension":"jpg","mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/c2b2ded664a1fbdc0483dd96d0b7deae84831a7b-1200x700.jpg","uploadId":"H7WTao1JKvhWv1JBicLCJENbGPV6jpQH","_type":"sanity.imageAsset","sha1hash":"c2b2ded664a1fbdc0483dd96d0b7deae84831a7b","assetId":"c2b2ded664a1fbdc0483dd96d0b7deae84831a7b","_createdAt":"2024-09-13T18:14:54Z","metadata":{"isOpaque":true,"blurHash":"MjHx1~IoS$S4oL%QRijZWrbH9vocWAoffP","_type":"sanity.imageMetadata","palette":{"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":4.67,"background":"#50659b"},"lightVibrant":{"background":"#e9cf8d","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.31},"darkVibrant":{"title":"#fff","population":0.56,"background":"#544d07","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":2.17,"background":"#a2a7c8","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":1.42,"background":"#ca762d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"title":"#fff","population":6.64,"background":"#4f4e2c","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"population":6.64,"background":"#4f4e2c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAMABQDASIAAhEBAxEB/8QAGAAAAgMAAAAAAAAAAAAAAAAAAAcCBAX/xAAfEAACAgICAwEAAAAAAAAAAAABAgADBBEGEiExYQX/xAAWAQEBAQAAAAAAAAAAAAAAAAACAwT/xAAdEQABBAIDAAAAAAAAAAAAAAADAAECEQQxBRJB/9oADAMBAAIRAxEAPwCeBhfnUkd7arNe+reptUZ/HVcV2voiKx8m2mtTWQCfgly3NtZEdhWWHgHqJI3InaVstA4C6aTkqyOIJWvfKRSRvREImxc7gMx8n5CBs83qLxhel//Z","dimensions":{"_type":"sanity.imageDimensions","width":1200,"aspectRatio":1.7142857142857142,"height":700},"exif":{"_type":"sanity.imageExifMetadata","DateTimeDigitized":"2014-09-12T07:37:33.000Z","ColorSpace":1,"PixelXDimension":1200,"PixelYDimension":700}},"_updatedAt":"2024-09-13T18:14:54Z","originalFilename":"Denver Colorado - f11photo - stock.adobe.com.jpeg","_rev":"WVB52uR738qojYGNKmrerb"}},"url":"multifaceted-approach-can-help-patients-benefit-from-the-expanded-lipid-lowering-toolbox"},{"published":"2024-09-16T16:29:41.215Z","authorDetails":[{"url":{"current":"rebecca-flournoy-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Rebecca Flournoy, MPH","firstName":"Rebecca","lastName":"Flournoy"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Reema Shah, MPH","firstName":"Reema","lastName":"Shah","url":{"_type":"slug","current":"reema-shah-mph"}},{"firstName":"Elizabeth","lastName":"Moisan","url":{"current":"elizabeth-moisan-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Elizabeth Moisan, MS"},{"showSocialShare":null,"displayName":"Cecilia Oregón, MPP, MPH","firstName":"Cecilia","lastName":"Oregón","url":{"current":"cecilia-oreg-n-mpp-mph","_type":"slug"},"profileImage":null,"biography":null}],"factCheckBy":[{"biography":null,"showSocialShare":null,"displayName":"Rebecca Flournoy, MPH","firstName":"Rebecca","lastName":"Flournoy","url":{"current":"rebecca-flournoy-mph","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"Reema Shah, MPH","firstName":"Reema","lastName":"Shah","url":{"current":"reema-shah-mph","_type":"slug"},"profileImage":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Elizabeth Moisan, MS","firstName":"Elizabeth","lastName":"Moisan","url":{"current":"elizabeth-moisan-ms","_type":"slug"}},{"biography":null,"showSocialShare":null,"displayName":"Cecilia Oregón, MPP, MPH","firstName":"Cecilia","lastName":"Oregón","url":{"_type":"slug","current":"cecilia-oreg-n-mpp-mph"},"profileImage":null}],"_id":"336a74f6-937d-40c6-a94c-b14c26f025f6","summary":"Experiences from a large, integrated, value-based health system suggest that telehealth can be an effective care delivery approach. Public policies can improve telehealth access and care.","thumbnail":{"_type":"mainImage","alt":"telemedicine | Image Credit: © rh2010 - stock.adobe.com","asset":{"_rev":"yLkPQ1Yunv4gUqVh5QBQaa","path":"images/0vv8moc6/ajmc/aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912.jpg","metadata":{"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":7360,"aspectRatio":1.498371335504886,"height":4912},"isOpaque":true,"blurHash":"VEDl=,D%4n?c-;_N%M-pD%xvM{-;_3DiWBt7xax]t7M{","_type":"sanity.imageMetadata","palette":{"vibrant":{"background":"#ba825c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.01},"dominant":{"background":"#bbbcbe","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.95},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":6.82,"background":"#61553c","_type":"sanity.imagePaletteSwatch"},"muted":{"background":"#b4745c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.05,"background":"#e7d1c6"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":6.07,"background":"#493a1a","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.95,"background":"#bbbcbe"}},"hasAlpha":false},"uploadId":"ueKegQc9OLg07IP1riXXhgBAywYfiVMU","_updatedAt":"2023-12-05T16:28:07Z","extension":"jpg","_type":"sanity.imageAsset","sha1hash":"aa55cba013e542363db5e3021a7d049b005c0d44","size":10640408,"mimeType":"image/jpeg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912.jpg","assetId":"aa55cba013e542363db5e3021a7d049b005c0d44","_createdAt":"2023-12-05T16:28:07Z","_id":"image-aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912-jpg","originalFilename":"telemedicine - rh2010.jpeg"}},"url":"telehealth-insights-from-an-integrated-care-system","issueGroup":{"_ref":"73c988a3-a73b-49fa-af49-dce7e755e713","_type":"reference"},"title":"Telehealth Insights From an Integrated Care System"},{"url":"building-a-virtual-model-for-care-after-cancer","published":"2024-08-19T16:19:00.000Z","authorDetails":[{"profileImage":null,"biography":[{"_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc","_type":"span"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"text":"AJMC","_key":"953d8c643cce","_type":"span","marks":["em"]},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4","nofollow":true,"blank":true}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"text":".","_key":"9737335da1ed2","_type":"span","marks":[]}]}],"showSocialShare":null,"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"current":"mary-caffrey","_type":"slug"}}],"factCheckBy":[{"url":{"_type":"slug","current":"mary-caffrey"},"profileImage":null,"biography":[{"_type":"block","style":"normal","_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_key":"b8dda18bb0dc","_type":"span","marks":["em"],"text":"AJMC"},{"marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08","_type":"span"},{"marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962","_type":"span"},{"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}]},{"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_type":"span","marks":[],"text":".","_key":"9737335da1ed2"}],"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4"}]}],"showSocialShare":null,"displayName":"Mary Caffrey","firstName":null,"lastName":null}],"issueGroup":{"_type":"reference","_ref":"8f469cb0-5c36-4eaf-ab0e-2a34a0c7bf53"},"title":"Building a Virtual Model for Care After Cancer","summary":null,"_id":"f8b60efe-f6db-4fc2-a830-b561053d4e91","thumbnail":{"caption":"Nurse offering virtual visit | Image credit: Pexels/ Tima Miroshnichenko","asset":{"uploadId":"2MwogAhJjfoY4HPFZ5xFzgjlENqac6KT","_rev":"wjCpg6dpTOIsmpmsT5C0z0","assetId":"ff16c42fb864c9e25a3c3f95ebe8c2519c41fc88","_updatedAt":"2024-08-19T18:07:41Z","mimeType":"image/jpeg","size":1146957,"originalFilename":"telemedicine.jpeg","extension":"jpg","_type":"sanity.imageAsset","sha1hash":"ff16c42fb864c9e25a3c3f95ebe8c2519c41fc88","path":"images/0vv8moc6/ajmc/ff16c42fb864c9e25a3c3f95ebe8c2519c41fc88-5928x3952.jpg","_id":"image-ff16c42fb864c9e25a3c3f95ebe8c2519c41fc88-5928x3952-jpg","metadata":{"blurHash":"VLLXb^Dh.9?bD%_4%gIUM_jZD%NG%MR*bb?cR*flo#t8","_type":"sanity.imageMetadata","palette":{"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.01,"background":"#945c5c"},"lightVibrant":{"population":0,"background":"#d7bca2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"darkVibrant":{"background":"#6e5434","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.19},"lightMuted":{"background":"#c4b7a8","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":2.7},"vibrant":{"background":"#bc8e62","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01},"dominant":{"population":7.7,"background":"#3e321f","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#3e321f","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.7}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAANABQDASIAAhEBAxEB/8QAGAAAAwEBAAAAAAAAAAAAAAAAAAYHAgT/xAAlEAABAwMDAwUAAAAAAAAAAAADAQIEAAURBhIhBxQWMTJCUXH/xAAVAQEBAAAAAAAAAAAAAAAAAAADBP/EABgRAQADAQAAAAAAAAAAAAAAAAAREyIS/9oADAMBAAIRAxEAPwCp9wbuoqPKj2lzxjFYssed5BLeSQQkdUXAl9rfypf1Bv08UWIYRdjmO2ps4ru6Q6onlucgZ3qVpGfJ2cL90N2+SVZk73udqkdzMy1RBviIqbHOVMrRTOo3Nwm9V4z6UVWmf//Z","dimensions":{"height":3952,"_type":"sanity.imageDimensions","width":5928,"aspectRatio":1.5},"isOpaque":true},"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/ff16c42fb864c9e25a3c3f95ebe8c2519c41fc88-5928x3952.jpg","_createdAt":"2024-08-19T18:07:41Z"},"_type":"mainImage","alt":"Nurse offering virtual visit | Image credit: Pexels/ Tima Miroshnichenko"}},{"title":"Revised EOM Offers More Favorable Opportunities for Community Practices, Experts Say","thumbnail":{"_type":"mainImage","alt":"COA seal | Image : COA","asset":{"uploadId":"55Ghe83hpIc18afc6jZj9tvxmCfNsnZ7","_rev":"sgy4yN0CjmArmRDnE4d79D","sha1hash":"17ee076fc9d3da91dfa9c86f1e4048fa882b29eb","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/17ee076fc9d3da91dfa9c86f1e4048fa882b29eb-602x602.png","mimeType":"image/png","size":89027,"_createdAt":"2024-05-21T20:44:39Z","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/17ee076fc9d3da91dfa9c86f1e4048fa882b29eb-602x602.png","assetId":"17ee076fc9d3da91dfa9c86f1e4048fa882b29eb","_id":"image-17ee076fc9d3da91dfa9c86f1e4048fa882b29eb-602x602-png","extension":"png","metadata":{"_type":"sanity.imageMetadata","palette":{"lightMuted":{"title":"#fff","population":3.12,"background":"#a0acc0","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"background":"#e31934","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":19.15},"dominant":{"foreground":"#fff","title":"#fff","population":19.23,"background":"#143c8c","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":1.07,"background":"#293653","_type":"sanity.imagePaletteSwatch"},"muted":{"foreground":"#fff","title":"#fff","population":0.42,"background":"#54719f","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"foreground":"#000","title":"#fff","population":0.07,"background":"#fa84a0","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"title":"#fff","population":19.23,"background":"#143c8c","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"aspectRatio":1,"height":602,"_type":"sanity.imageDimensions","width":602},"isOpaque":false,"blurHash":"eBK9_:sp2@XSI8jGkWWUMdjb1HWV_#VsQmR+rrRPt,t7ptj@HXbF6-"},"_updatedAt":"2024-05-21T20:44:39Z","originalFilename":"COA_seal_2019-4C.png"}},"authorDetails":[{"lastName":null,"url":{"current":"mary-caffrey","_type":"slug"},"profileImage":null,"biography":[{"_type":"block","style":"normal","_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc","_type":"span"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"text":"AJMC","_key":"953d8c643cce","_type":"span","marks":["em"]},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}]},{"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"text":".","_key":"9737335da1ed2","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"_key":"4f88673cb2c4","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/"}]}],"showSocialShare":null,"displayName":"Mary Caffrey","firstName":null}],"factCheckBy":[{"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"_type":"slug","current":"mary-caffrey"},"profileImage":null,"biography":[{"_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_key":"b8dda18bb0dc","_type":"span","marks":["em"],"text":"AJMC"},{"marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08","_type":"span"},{"marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962","_type":"span"},{"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4"}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_type":"span","marks":[],"text":".","_key":"9737335da1ed2"}]}],"showSocialShare":null}],"issueGroup":{"_ref":"8f469cb0-5c36-4eaf-ab0e-2a34a0c7bf53","_type":"reference"},"summary":null,"url":"revised-eom-offers-more-favorable-opportunities-for-community-practices-experts-say","published":"2024-08-16T17:21:00.000Z","_id":"eaa4797e-cc0e-4b10-b3c5-169ea3739552"},{"title":"Collaborative Innovation: Flatiron Health and Canopy Partner to Streamline Continuous Care for Oncology Practices","authorDetails":[{"lastName":"Kwiatkowsky","url":{"current":"lavi-kwiatkowsky","_type":"slug"},"profileImage":null,"biography":[{"markDefs":[],"children":[{"marks":[],"text":"Lavi Kwiatkowsky is the founder and CEO of Canopy.","_key":"33c855f42e2b0","_type":"span"}],"_type":"block","style":"normal","_key":"4839ffeb2829"}],"showSocialShare":null,"displayName":"Lavi Kwiatkowsky","firstName":"lavi"},{"lastName":"Calkins","url":{"current":"geoff-calkins","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Geoff Calkins","firstName":"Geoff"}],"thumbnail":{"caption":"Flatiron + Canopy logo | Image: Canopy","asset":{"_type":"sanity.imageAsset","originalFilename":"flatiron canopy.png","_createdAt":"2024-08-16T11:54:45Z","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/48b05b74a043a14725208c64dc5511c83f873960-2048x738.png","size":930539,"_rev":"EDJmlW7GHoHEwq10zl3D3G","mimeType":"image/png","path":"images/0vv8moc6/ajmc/48b05b74a043a14725208c64dc5511c83f873960-2048x738.png","_id":"image-48b05b74a043a14725208c64dc5511c83f873960-2048x738-png","extension":"png","uploadId":"3ct5wI5akdtTDeBzgjxMzDWJAYaAnmYK","assetId":"48b05b74a043a14725208c64dc5511c83f873960","_updatedAt":"2024-08-16T11:54:45Z","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2048,"aspectRatio":2.7750677506775068,"height":738},"isOpaque":true,"blurHash":"D47nu1xU%Lx^4n?dxtt7ofM{","_type":"sanity.imageMetadata","palette":{"muted":{"background":"#5e599d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.1},"lightVibrant":{"title":"#000","population":0.03,"background":"#d5d4fc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"title":"#fff","population":0.01,"background":"#041c71","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"title":"#fff","population":0.58,"background":"#a4afd8","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"foreground":"#fff","title":"#fff","population":42.73,"background":"#1c2c84","_type":"sanity.imagePaletteSwatch"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":42.73,"background":"#1c2c84"},"_type":"sanity.imagePalette","darkMuted":{"background":"#465281","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.44}},"hasAlpha":true},"sha1hash":"48b05b74a043a14725208c64dc5511c83f873960"},"_type":"mainImage","alt":"Flatiron + Canopy logo | Image: Canopy"},"url":"collaborative-innovation-flatiron-health-and-canopy-partner-to-streamline-continuous-care-for-oncology-practices","published":"2024-08-16T11:30:00.000Z","factCheckBy":[{"showSocialShare":null,"displayName":"Lavi Kwiatkowsky","firstName":"lavi","lastName":"Kwiatkowsky","url":{"current":"lavi-kwiatkowsky","_type":"slug"},"profileImage":null,"biography":[{"children":[{"_type":"span","marks":[],"text":"Lavi Kwiatkowsky is the founder and CEO of Canopy.","_key":"33c855f42e2b0"}],"_type":"block","style":"normal","_key":"4839ffeb2829","markDefs":[]}]},{"lastName":"Calkins","url":{"_type":"slug","current":"geoff-calkins"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Geoff Calkins","firstName":"Geoff"}],"_id":"77701ccb-39e1-4b49-ac6b-b5aa65801a00","issueGroup":{"_ref":"8f469cb0-5c36-4eaf-ab0e-2a34a0c7bf53","_type":"reference"},"summary":null},{"title":"Cardiometabolic Interventions Focus on Accessibility, Evidence-Based Medicine","published":"2024-06-14T13:00:00.000Z","authorDetails":[{"displayName":"Giuliana Grossi","firstName":null,"lastName":null,"url":{"current":"giuliana-grossi","_type":"slug"},"profileImage":{"alt":"Giuliana Grossi","asset":{"_ref":"image-5dc1da24786c43a7f87e4ea0a7ae3880e6cee39f-430x430-png","_type":"reference"},"_type":"mainImage"},"biography":null,"showSocialShare":null}],"factCheckBy":[{"biography":null,"showSocialShare":null,"displayName":"Giuliana Grossi","firstName":null,"lastName":null,"url":{"current":"giuliana-grossi","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Giuliana Grossi","asset":{"_ref":"image-5dc1da24786c43a7f87e4ea0a7ae3880e6cee39f-430x430-png","_type":"reference"}}}],"_id":"1472df1f-ab77-4b68-8ced-12ff81256022","issueGroup":{"_ref":"c6747bef-322f-4aa5-bf20-1af9d678cde0","_type":"reference"},"url":"cardiometabolic-interventions-focus-on-accessibility-evidence-based-medicine","summary":"At an Institute for Value-Based Medicine® (IVBM) event cohosted by The American Journal of Managed Care® and Sutter Health, experts illuminated the current state of cardiometabolic health care and offered a glimpse into the future.","thumbnail":{"_type":"mainImage","alt":"San Francisco's Golden Gate Bridge | Image Credit: © phitha - stock.adobe.com","asset":{"mimeType":"image/jpeg","size":416089,"_updatedAt":"2024-06-07T15:30:01Z","_rev":"SWZtARO2mf3vRstToueLld","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/1f3095024fd984fa3a60b43c4cf33663635bcaf7-1200x800.jpg","path":"images/0vv8moc6/ajmc/1f3095024fd984fa3a60b43c4cf33663635bcaf7-1200x800.jpg","_id":"image-1f3095024fd984fa3a60b43c4cf33663635bcaf7-1200x800-jpg","extension":"jpg","uploadId":"O5nnIZFuz4knEBd9QmteN8nCCmR8xh2K","_createdAt":"2024-06-07T15:30:01Z","originalFilename":"San Francisco Golden Gate Bridge - phitha - stock.adobe.com.jpeg","metadata":{"exif":{"ExposureProgram":3,"ApertureValue":6.9188632619439865,"BrightnessValue":-0.44765625,"FocalPlaneResolutionUnit":3,"ExposureBiasValue":0,"Saturation":0,"LensSpecification":[70,300,4.5,5.6],"MeteringMode":5,"LensModel":"FE 70-300mm F4.5-5.6 G OSS","FNumber":11,"RecommendedExposureIndex":200,"_type":"sanity.imageExifMetadata","ExposureTime":3.2,"PixelXDimension":1200,"FocalPlaneYResolution":2164.4328018223237,"DateTimeOriginal":"2016-06-04T04:25:41.000Z","ColorSpace":1,"WhiteBalance":1,"ISO":200,"LightSource":14,"FocalPlaneXResolution":2164.4328018223237,"FocalLengthIn35mmFormat":220,"ShutterSpeedValue":-1.6780719083366258,"SceneCaptureType":0,"DateTimeDigitized":"2016-06-04T04:25:41.000Z","FocalLength":220,"CustomRendered":0,"DigitalZoomRatio":1,"MaxApertureValue":4.970853658536585,"Contrast":0,"PixelYDimension":800,"SensitivityType":2,"ExposureMode":0,"Sharpness":0},"isOpaque":true,"blurHash":"VuJ@2qs:WCjYbb}%soahbIjs-:R*WBoJW:I.W=WEoLj[","_type":"sanity.imageMetadata","palette":{"dominant":{"population":8.5,"background":"#9099c0","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"population":7.93,"background":"#2e3250","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"foreground":"#fff","title":"#fff","population":0.47,"background":"#9c5c58","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":4.62,"background":"#fbe182"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":3.69,"background":"#6f2c2a","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"foreground":"#000","title":"#fff","population":8.5,"background":"#9099c0","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":7.2,"background":"#f2a973","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"aspectRatio":1.5,"height":800,"_type":"sanity.imageDimensions","width":1200}},"_type":"sanity.imageAsset","sha1hash":"1f3095024fd984fa3a60b43c4cf33663635bcaf7","assetId":"1f3095024fd984fa3a60b43c4cf33663635bcaf7"}}},{"_id":"4d553701-915f-4873-8b9f-4f53893d6561","issueGroup":{"_ref":"c6747bef-322f-4aa5-bf20-1af9d678cde0","_type":"reference"},"title":"Experts Highlight How GLP-1s Have Revolutionized Management of T2D and Obesity ","summary":"The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists has been revolutionary.","published":"2024-06-13T19:00:00.000Z","thumbnail":{"_type":"mainImage","alt":"Cleveland Ohio | Image Credit: © Ai - stock.adobe.com.jpeg","asset":{"uploadId":"gcL2RcGUNOwVnVWGsh0ao9mQiEvDHrKK","_rev":"FTf7O3KU2GxuMy4tElpSB4","assetId":"264df279db594adda69bc3737a08c6773f27a6ef","_createdAt":"2024-06-07T15:42:37Z","_id":"image-264df279db594adda69bc3737a08c6773f27a6ef-1200x800-jpg","extension":"jpg","path":"images/0vv8moc6/ajmc/264df279db594adda69bc3737a08c6773f27a6ef-1200x800.jpg","_type":"sanity.imageAsset","sha1hash":"264df279db594adda69bc3737a08c6773f27a6ef","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/264df279db594adda69bc3737a08c6773f27a6ef-1200x800.jpg","size":501001,"originalFilename":"Cleveland Ohio - Ai - stock.adobe.com.jpeg","metadata":{"isOpaque":true,"blurHash":"VwHx:8$xRit5WA_4$~jEaej[T1oMWEa}axENR-f6bIWC","_type":"sanity.imageMetadata","palette":{"vibrant":{"foreground":"#fff","title":"#fff","population":5.13,"background":"#0d90d3","_type":"sanity.imagePaletteSwatch"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.22,"background":"#677397"},"_type":"sanity.imagePalette","darkMuted":{"background":"#30384f","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.79},"muted":{"background":"#677397","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.22},"lightVibrant":{"background":"#efc989","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":2.52},"darkVibrant":{"population":0,"background":"#043484","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":2.56,"background":"#8897be","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"aspectRatio":1.5,"height":800,"_type":"sanity.imageDimensions","width":1200},"exif":{"ExposureMode":0,"FNumber":20,"MeteringMode":5,"MaxApertureValue":2.9708536585365852,"FocalLengthIn35mmFormat":27,"LensSerialNumber":"48A03748","LensMake":"FUJIFILM","PixelXDimension":1200,"BrightnessValue":5.84,"DateTimeOriginal":"2016-07-24T18:28:07.000Z","ExposureBiasValue":0.33,"Saturation":1,"ISO":500,"ColorSpace":1,"ExposureTime":0.08333333333333333,"WhiteBalance":1,"LensSpecification":[18,55,2.8,4],"PixelYDimension":800,"ExposureProgram":3,"CustomRendered":0,"FocalPlaneXResolution":2083.4231274638632,"ApertureValue":8.643856143856144,"FocalPlaneYResolution":2083.4231274638632,"DateTimeDigitized":"2016-07-24T00:00:00.000Z","Sharpness":0,"ShutterSpeedValue":3.584962502403692,"LightSource":11,"FocalPlaneResolutionUnit":3,"SensitivityType":1,"FocalLength":18,"_type":"sanity.imageExifMetadata","LensModel":"XF18-55mmF2.8-4 R LM OIS","SensingMethod":2,"SceneCaptureType":0,"SubjectDistanceRange":0}},"mimeType":"image/jpeg","_updatedAt":"2024-06-07T15:42:37Z"}},"url":"experts-highlight-how-glp-1s-have-revolutionized-management-of-t2d-and-obesity","authorDetails":[{"firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00","_type":"span"}],"_type":"block","style":"normal","_key":"4a950aea97b3"},{"_type":"block","style":"normal","_key":"b28d8058b3d8","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_key":"c419f18a7ffe","nofollow":true,"blank":true,"_type":"link","href":"https://twitter.com/joszt"}],"children":[{"_type":"span","marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5"},{"marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01","_type":"span"},{"_key":"67a67d3764f02","_type":"span","marks":[],"text":" or "},{"text":"Twitter","_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"]},{"text":".","_key":"67a67d3764f04","_type":"span","marks":[]}]}],"showSocialShare":true,"displayName":"Laura Joszt, MA"}],"factCheckBy":[{"firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"},"_type":"mainImage","alt":"Laura Joszt headshot"},"biography":[{"_key":"4a950aea97b3","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"_type":"span","marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00"}],"_type":"block","style":"normal"},{"_key":"b28d8058b3d8","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d","nofollow":true},{"_key":"c419f18a7ffe","nofollow":true,"blank":true,"_type":"link","href":"https://twitter.com/joszt"}],"children":[{"marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5","_type":"span"},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"marks":[],"text":" or ","_key":"67a67d3764f02","_type":"span"},{"_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"],"text":"Twitter"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block","style":"normal"}],"showSocialShare":true,"displayName":"Laura Joszt, MA"}]},{"issueGroup":{"_ref":"c6747bef-322f-4aa5-bf20-1af9d678cde0","_type":"reference"},"summary":"The use of a novel digital health platform achieved a 55% reduction in time to treatment among women with a new diagnosis of breast cancer.","published":"2024-06-13T13:00:00.000Z","authorDetails":[{"showSocialShare":null,"displayName":"Dennis R. Holmes, MD","firstName":"Dennis","lastName":"Holmes","url":{"current":"dennis-r-holmes-md","_type":"slug"},"profileImage":null,"biography":null},{"displayName":"Steven D. Evans, MD","firstName":"Steven","lastName":"Evans","url":{"current":"steven-d-evans-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Warren","lastName":"Fisher","url":{"_type":"slug","current":"warren-fisher-do"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Warren Fisher, DO"},{"displayName":"Darren Wheeler, MD","firstName":"Darren","lastName":"Wheeler","url":{"current":"darren-wheeler-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Riya Pulicharam, MD, CPI","firstName":"Riya","lastName":"Pulicharam","url":{"current":"riya-pulicharam-md-cpi","_type":"slug"}}],"factCheckBy":[{"showSocialShare":null,"displayName":"Dennis R. Holmes, MD","firstName":"Dennis","lastName":"Holmes","url":{"_type":"slug","current":"dennis-r-holmes-md"},"profileImage":null,"biography":null},{"firstName":"Steven","lastName":"Evans","url":{"_type":"slug","current":"steven-d-evans-md"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Steven D. Evans, MD"},{"firstName":"Warren","lastName":"Fisher","url":{"current":"warren-fisher-do","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Warren Fisher, DO"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Darren Wheeler, MD","firstName":"Darren","lastName":"Wheeler","url":{"current":"darren-wheeler-md","_type":"slug"}},{"showSocialShare":null,"displayName":"Riya Pulicharam, MD, CPI","firstName":"Riya","lastName":"Pulicharam","url":{"current":"riya-pulicharam-md-cpi","_type":"slug"},"profileImage":null,"biography":null}],"_id":"e881417a-9e64-48ca-9b72-7daafa2dd9c4","title":"Reducing Delays in Breast Cancer Care Using an Innovative Digital Health Platform","thumbnail":{"_type":"mainImage","alt":"Medical technology and digital health network concept | Image Credit: © ipopba - stock.adobe.com","asset":{"sha1hash":"1e602bba35858bd62230432132517d1d42061e3d","path":"images/0vv8moc6/ajmc/1e602bba35858bd62230432132517d1d42061e3d-1280x800.jpg","_id":"image-1e602bba35858bd62230432132517d1d42061e3d-1280x800-jpg","originalFilename":"Medicine doctor hold icon health and electronic medical record on interface. Digital healthcare and network connection on hologram virtual screen, insurance. medical technology and network concept - ipopba - stock.adobe.com.jpeg","metadata":{"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1280,"aspectRatio":1.6,"height":800},"isOpaque":true,"blurHash":"VKJ01o~pIBTJo#K6MxxuRjs:R6xuNGxuRORi-;IUSexb","_type":"sanity.imageMetadata","palette":{"darkMuted":{"background":"#655176","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.14},"muted":{"title":"#fff","population":7.54,"background":"#629eb9","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"population":3.38,"background":"#badff5","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"darkVibrant":{"background":"#205a7b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":8.47},"lightMuted":{"foreground":"#000","title":"#fff","population":4.58,"background":"#a4c2d3","_type":"sanity.imagePaletteSwatch"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.22,"background":"#2bc4d6"},"dominant":{"title":"#fff","population":8.47,"background":"#205a7b","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette"},"hasAlpha":false},"_type":"sanity.imageAsset","_createdAt":"2023-09-25T20:33:46Z","_updatedAt":"2023-09-25T20:33:46Z","uploadId":"hTRTLrPbL2uAPSQkjvmAG41W4tGru8UX","mimeType":"image/jpeg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/1e602bba35858bd62230432132517d1d42061e3d-1280x800.jpg","size":323017,"assetId":"1e602bba35858bd62230432132517d1d42061e3d","extension":"jpg","_rev":"pEhoUqandJkxjPidorVwRV"}},"url":"reducing-delays-in-breast-cancer-care-using-an-innovative-digital-health-platform"}],"isLiveSite":true,"host":"www.ajmc.com","settings":{"title":"AJMC","networkID":"4688","adUnit":"ajmc.com","liveDomain":"www.ajmc.com","publicationName":"AJMC","logo":"/ajmc_logo_inverted.png","white_logo":"/ajmc_logo_inverted.png","logoHeight":"50px","enableEdgeCache":true,"sMaxAge":300,"staleWhileRevalidate":359,"clinicalTopicTopLatestNews":true,"megaMenuTaxName":"topic","megaMenuChildren":true,"sharingImageUrl":"https://s3.amazonaws.com/mjhlifesciences.com/sitelogos/AJMC_1200x637.png","twitterHandle":"@AJMC_Journal","publicationMapping":"publications","useNewSubNavMegaMenu":true,"redesignDetail":true,"redesignSAP":true,"useNewFooter":true,"newFooterLogos":[{"img":"/CHA_Logo.png","alt":"CH Logo","mobileWidth":"158px","mobileHeight":"42px","link":"/topic/center-on-health-equity-and-access","target":"_self"},{"img":"/CB.png","alt":"Center for Biosimilars Logo","mobileWidth":"170px","mobileHeight":"42px","link":"https://www.centerforbiosimilars.com/","target":"_blank"}],"useV3Components":true,"useAuthorRedesign":true,"navigationOptions":{"version":"2","variant":"4","customSpecialtyText":"Speciality Area"},"gateEnabled":"modal"},"homepage_creative_layout":{"creativeLayout":null}},"targeting":{"content_placement":["compendium/atopic-dermatitis"],"document_url":["compendium/atopic-dermatitis"],"document_group":[],"rootDocumentGroup":[],"hostname":"www.ajmc.com"},"statusCode":200,"data":{"page":{"orderDesc":null,"creativeLayoutDetail":null,"isDsoGated":null,"labelRequired":false,"theme":"default","featureContent":null,"excludeFromSitemap":false,"relatedMegaMenu":null,"title":"Compendium","creativeLayoutLatestNews":null,"contentCategories":null,"contentCategory":null,"cmeConfig":null,"articleDetailConfig":{"issueMapping":"/publications","enableSegmentRecommend":true,"brightcoveAccountID":"10203567001","disqusShortName":"www-ajmc-com","downloadCitation":true,"shareOptions":{"shareSubject":"Check out this article!","twitterHandle":"AJMC","siteName":"ajmc","hideFacebook":false,"SocialIconSize":32,"twitterSiteName":"@AJMC_Journal","hidePinterest":false},"brightcovePlayerID":"pbDmfQhRw","drupalleadBaseURL":"https://drupalleads.mjh.group/injectablewebform/output/"},"useV3":true,"url":{"current":"/compendium","_type":"slug"},"taxonomy":{"_createdAt":"2020-03-30T18:16:46Z","name":"Compendium","_updatedAt":"2024-04-09T09:14:18Z","identifier":"compendium","_rev":"oruil6rlosjyltJbhrNMGF","pixelTrackingCode":null,"_type":"taxonomy","_id":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","isMainTopic":true},"filterRequired":false,"searchConfig":{"baseUrl":"/view/"},"pages":null,"videoPlayerConfig":null,"linkedPage":null,"pageSliders":null,"creativeLayout":null,"docGroup":null,"content":null,"filters":null,"franchise":null,"externalLinks":null,"pageType":"Clinical Topic","identifier":null,"parent":null,"hasSubCategory":false,"gateCode":null,"disableEpisode":null,"intro":null,"archived":false,"label":null,"styling":{"useDefaultLayout":true,"border":{"borderType":"lines","borderRadius":{"bottomRight":"0rem","topLeft":"0rem","topRight":"0rem","bottomLeft":"0rem"},"_type":"border","borderSize":0},"contentControl":{"showSummary":true,"_type":"contentControl","showPublished":true,"readMore":true,"showAuthor":true},"imageControl":{"_type":"imageControl","showImage":true,"thumbnailRadius":{"bottomLeft":"0rem","bottomRight":"0rem","topLeft":"0rem","topRight":"0rem"}},"divider":{"_type":"divider","dividerSize":1},"titleOptions":{"_type":"titleOptions","titleSize":"1rem"}},"fixIdentifier":null},"pageData":{"totalCount":220,"pageSize":30,"pageNumber":1,"data":[{"factCheckAuthors":null,"_id":"98294a0b-05fb-4d40-bdd7-d96e1356d1b1","title":"Study: AD Identified as Potential Risk Factor for Headache Disorder","thumbnail":{"_type":"mainImage","alt":"Female patient with headache pain | Image Credit: Artem Furman - stock.adobe.com","asset":{"_ref":"image-20889be9c8c12dc41a85d9e54ca3d9942207c31d-5616x3744-jpg","_type":"reference"}},"published":"2024-04-16T18:00:19.672Z","updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"url":"study-ad-identified-as-potential-risk-factor-for-headache-disorder","summary":"Patients with atopic dermatitis (AD) may have an increased risk of headache disorder and migraines.","contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"}},{"thumbnail":{"_type":"mainImage","alt":"sleeping infant holding mother's finger | Image Credit: Bostan Natalia - stock.adobe.com","asset":{"_ref":"image-fbab2b19d55aa46e81db8af632893b82be2bde47-6000x4000-jpg","_type":"reference"}},"published":"2024-04-02T16:00:00.000Z","contentCategory":{"_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"_id":"b80a0a60-adea-4540-9a44-a1e9ff6a2041","title":"Children Born to Mothers With Stress, Mental Health Conditions During Pregnancy at Higher AD Risk","url":"children-born-to-mothers-with-stress-mental-health-conditions-during-pregnancy-at-higher-ad-risk","summary":"A meta-analysis found significant associations between maternal stress, anxiety, depression, and adverse life events during pregnancy with increased atopic dermatitis (AD) risk in offspring.","updatedOn":null},{"thumbnail":{"alt":"child scratching atopic dermatitis | Image Credit: Марина Терехова - stock.adobe.com","asset":{"_ref":"image-73291959f906333046db4310a9d050f6e67ed450-6240x3801-jpg","_type":"reference"},"_type":"mainImage"},"updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"_id":"910e1c90-6931-43f3-a794-ed77a394cf10","title":"Children With AD, Neurodevelopmental Comorbidities at Greater Odds of Learning, Memory Difficulties","published":"2024-03-18T16:00:00.000Z","contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"factCheckAuthors":null,"url":"children-with-ad-neurodevelopmental-comorbidities-at-greater-odds-of-learning-memory-difficulties","summary":"Children with atopic dermatitis (AD) face higher chances of learning and memory difficulties, particularly when they have neurodevelopmental comorbidities, like attention-deficit/hyperactivity disorder."},{"contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"_id":"05e2c2d6-a83b-4fc5-b5d7-0deb23a04713","summary":"A considerable number of patients with atopic dermatitis (AD) and limited health literacy, especially older individuals, experienced impaired health-related quality of life.","published":"2024-03-10T16:00:00.000Z","updatedOn":null,"title":"Study: Patients With AD, Limited Health Literacy Face Impaired Quality of Life","url":"study-patients-with-ad-limited-health-literacy-face-impaired-quality-of-life","thumbnail":{"_type":"mainImage","alt":"Quality of life | Image Credit: gustavofrazao - stock.adobe.com","asset":{"_ref":"image-134521fd8c460ed94dcc712d4c0a88ab6fa97963-3301x2395-jpg","_type":"reference"}}},{"thumbnail":{"asset":{"_ref":"image-a30f8534226e504e1f369b1f64da0261d00e909f-6240x4160-jpg","_type":"reference"},"_type":"mainImage","alt":"Adult scratching atopic dermatitis on arm | Image Credit: ltyuan - stock.adobe.com"},"title":"Dupilumab Considered Safe, Effective for AD in Real-Life Settings","url":"dupilumab-considered-safe-effective-for-ad-in-real-life-settings","published":"2024-03-04T17:00:00.000Z","updatedOn":null,"contentCategory":{"name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"_id":"4633b0d8-9f1a-4ccb-bd25-262903e7f753","summary":"This study enhances current understandings of dupilumab use in patients with atopic dermatitis (AD) by showing its real-world effectiveness and safety."},{"url":"upadacitinib-effective-in-treating-patients-with-moderate-to-severe-ad-study-says","updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"contentCategory":{"_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2"},"factCheckAuthors":null,"_id":"5c5b65f1-c745-44f8-bae5-cb012c5f55f1","title":"Upadacitinib Effective in Treating Patients With Moderate to Severe AD, Study Says","thumbnail":{"_type":"mainImage","alt":"Upadacitinib | Image Credit: luchschenF - stock.adobe.com","asset":{"_ref":"image-2f234603bd7f97415e1893931f8dbaf82d713242-7952x5304-jpg","_type":"reference"}},"summary":"Adult patients with moderate to severe atopic dermatitis (AD) had a 1-year and 1.5-year upadacitinib drug survival of 91.5% and 80.2%, respectively.","published":"2024-02-14T22:00:19.931Z"},{"_id":"cc005ba2-329c-4181-8226-386bca66cc35","thumbnail":{"alt":"female patient speaking with physician on video call | Image Credit: rh2010 - stock.adobe.com","asset":{"_ref":"image-aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912-jpg","_type":"reference"},"_type":"mainImage"},"summary":"This systemic review determined telemedicine to be as effective as in-person appointments for the follow-up of patients with atopic dermatitis (AD).","updatedOn":null,"contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"},"title":"Telemedicine Considered Equivalent to In-Person Care for AD Follow-Up","url":"telemedicine-considered-equivalent-to-in-person-care-for-ad-follow-up","published":"2024-02-08T20:25:18.246Z","authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null},{"_id":"489e17c0-cdb8-4405-80d7-4ecb2ef28299","title":"Study: Tralokinumab Shows More Frequent Injection Site Reactions Than Dupilumab in Patients With AD","url":"study-tralokinumab-caused-more-frequent-injection-site-reactions-than-dupilumab-in-patients-with-ad","summary":"Although injection site reactions were common occurrences in both the tralokinumab and dupilumab groups, tralokinumab caused ISRs more frequently.","published":"2024-02-07T21:30:24.307Z","updatedOn":null,"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"thumbnail":{"_type":"mainImage","alt":"Injection site reaction | Image Credit: Irina Schmidt - stock.adobe.com","asset":{"_ref":"image-cfde0828443f149997a7a2086456ee374f7a9d34-4141x2761-jpg","_type":"reference"}}},{"updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"_id":"53c80acd-2492-46f1-8053-766a82589286","url":"combination-dupilumab-topical-corticosteroids-treatment-demonstrated-efficacy-in-children-with-ad","summary":"Dupilumab and topical corticosteroids can be used to treat symptoms in children with atopic dermatitis (AD).","published":"2024-02-02T17:00:00.000Z","contentCategory":{"name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory"},"factCheckAuthors":null,"title":"Combination Dupilumab, Topical Corticosteroids Treatment Demonstrated Efficacy in Children With AD","thumbnail":{"_type":"mainImage","alt":"Child with atopic dermatitis (AD) | Image Credit: Юля Шевцова - stock.adobe.com","asset":{"_ref":"image-04bfbda193785ce69eaabd6ae5b01bb50ead4248-5351x3567-jpg","_type":"reference"}}},{"url":"climatic-hazards-directly-impact-patients-with-ad-review-says","summary":"Global warming, wildfires, precipitation, floods, and storms impact patients with atopic dermatitis (AD).","updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"_id":"63053607-a074-49dc-859a-b9c483f99dd4","title":"Climatic Hazards Directly Impact Patients With AD, Review Says","contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"},"thumbnail":{"_type":"mainImage","alt":"climate change | Image Credit: jozsitoeroe - stock.adobe.com","asset":{"_ref":"image-b41a82faddae95bdd8d4209b107c61a707625a21-7768x4000-jpg","_type":"reference"}},"published":"2024-01-24T08:01:00.000Z"},{"title":"AD Patients, Caregivers Prioritize Symptom Control, Minimizing Adverse Effects During Treatment","thumbnail":{"alt":"Atopic dermatitis treatment | Image Credit: Ladanifer - stock.adobe.com","asset":{"_ref":"image-851684487922df1e6e0de47826946729a90c0d4a-5951x3967-jpg","_type":"reference"},"_type":"mainImage"},"contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"_id":"6f5fd417-79ce-4db6-aa23-717fc5eba662","url":"ad-patients-caregivers-prioritize-symptom-control-minimizing-adverse-effects-during-treatment","summary":"The researchers suggested that physicians consider age-relevant atopic dermatitis (AD) treatment preferences in discussions with patients and caregivers.","published":"2024-01-19T14:00:00.000Z","updatedOn":null},{"_id":"7dc5cb59-6df5-41a7-a919-59be3179f0a8","url":"weekend-catch-up-sleep-prevents-suicidal-ideation-in-adolescent-patients-with-ad-study-says","summary":"This study suggests that adolescents with atopic dermatitis (AD) sleep less, have greater sleep dissatisfaction, and longer weekend catch-up sleep (WCUS) than those without AD.","factCheckAuthors":null,"title":"Weekend Catch-Up Sleep Prevents Suicidal Ideation in Adolescent Patients With AD, Study Says ","thumbnail":{"_type":"mainImage","alt":"Adolescent sleeping | Image Credit: digitalskillet1 - stock.adobe.com","asset":{"_ref":"image-66d9a98c5a3fc8dcd9ac21c82ed26ff73451d6a7-5760x3840-jpg","_type":"reference"}},"published":"2024-01-11T22:00:44.243Z","updatedOn":null,"contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}]},{"title":"Dr Andy Blauvelt Recommends New Novel AD Treatments","summary":"Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, recommends new novel topical therapies over topical steroids for patients with atopic dermatitis (AD).","updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"},{"displayName":"Pearl Steinzor","url":"pearl-steinzor"}],"factCheckAuthors":null,"_id":"7969a5a1-0657-425c-94c7-8611badb3963","url":"dr-andy-blauvelt-recommends-new-novel-ad-treatments","thumbnail":{"_type":"mainImage","alt":"dr andy blauvelt","asset":{"_ref":"image-d0b6ca281cb1bd4dd15d50f8f1378632ed396b40-2880x1537-png","_type":"reference"}},"published":"2024-01-02T22:00:38.049Z","contentCategory":{"_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z"}},{"summary":"Elaine Siegfried, MD, of Saint Louis University School of Medicine, discusses how the recent guideline update by the American Academy of Dermatology (AAD) affects dermatologists' atopic dermatitis (AD) treatment decisions.","authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"contentCategory":{"_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB"},"_id":"3fd60741-c423-41f0-8456-6f16cb21fd9d","title":"Dr Elaine Siegfried Describes How AAD Guideline Update Impacts AD Treatment","url":"dr-elaine-siegfried-describes-how-aad-guideline-update-impacts-ad-treatment","thumbnail":{"_type":"mainImage","alt":"dr elaine siegfried","asset":{"_ref":"image-b156aa69b8e4268b42d4b096d87eaadd7e027450-2665x1531-png","_type":"reference"}},"published":"2024-01-01T17:00:00.000Z","updatedOn":null},{"contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"thumbnail":{"_type":"mainImage","alt":"top 5 AD articles ","caption":"Top 5 Atopic Dermatitis Articiles\n\nImage credit: Venngage","asset":{"_ref":"image-6a45cb4b9431c2845646a6ca5a058dddda29d27e-1020x520-png","_type":"reference"}},"summary":"This year’s most-read articles on atopic dermatitis (AD) explored different treatment and education methods.","updatedOn":null,"published":"2023-12-28T17:00:00.000Z","authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"_id":"cb2d260c-e37f-4412-82d3-fbee405b9f31","title":"Top 5 Most-Read AD Content of 2023","url":"top-5-most-read-ad-content-of-2023"},{"factCheckAuthors":null,"_id":"eef0103b-bb41-4be7-85ee-6cc455dcd8a8","title":"Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, Salivary Biomarkers","thumbnail":{"_type":"mainImage","alt":"atopic dermatitis","caption":"Atopic dermatitis\n\nImage credit: lial88 - stock.adobe.com","asset":{"_ref":"image-1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832-jpg","_type":"reference"}},"published":"2023-12-20T17:00:00.000Z","updatedOn":null,"contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"},"url":"exploring-the-relationship-between-ad-psychological-stress-sleep-disturbances-salivary-biomarkers","summary":"Understanding these relationships is crucial for developing effective clinical management strategies for patients with AD, according to a recent literature review.","authors":[{"displayName":"Lauren Buchanan, MA","url":"lauren-buchanan-ma-managing-editor"}]},{"_id":"78680b4b-b68f-4870-94bd-7b85a2eef3d2","title":"ICYMI: Highlights From RAD 2023","contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"published":"2023-12-17T13:00:00.000Z","updatedOn":null,"authors":[{"displayName":"Pearl Steinzor","url":"pearl-steinzor"}],"factCheckAuthors":null,"url":"icymi-highlights-from-rad-2023","thumbnail":{"_type":"mainImage","alt":"ICYMI: Highlights From RAD 2023","asset":{"_type":"reference","_ref":"image-263c6d1bcbe64c6d016036ee243011fbbbec2c05-3187x1625-png"}},"summary":"Our top coverage from this year’s Revolutionizing Atopic Dermatitis (RAD) conference highlighted the evolving therapy landscape for patients with AD. "},{"summary":"Elaine Siegfried, MD, of Saint Louis University School of Medicine discusses the use of biologics to treat atopic dermatitis (AD) and how they differ from other treatments.","published":"2023-12-12T20:30:22.698Z","updatedOn":null,"contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"factCheckAuthors":null,"title":"Dr Elaine Siegfried Discusses Using Biologics to Treat AD","thumbnail":{"_type":"mainImage","alt":"dr elaine siegfried","asset":{"_ref":"image-b156aa69b8e4268b42d4b096d87eaadd7e027450-2665x1531-png","_type":"reference"}},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"_id":"f8a362f8-f756-4ee9-a022-73c2318fd424","url":"dr-elaine-siegfried-discusses-using-biologics-to-treat-ad"},{"url":"worsening-severity-of-ad-in-children-associated-with-increased-comorbidity-onset-risk","summary":"Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort.","updatedOn":null,"factCheckAuthors":null,"_id":"17ce3342-1dc1-44f5-9e3a-bc5a197c968d","title":"Worsening Severity of AD in Children Associated With Increased Comorbidity Onset Risk","thumbnail":{"_type":"mainImage","alt":"child with AD","caption":"Child with AD\n\nImage credit: triocean - stock.adobe.com","asset":{"_ref":"image-618023f2e60041d285c98320303dd0edbc2b23eb-5760x3840-jpg","_type":"reference"}},"published":"2023-12-10T17:00:00.000Z","contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"},"authors":[{"displayName":"Joshua Fitch","url":"joshua-fitch"}]},{"_id":"719f8518-5903-4d9c-bad4-ce4e52a737dc","url":"most-patients-with-ad-satisfied-with-baricitinib-treatment-study-says","thumbnail":{"caption":"Baricitinib\n\nImage credit: laurencesoulez - stock.adobe.com","asset":{"_ref":"image-690165cc12a8154f8ce3951a41de04f986e84123-5341x3560-jpg","_type":"reference"},"_type":"mainImage","alt":"Baricitinib"},"updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"title":"Most Patients With AD Satisfied With Baricitinib Treatment, Study Says","summary":"Based on the Likert scale, most patients with atopic dermatitis (AD) using baricitinib reported being either “satisfied” (76%) or “very satisfied” (18%).","published":"2023-12-05T19:00:33.748Z","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"}},{"_id":"b2607718-1381-49f3-92d1-e38276865382","title":"Mental Health Concerns Prevalent in Patients With AD, Poster Says","summary":"A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis (AD).","authors":[{"displayName":"Heidi Anne Duerr, MPH","url":"heidi-anne-duerr-mph"}],"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"factCheckAuthors":null,"url":"mental-health-concerns-prevalent-in-patients-with-ad-poster-says","thumbnail":{"_type":"mainImage","alt":"patient with mental health issues","caption":"Patient with mental health issues\nImage credit: terovesalainen - stock.adobe.com","asset":{"_ref":"image-e926faf39a0b61879b4fd879bf5ce1ff514ca867-8305x5304-jpg","_type":"reference"}},"published":"2023-11-24T17:00:00.000Z","updatedOn":null},{"title":"AAD Updates Guidelines for AD Treatment Using Phototherapy, Systemic Therapies","thumbnail":{"_type":"mainImage","alt":"doctor speaking with patient","caption":"Doctor speaking with patient\n\nImage credit: New Africa - stock.adobe.com","asset":{"_ref":"image-f4bb8db60db72afc836851f5efacf1358e4e0649-6497x4331-jpg","_type":"reference"}},"summary":"These new atopic dermatitis (AD) treatment guidelines from the American Academy of Dermatology (AAD) update their 2014 recommendations for the management of AD with phototherapy and systemic therapies.","published":"2023-11-21T17:00:00.000Z","authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"_id":"6eb8d013-cc35-433a-9009-730001f963ef","url":"aad-updates-guidelines-for-ad-treatment-using-phototherapy-systemic-therapies","updatedOn":null,"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"factCheckAuthors":null},{"title":"Dr April Armstrong Proposes New AD Treatment Standards","thumbnail":{"_type":"mainImage","alt":"dr april armstrong","caption":"April Armstrong, MD, MPH","asset":{"_ref":"image-f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615-png","_type":"reference"}},"updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"},{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"_id":"32a7b2ab-32a0-4d03-b566-af22aaee7132","summary":"With the recent development of various new treatments, April Armstrong, MD, MPH, discusses the new standards she and other dermatologists hope to set for treating patients with atopic dermatitis (AD).\n","published":"2023-11-14T19:00:42.051Z","contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"factCheckAuthors":null,"url":"dr-april-armstrong-proposes-new-ad-treatment-standards"},{"thumbnail":{"_type":"mainImage","alt":"adult patient with atopic dermatitis (AD)","caption":"Adult patient with atopic dermatitis (AD)\nImage credit: ltyuan - stock.adobe.com","asset":{"_ref":"image-77c2c84d9048d107cc226b88c416df6c7d4ebfad-6240x4160-jpg","_type":"reference"}},"published":"2023-11-09T15:30:00.000Z","updatedOn":null,"_id":"f639ee96-3d08-4371-9b5d-2287d9542331","url":"long-term-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic-dermatitis","contentCategory":{"_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2"},"authors":[{"displayName":"Lauren Buchanan, MA","url":"lauren-buchanan-ma-managing-editor"}],"factCheckAuthors":null,"title":"Long-Term Safety of Dupilumab in Adults With Moderate to Severe Atopic Dermatitis","summary":"The results from this 5-year, open-label extension trial affirm the safety of dupilumab in adults with moderate to severe AD."},{"url":"dr-peter-lio-describes-the-ad-treatment-toolkit","summary":"Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine, describes different methods dermatologists can use to treat atopic dermatitis (AD). ","published":"2023-11-06T17:00:00.000Z","updatedOn":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"},{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"factCheckAuthors":null,"_id":"52ff2e55-637c-4799-a9f6-33f842bd37f0","title":"Dr Peter Lio Describes the AD Treatment Toolbox","thumbnail":{"_type":"mainImage","alt":"dr peter lio","asset":{"_ref":"image-33d6ae51e99089b0a522cb66b24dc01f917b0230-2880x1613-png","_type":"reference"}},"contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"}},{"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"factCheckAuthors":null,"url":"middle-aged-older-adults-with-ad-at-increased-risk-of-cognitive-dysfunction","thumbnail":{"asset":{"_ref":"image-40872453de9916931451a20765bdfb9e5d8efc2a-6720x4480-jpg","_type":"reference"},"_type":"mainImage","alt":"middle aged patient with atopic dermatitis","caption":"Middle aged patient with atopic dermatitis\n\nImage credit: 9nong - stock.adobe.com"},"published":"2023-11-03T16:00:00.000Z","updatedOn":null,"_id":"fe4ea159-15f5-4ff2-aa7c-b1b29ce0c826","title":"Middle-Aged, Older Adults With AD at Increased Risk of Cognitive Dysfunction","summary":"Because of their study's findings, the researchers urged clinicians to screen patients with atopic dermatitis (AD) for cognitive dysfunction.","contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"}},{"summary":"April Armstrong, MD, MPH, of University of California, Los Angeles, discussed how recent biologics advancements improved moderate-to-severe atopic dermatitis (AD) treatment. ","published":"2023-10-30T13:00:00.000Z","updatedOn":null,"contentCategory":{"name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"},{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"url":"dr-april-armstrong-how-recent-biologics-advancements-improved-ad-treatment","title":"Dr April Armstrong: How Recent Biologics Advancements Improved AD Treatment","thumbnail":{"_type":"mainImage","alt":"dr april armstrong","asset":{"_ref":"image-f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615-png","_type":"reference"}},"factCheckAuthors":null,"_id":"f3817828-7057-45b4-916c-855d1ff42d20"},{"_id":"5133b0e8-6f73-41ba-8453-314fea26faa4","title":"More Than Half of Adults With Moderate to Severe AD Report Conditions That May Influence Selection of JAK Inhibitors","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"factCheckAuthors":null,"updatedOn":null,"authors":[{"displayName":"Emma Andrus","url":"emma-andrus"}],"url":"more-than-half-of-adults-with-moderate-to-severe-ad-report-conditions-that-may-influence-selection-of-jak-inhibitors","thumbnail":{"_type":"mainImage","alt":"Atopic dermatitis | Image credit: Ольга Тернавская - stock.adobe.com","asset":{"_ref":"image-6d34edecb4f7a1affdcf52e756ae5e81497c471f-5472x3648-jpg","_type":"reference"}},"summary":"The most common conditions or concerns patients with atopic dermatitis (AD) reported having that may influence their selection of a JAK inhibitor included an increased risk of MACE and an age above 65 years.","published":"2023-10-27T14:12:07.906Z"},{"_id":"945e91b9-eac9-4c4b-8baf-42d495cb4a63","title":"Dr April Armstrong: Clinician Education Needed to Overcome AD Treatment Barriers","updatedOn":null,"contentCategory":{"_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos"},"factCheckAuthors":null,"url":"dr-april-armstrong-clinician-education-needed-to-overcome-ad-treatment-barriers","thumbnail":{"_type":"mainImage","alt":"dr april armstrong","asset":{"_ref":"image-f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615-png","_type":"reference"}},"summary":"April Armstrong, MD, MPH, of University of California, Los Angeles, gave an overview of her Fall Clinical Dermatology session on treating atopic dermatitis (AD) in patients with diverse skin tones and weighed in on how to address related treatment barriers.","published":"2023-10-26T16:00:00.000Z","authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"},{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}]},{"factCheckAuthors":null,"_id":"ef909238-5c33-477f-a00c-9d1ca4be1447","url":"dr-april-armstrong-identifies-main-ad-health-care-gaps","thumbnail":{"_type":"mainImage","alt":"dr april armstrong","asset":{"_ref":"image-f70b3c100a1f2229ee8053058243a4d51720194f-2865x1615-png","_type":"reference"}},"summary":"April Armstrong, MD, MPH, of University of California, Los Angeles, explained that the main health care gap within the atopic dermatitis (AD) realm is that many clinicians are not comfortable prescribing systemic medications.","published":"2023-10-24T16:00:00.000Z","contentCategory":{"_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB"},"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"},{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"title":"Dr April Armstrong Identifies Main AD Health Care Gaps","updatedOn":null}],"targeting":{"content_placement":["compendium/atopic-dermatitis"],"document_url":["compendium/atopic-dermatitis"],"document_group":[],"rootDocumentGroup":[],"hostname":"www.ajmc.com"},"currentTopic":{"ptceKeywordMapping":null,"pixelTrackingCode":null,"thumbnail":null,"summary":[{"_key":"f8a866978242","markDefs":[],"children":[{"marks":[],"text":"The ","_key":"b81520a412d2","_type":"span"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal"}],"url":"atopic-dermatitis","cmeType":null,"perKeywordMapping":null,"parent":{"_id":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","name":"Compendium","url":"compendium","parent":null},"_id":"19c99996-848f-4c14-a61f-2d8d2979e191","name":"Atopic Dermatitis"},"filterData":[],"relatedTopics":null,"podcastsData":[],"videoSeriesData":[],"videoNonSeriesData":[{"url":{"current":"dr-martin-dahl-summarizes-findings-limitations-of-study-analyzing-anb032-use-in-patients-with-ad","_type":"slug"},"_id":"d10a33b3-cd9b-494b-84c7-d29797a0daae","_rev":"CNd7ZLye2HnkvPTKKiQ1Jr","thumbnail":{"asset":{"uploadId":"CFqwcHa2ybFhqtHbjHMNdAaqgs6pqeGj","_updatedAt":"2024-04-29T15:44:48Z","originalFilename":"Screenshot 2024-04-29 at 11.12.07 AM.png","extension":"png","_type":"sanity.imageAsset","_createdAt":"2024-04-29T15:44:48Z","_id":"image-c924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616-png","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2880,"aspectRatio":1.7821782178217822,"height":1616},"isOpaque":true,"blurHash":"MoHWlvj[u6ogZ~~paxnga|VrwHWCsoaxXT","_type":"sanity.imageMetadata","palette":{"darkMuted":{"population":0.09,"background":"#355461","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"background":"#8f817d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.3},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.17,"background":"#81d0fc"},"darkVibrant":{"background":"#1e5879","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38},"lightMuted":{"foreground":"#000","title":"#fff","population":0.28,"background":"#8dafbb","_type":"sanity.imagePaletteSwatch"},"vibrant":{"background":"#5fbfe9","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.46},"dominant":{"title":"#fff","population":7.3,"background":"#8f817d","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette"},"hasAlpha":true},"_rev":"cI6iarc4JrUd2Pnpbhw0Mp","mimeType":"image/png","sha1hash":"c924cc1df18e59962cff88e0874f506878e7a8f5","path":"images/0vv8moc6/ajmc/c924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png","assetId":"c924cc1df18e59962cff88e0874f506878e7a8f5","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/c924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616.png","size":5044921}},"documentGroupMapping":[{"_ref":"132c11b2-1f54-4649-9fcf-d7d3788643f7","_type":"reference","_key":"d786cbd97494"},{"_ref":"2fa14601-28b8-47d1-a9f2-6b0ea39b92ac","_type":"reference","_key":"1baedfde0ab5"}],"articleType":"News","_updatedAt":"2024-04-30T13:46:53Z","source":null,"_type":"article","ExcludeFromPubMedXML":false,"taxonomyMapping":[{"_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320"},{"_rev":"Zzg2CQjl4x3UedGJkY3tyu","_type":"taxonomy","name":"Conference","_id":"1862ee25-8e65-4dbe-8fd3-d4c11642b211","_updatedAt":"2022-07-31T01:47:04Z","identifier":"conference","_createdAt":"2020-03-30T19:06:53Z"},{"_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","summary":[{"_key":"f8a866978242","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal"}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis"}],"summary":"Martin Dahl, PhD, of AnaptysBio discusses the findings and limitations of a study analyzing use of ANB032 in patients with atopic dermatitis (AD).","published":"2024-05-01T13:00:00.000Z","title":"Dr Martin Dahl Summarizes Findings, Limitations of Study Analyzing ANB032 Use in Patients With AD","authorMapping":[{"lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"},"_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl ","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC"},{"_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke","displayName":"Brooke McCormick","_type":"author","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal"},{"style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block"},{"_key":"98aee68dab9d","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd"}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal"}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q"}],"_createdAt":"2024-04-29T15:36:04Z","is_visible":true,"factCheckAuthorMapping":null,"seoTag":["dr martin dahl","atopic dermatitis","AAD","interview"],"body":[{"videoObject":{"_type":"videoDetails","videoTitle":"Dr Martin Dahl Summarizes Findings, Limitations of Study Analyzing ANB032 Use in Patients With AD","thumbnail":{"_type":"image","asset":{"_ref":"image-c924cc1df18e59962cff88e0874f506878e7a8f5-2880x1616-png","_type":"reference"}},"videoDuration":"PT2M01S","videoDescription":"dr martin dahl, atopic dermatitis, AAD"},"_type":"video","videoID":"6351979076112","disableAutoPlayVideo":false,"source":"brightcove","_key":"33f8f3f831ec"},{"style":"normal","_key":"d7822dbc762b","markDefs":[],"children":[{"_type":"span","marks":["em"],"text":"This content was produced independently by ","_key":"16544eabdacf0"},{"_type":"span","marks":[],"text":"The American Journal of Managed Care®","_key":"16544eabdacf1"},{"_type":"span","marks":["em"],"text":" and is not endorsed by the American Academy of Dermatology.","_key":"16544eabdacf2"}],"_type":"block"},{"children":[{"_type":"span","marks":[],"text":"","_key":"ad9651a2b4180"}],"_type":"block","style":"normal","_key":"18ceb3ba5374","markDefs":[]},{"markDefs":[{"_key":"f07297712543","nofollow":false,"blank":true,"_type":"link","href":"https://www.ajmc.com/view/dr-martin-dahl-discusses-the-pathophysiology-of-ad-and-benefits-of-anb032"}],"children":[{"_type":"span","marks":[],"text":"Martin Dahl, PhD, senior vice president of research at AnaptysBio, summarized the findings and limitations of a ","_key":"dcc7d6858f6f"},{"_type":"span","marks":["f07297712543"],"text":"study","_key":"a3253fba6b1f"},{"_type":"span","marks":[],"text":" that analyzed the use of ANB032, a novel nondepleting antibody that has the potential to treat many systemic inflammatory diseases, in patients with atopic dermatitis (AD). ","_key":"709d81fea791"}],"_type":"block","style":"normal","_key":"4bc40932be36"},{"children":[{"_type":"span","marks":[],"text":"","_key":"a17f48d92733"}],"_type":"block","style":"normal","_key":"18cac664749c","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"This study's findings were presented in a ","_key":"65f1c7d9a02b"},{"_type":"span","marks":["9340b2dbe6f9"],"text":"poster","_key":"62a8ba7dd499"},{"_key":"bba4cb5458af","_type":"span","marks":[],"text":" at the "},{"_type":"span","marks":["f8b111641bb0"],"text":"2024 American Academy of Dermatology (AAD) annual meeting","_key":"04a59f04b0d3"},{"_type":"span","marks":[],"text":".","_key":"6a8f228bc6b7"}],"_type":"block","style":"normal","_key":"553760bccb21","markDefs":[{"blank":true,"_type":"link","href":"https://www.ajmc.com/conference/aad","_key":"f8b111641bb0","nofollow":false},{"_key":"9340b2dbe6f9","nofollow":true,"blank":true,"_type":"link","href":"https://eposters.aad.org/abstracts/50585"}]},{"_type":"block","style":"normal","_key":"0bca0bb4d6dd","markDefs":[],"children":[{"text":"","_key":"62f8b57040c40","_type":"span","marks":[]}]},{"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"53df8ed63ce90"}],"_type":"block","style":"normal","_key":"6908e2a60fe8","markDefs":[]},{"_type":"block","style":"normal","_key":"e5d5ec141a1d","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"fbb177a68d73"}]},{"markDefs":[],"children":[{"marks":["strong"],"text":"What were your primary findings? Did anything surprise you?","_key":"ecf8eaf1f9230","_type":"span"}],"_type":"block","style":"normal","_key":"a3ec0431af64"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"a812c22b2edf"}],"_type":"block","style":"normal","_key":"4d6a4ba4194a"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Our primary findings were confirmatory that BTLA [B and T cell lymphocyte attenuator] is expressed on the dendritic cells. It replicates a lot of literature that's out there describing the role of BTLA in dendritic cell and T-cell biology. ","_key":"7aa546aa89760"}],"_type":"block","style":"normal","_key":"79a528874ec8"},{"markDefs":[],"children":[{"text":"","_key":"8ae6168d1a9a","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"8ec123844ee7"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The results were not surprising. I think we're excited to see this induction of regulatory T cells; we'd like to see that replicated in humans. In fact, that biology, if it can be shown to happen in the skin, could contribute to the long-term durable responses. ","_key":"92912584a73d"}],"_type":"block","style":"normal","_key":"72c55d5682c8"},{"style":"normal","_key":"a46c984cc474","markDefs":[],"children":[{"_key":"ff3a484c16b0","_type":"span","marks":[],"text":""}],"_type":"block"},{"_type":"block","style":"normal","_key":"1a686ec5689f","markDefs":[],"children":[{"marks":[],"text":"Through the agonistic mechanism, we're turning the T cells off, which should bring the patient to a more homeostatic state and reduce their inflammatory burden. Through the expansion of regulatory T cells and the deactivation of dendritic cells, we should see a durable response that helps them maintain that tolerogenic state for a longer period, even off-drug.","_key":"6da77abcd3c5","_type":"span"}]},{"_key":"371c57175b39","markDefs":[],"children":[{"marks":[],"text":"","_key":"9512efca275c","_type":"span"}],"_type":"block","style":"normal"},{"_key":"331ad3e0734e","markDefs":[],"children":[{"_type":"span","marks":["strong"],"text":"Were there any study limitations? If so, what future study directions may address these challenges?","_key":"a7b13fbfd02f0"}],"_type":"block","style":"normal"},{"_key":"240c91dbc299","markDefs":[],"children":[{"marks":[],"text":"","_key":"e917e954f3ef0","_type":"span"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"84b8628ec135","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Let's see. The limitation here is that we're studying everything in vitro. Our phase 2 study in humans in atopic dermatitis will include biopsy samples from the skin, as well as tape stripping, and we're looking to confirm some of these findings in our phase 2 study.","_key":"fb10d7afe52e0"}]},{"_key":"d53cff906699","markDefs":[],"children":[{"text":"","_key":"53d3faf3b9ed","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"style":"normal","_key":"f5434ea9bd1c","markDefs":[],"children":[{"text":"How do environmental factors, such as allergens and irritants, interact with genetic susceptibility to exacerbate or trigger AD episodes? How can this understanding inform therapeutic strategies?","_key":"632ff22c67090","_type":"span","marks":["strong"]}],"_type":"block"},{"_type":"block","style":"normal","_key":"664e64a34011","markDefs":[],"children":[{"marks":[],"text":"","_key":"8274161ec3db","_type":"span"}]},{"style":"normal","_key":"531fff627bed","markDefs":[],"children":[{"_type":"span","marks":[],"text":"That's a great question. So, all of those factors, many of the environmental factors, the pathogen-derived factors, can be activating signals for dendritic cells; we used one of those to induce BTLA expression on the dendritic cells in our studies. ","_key":"7450fd2d37200"}],"_type":"block"},{"style":"normal","_key":"57c1a1fbbc31","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"754ddbabda8d"}],"_type":"block"},{"markDefs":[],"children":[{"_key":"4839f59c2988","_type":"span","marks":[],"text":"All of those things can contribute to exacerbations or chronic disease in the setting of atopic dermatitis, and that's exactly the signal we're trying to go after downstream by targeting the dendritic cells and the T cells with ANB032."}],"_type":"block","style":"normal","_key":"84e2a32c298f"}],"link":"/view/dr-martin-dahl-summarizes-findings-limitations-of-study-analyzing-anb032-use-in-patients-with-ad","updatedOn":null,"contentCategory":{"_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z"}},{"authorMapping":[{"profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"},"lastName":"Steinzor","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl "},{"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block","style":"normal","_key":"9af540ce04de"},{"_key":"98aee68dab9d","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd","nofollow":true}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal"}],"firstName":"Brooke","displayName":"Brooke McCormick","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"}}],"taxonomyMapping":[{"identifier":"conference","_createdAt":"2020-03-30T19:06:53Z","_rev":"Zzg2CQjl4x3UedGJkY3tyu","_type":"taxonomy","name":"Conference","_id":"1862ee25-8e65-4dbe-8fd3-d4c11642b211","_updatedAt":"2022-07-31T01:47:04Z"},{"name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy"},{"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","summary":[{"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal","_key":"f8a866978242","markDefs":[]}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"name":"Atopic Dermatitis","identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht"},{"parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","summary":[{"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block","style":"normal","_key":"dd8ad578cd0b","markDefs":[]}],"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_type":"taxonomy"}],"seoTag":["pediatric atopic dermatitis","roflumilast cream","dr lawrence eichenfield"],"_type":"article","link":"/view/dr-lawrence-eichenfield-hopeful-for-new-pediatric-ad-treatment-option","_updatedAt":"2024-04-01T17:41:41Z","title":"Dr Lawrence Eichenfield Hopeful for New Pediatric AD Treatment Option","summary":"Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital in San Diego, shared the implications of the findings from INTEGUMENT-PED, the phase 3 study assessing the efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients with atopic dermatitis (AD), for future clinical practice.","_rev":"rZQr95siN907rd8oHVjcsg","url":{"current":"dr-lawrence-eichenfield-hopeful-for-new-pediatric-ad-treatment-option","_type":"slug"},"articleType":"Commentary","source":null,"factCheckAuthorMapping":null,"published":"2024-04-16T16:00:00.000Z","contentCategory":{"_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z"},"_id":"b6f06f48-6c96-405e-ac1a-fb7d6a145f31","ExcludeFromPubMedXML":false,"is_visible":true,"thumbnail":{"asset":{"_type":"sanity.imageAsset","description":null,"title":null,"path":"images/0vv8moc6/ajmc/b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png","assetId":"b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429","_createdAt":"2024-03-26T21:34:25Z","extension":"png","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png","_id":"image-b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620-png","_updatedAt":"2024-03-28T21:15:42Z","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2879,"aspectRatio":1.7771604938271606,"height":1620},"isOpaque":true,"blurHash":"MUMt8T%M%gVsR5~qt6D%WBIoIqjZnhxu%M","_type":"sanity.imageMetadata","palette":{"dominant":{"population":7.66,"background":"#ccc6bd","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#282a39","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.03},"muted":{"title":"#fff","population":7.37,"background":"#b38074","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#fceee6","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.01},"darkVibrant":{"title":"#fff","population":0.4,"background":"#0b0b1d","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":7.66,"background":"#ccc6bd","_type":"sanity.imagePaletteSwatch"},"vibrant":{"background":"#d4988b","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.08}},"hasAlpha":true},"mimeType":"image/png","size":3857448,"uploadId":"5mOb5GjfekSyaRdfWSVpYdfkRHztXJiX","_rev":"YHXKmVkIDvc4JRBFq5tgOD","sha1hash":"b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429","opt":{"media":{"tags":null}},"originalFilename":"Lawrence Eichenfeld.png","altText":null}},"body":[{"_type":"video","videoID":"6349818847112","disableAutoPlayVideo":false,"source":"brightcove","_key":"aa14550c35a6","videoObject":{"videoTitle":"Dr Lawrence Eichenfield Hopeful for New Pediatric AD Treatment Option","thumbnail":{"_type":"image","asset":{"_ref":"image-b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620-png","_type":"reference"}},"videoDuration":"PT2M06S","videoDescription":"dr lawerence eichenfield, roflumilast cream, pediatric atopic dermatitis","_type":"videoDetails"}},{"children":[{"_type":"span","marks":["em"],"text":"This content was produced independently by","_key":"4c33ac17c4b1"},{"_type":"span","marks":[],"text":" The American Journal of Managed Care","_key":"0f8455821318"},{"_type":"span","marks":["superscript"],"text":"®","_key":"8a7cc77a9929"},{"text":" ","_key":"09c1fc9b6483","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"(AJMC","_key":"cf7978f4b557"},{"_type":"span","marks":["em","superscript"],"text":"®","_key":"5e67a4d1ae38"},{"_type":"span","marks":["em"],"text":") and is not endorsed by the American Academy of Dermatology.","_key":"62302e0cc3b5"}],"_type":"block","style":"normal","_key":"5bf9b58c7467","markDefs":[]},{"markDefs":[],"children":[{"text":"","_key":"bb77bf1db00b","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"cb6079ff6888"},{"_type":"block","style":"normal","_key":"efec704e36c9","markDefs":[{"href":"https://www.ajmc.com/conference/aad","_key":"dfc0ec17313c","nofollow":false,"blank":true,"_type":"link"}],"children":[{"_key":"7f538357c5cc","_type":"span","marks":[],"text":"At the "},{"marks":["dfc0ec17313c"],"text":"2024 American Academy of Dermatology Annual Meeting","_key":"d4d19a0ecf96","_type":"span"},{"_type":"span","marks":[],"text":", Lawrence Eichenfield, MD, chief of pediatric dermatology at Rady Children's Hospital in San Diego and professor of dermatology and pediatrics at the University of California, San Diego, presented late-breaking findings from the INTEGUMENT-PED phase 3 randomized controlled trial of roflumilast cream 0.05% in children 2 to 5 years of age with atopic dermatitis (AD). ","_key":"eae536810101"}]},{"_key":"13ffd4fb83ec","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"56b83b74ae9a"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"text":"In an interview with ","_key":"4ef31a5803d5","_type":"span","marks":[]},{"text":"AJMC","_key":"4c4e0ee1779d","_type":"span","marks":["em"]},{"text":", Eichenfield said that roflumilast cream 0.05% had positive results in pediatric patients with AD in terms of efficacy and safety. He noted that he is looking forward to roflumilast cream being \"hopefully approved\" and \"potentially having this in our armamentarium for treating young children.\"","_key":"198998652e4b","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"fb1b2be47f13"},{"style":"normal","_key":"1d53b5bf0b22","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"bfa4ab902a1b"}],"_type":"block"},{"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"ff250d953162"}],"_type":"block","style":"normal","_key":"e48ed445cd96","markDefs":[]},{"style":"normal","_key":"d3be5c98307f","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"053cd448f217"}],"_type":"block"},{"_type":"block","style":"normal","_key":"3485545bb284","markDefs":[],"children":[{"_type":"span","marks":["strong"],"text":"How do the results of the INTEGUMENT-PED study contribute to our understanding of AD treatment options for young children? What implications might they have for clinical practice and future research?","_key":"438dad422457"}]},{"markDefs":[],"children":[{"text":" ","_key":"33b853704820","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"f353fba6bebe"},{"markDefs":[],"children":[{"marks":[],"text":"First, to go through some of the basics, the study hit the sort of standard outcome measures that we look for. What percentage of patients made it to clear or almost cleared? About 25% of those were within a 4-week time period with once-a-day application with a big delta, or almost 15% delta, between the vehicle.","_key":"a628df170ce50","_type":"span"}],"_type":"block","style":"normal","_key":"94b0f68b8b27"},{"_key":"e2f20eb3adfe","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"b544179966ce"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"marks":[],"text":"It was very interesting to me that a lot of the population that got that clear, or almost clear, were already clear or almost clear by 2 weeks, and there was almost 80 something percent of those because it was 21% of the patients made clear or almost clear at week 2. ","_key":"870997c6b549","_type":"span"}],"_type":"block","style":"normal","_key":"db9fcb3e0f2b"},{"_key":"6bf8f16d6682","markDefs":[],"children":[{"text":"","_key":"2f0452be7239","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"_key":"1b97a6ffb9f8","markDefs":[],"children":[{"_key":"15a390b1134e","_type":"span","marks":[],"text":"The secondary outcome measures being clear or almost clear at EASI [Eczema Area and Severity Index] 75, and the percentage of patients who had at least a 4-part drop in itch as compared to their baseline was consistent with a nice separation from the vehicle cream throughout the course of the study. "}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":[],"text":"","_key":"1a3672467aa6"}],"_type":"block","style":"normal","_key":"40de91023b82","markDefs":[]},{"children":[{"text":"When we looked very early, the improvement in the itch with roflumilast was seen as early as 24 hours after the first application. So, it was a very rapid separation of itch scores from the vehicle. ","_key":"5b0be61f77c5","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"241622d66e16","markDefs":[]},{"_type":"block","style":"normal","_key":"98066bb40ac0","markDefs":[],"children":[{"_key":"04c02660eff6","_type":"span","marks":[],"text":""}]},{"children":[{"_type":"span","marks":[],"text":"Overall, I think having this move forward and hopefully be approved as a new nonsteroidal, which is very well formulated, can be helpful in our care of patients with atopic dermatitis. We show in this case that it helped to improve eczema in 2- to 5-year-olds with early clinical responses and very good tolerance levels. So, we look forward to potentially having this in our armamentarium for treating young children.","_key":"e0e2a09acd0f"}],"_type":"block","style":"normal","_key":"ee95872f9ed0","markDefs":[]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"40ed23403871"}],"_type":"block","style":"normal","_key":"66587a189122"}],"documentGroupMapping":[{"_type":"reference","_key":"95a4093f7121","_ref":"2fa14601-28b8-47d1-a9f2-6b0ea39b92ac"},{"_ref":"132c11b2-1f54-4649-9fcf-d7d3788643f7","_type":"reference","_key":"9220914b4889"}],"_createdAt":"2024-03-27T16:35:38Z","updatedOn":null},{"seoTag":["roflumilast cream","atopic dermatitis treatment","dr lawrence eichenfield"],"_updatedAt":"2024-03-27T19:09:54Z","_type":"article","factCheckAuthorMapping":null,"_createdAt":"2024-03-26T20:59:08Z","_id":"1093b65e-d401-4994-82f8-37563bf5cd7f","thumbnail":{"asset":{"metadata":{"isOpaque":true,"blurHash":"MUMt8T%M%gVsR5~qt6D%WBIoIqjZnhxu%M","_type":"sanity.imageMetadata","palette":{"vibrant":{"background":"#d4988b","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.08},"dominant":{"population":7.66,"background":"#ccc6bd","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#282a39","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.03},"muted":{"foreground":"#fff","title":"#fff","population":7.37,"background":"#b38074","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"foreground":"#000","title":"#000","population":0.01,"background":"#fceee6","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"background":"#0b0b1d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.4},"lightMuted":{"background":"#ccc6bd","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":7.66}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2879,"aspectRatio":1.7771604938271606,"height":1620}},"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png","_id":"image-b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620-png","_updatedAt":"2024-03-28T21:15:42Z","uploadId":"5mOb5GjfekSyaRdfWSVpYdfkRHztXJiX","mimeType":"image/png","size":3857448,"altText":null,"_rev":"YHXKmVkIDvc4JRBFq5tgOD","sha1hash":"b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429","opt":{"media":{"tags":null}},"originalFilename":"Lawrence Eichenfeld.png","extension":"png","_type":"sanity.imageAsset","description":null,"title":null,"path":"images/0vv8moc6/ajmc/b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620.png","assetId":"b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429","_createdAt":"2024-03-26T21:34:25Z"}},"is_visible":true,"body":[{"_type":"video","videoID":"6349820329112","disableAutoPlayVideo":false,"source":"brightcove","_key":"fa6f2af025dc","videoObject":{"videoDescription":"dr lawerence eichenfield, atopic dermatitis, roflumilast cream, AAD","_type":"videoDetails","videoTitle":"Dr Lawrence Eichenfield Discusses Positive Results of Roflumilast Cream 0.05% in Pediatric Patients","thumbnail":{"_type":"image","asset":{"_ref":"image-b5b5d5d8b937c4f20aa40ae4bf8e5677d0919429-2879x1620-png","_type":"reference"}},"videoDuration":"PT5M07S"}},{"children":[{"_key":"7f199479040a","_type":"span","marks":["em"],"text":"This content was produced independently by"},{"_type":"span","marks":[],"text":" The American Journal of Managed Care","_key":"4abd60a08528"},{"_type":"span","marks":["superscript"],"text":"®","_key":"4c6e2b57e5b4"},{"_type":"span","marks":[],"text":" ","_key":"5297d8e80362"},{"_type":"span","marks":["em"],"text":"(AJMC","_key":"313959301c16"},{"text":"®","_key":"508b850a7ecb","_type":"span","marks":["superscript"]},{"_type":"span","marks":["em"],"text":") and is not endorsed by the American Academy of Dermatology.","_key":"583b2417b3bb"}],"_type":"block","style":"normal","_key":"3336c9765aa8","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"","_key":"a1e3d28cb7a8"}],"_type":"block","style":"normal","_key":"391223e4c13a","markDefs":[]},{"_type":"block","style":"normal","_key":"da103785c1c6","markDefs":[{"nofollow":false,"blank":true,"_type":"link","href":"https://www.ajmc.com/conference/dermatology-coverage","_key":"da296d1565d3"}],"children":[{"_type":"span","marks":[],"text":"At the ","_key":"5c9337b1950c"},{"_type":"span","marks":["da296d1565d3"],"text":"2024 American Academy of Dermatology Annual Meeting","_key":"50a5f42e75d2"},{"_type":"span","marks":[],"text":", Lawrence Eichenfield, MD, chief of pediatric dermatology at Rady Children's Hospital - San Diego and professor of dermatology and pediatrics at University of California, San Diego, presented late-breaking findings of roflumilast cream 0.05% in children aged 2 to 5 years with atopic dermatitis (AD) from the INTEGUMENT-PED phase 3 randomized controlled trial. ","_key":"4f85170bad1d"}]},{"_key":"ae36cf2ebedb","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"f0bf528eaf2d"}],"_type":"block","style":"normal"},{"style":"normal","_key":"74bed3000d8e","markDefs":[],"children":[{"_key":"f161aeda5d11","_type":"span","marks":[],"text":"In this interview with "},{"_type":"span","marks":["em"],"text":"AJMC","_key":"f3c99bc55c04"},{"_type":"span","marks":[],"text":", Eichenfield says that roflumilast cream 0.05% had \"very good results\" in pediatric patients with AD in terms of efficacy and safety. ","_key":"4e1a012f8ade"}],"_type":"block"},{"children":[{"_key":"70be043cd0e3","_type":"span","marks":[],"text":""}],"_type":"block","style":"normal","_key":"7a5f7360e76a","markDefs":[]},{"markDefs":[],"children":[{"marks":["strong","underline"],"text":"Transcript","_key":"eb418164f097","_type":"span"}],"_type":"block","style":"normal","_key":"23fcfbb03857"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"d9ecd07e8d9e"}],"_type":"block","style":"normal","_key":"b3e41335eee6"},{"markDefs":[],"children":[{"text":"Can you provide an overview of the primary findings from INTEGUMENT-PED, the phase 3 study assessing the efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients with AD?","_key":"fb4121eb35a50","_type":"span","marks":["strong"]}],"_type":"block","style":"normal","_key":"88cc794344da"},{"children":[{"_type":"span","marks":[],"text":"","_key":"f193587f93b9"}],"_type":"block","style":"normal","_key":"19d0776f1a83","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"First of all, roflumilast is a topical PDE-4 [phosphodiesterase-4] inhibitor, and this drug is approved right now at a 0.3% strength for psoriasis as a cream and as a foam for seborrheic dermatitis. ","_key":"b32c70588e750"}],"_type":"block","style":"normal","_key":"236ea6f556a0","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"","_key":"f29a7b956e47"}],"_type":"block","style":"normal","_key":"ed2ed44237db","markDefs":[]},{"markDefs":[],"children":[{"marks":[],"text":"This study fits into the earlier portfolio of studies looking at roflumilast cream for atopic dermatitis. There had been a study in patients 6 years of age and older through adults, studying roflumilast 0.15% cream application for atopic dermatitis. ","_key":"0881b7bbfe72","_type":"span"}],"_type":"block","style":"normal","_key":"57652527d1f9"},{"_key":"2130be685d34","markDefs":[],"children":[{"text":"","_key":"00e2a94d1bf3","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"This is the study of patients 2 to 5 years of age with mild to moderate atopic dermatitis, using a formulation of roflumilast cream, which is 0.05%. The study was done in a typical fashion and showed very good results in terms of the core standard end points that we look for, for both efficacy and safety, as a topical for atopic dermatitis in this pediatric population.","_key":"afa9c95d8ae8"}],"_type":"block","style":"normal","_key":"90b3fcdfdf2b"},{"_key":"42b907bcfafa","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"9a4e5b9de71d"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"c3a6bcd34485","markDefs":[],"children":[{"_type":"span","marks":["strong"],"text":"What were the key inclusion criteria for selecting participants in this study? How representative were they of the pediatric population with AD?","_key":"70474089ab2c"}]},{"_type":"block","style":"normal","_key":"a6ac608cdc56","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"e57d114c58cf"}]},{"children":[{"_type":"span","marks":[],"text":"Patients in this study had to be 2 to 5 years of age with mild to moderate atopic dermatitis. They had to have a minimum body surface area of 3%, and they had to have an EASI [Eczema Area and Severity Index]","_key":"4db388fc5d400"},{"_type":"span","marks":["strong"],"text":" ","_key":"57bc8dd5895b"},{"_key":"4338dd5bb9a7","_type":"span","marks":[],"text":"score that was 5 or greater. That's a pretty typical population within this age group, for 2 to 5 year olds. We have a lot of mild or moderate atopic dermatitis in that subgroup—the 3% body surface area—it's just not including those with little focal area of atopic dermatitis. Baseline EASI was consistent with that. "}],"_type":"block","style":"normal","_key":"b33c2e3d4808","markDefs":[]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"2665c974bd02"}],"_type":"block","style":"normal","_key":"dd977262a953"},{"_key":"891a50b7a8d9","markDefs":[],"children":[{"_type":"span","marks":[],"text":"So, it doesn't represent all patients, just within that little age group, but it's a pretty reasonable inclusion criteria for much of the eczema that we see in younger children.","_key":"aa8001a63dea"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_key":"42a8fd51a298","_type":"span","marks":[],"text":""}],"_type":"block","style":"normal","_key":"527df700c38d"},{"markDefs":[],"children":[{"text":"Could you provide insights into the safety profile of roflumilast cream observed during the trial? Were there any unexpected adverse events or safety concerns in this pediatric population?","_key":"01ddbe827e55","_type":"span","marks":["strong"]}],"_type":"block","style":"normal","_key":"bdef2ed379fb"},{"_type":"block","style":"normal","_key":"b395c6726f2a","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"c3468a30f0fa"}]},{"style":"normal","_key":"80cdb810dcd2","markDefs":[],"children":[{"_type":"span","marks":[],"text":"This study was using the drug as a daily application as compared to vehicle cream for a 4-week time period. There was a very low dropout rate during the study, something that we like to see in topical studies so that we don't have a sense that patients abandoned the study because of problems with either safety or tolerance, which are, I think, the 2 aspects when it comes to a topical that we're looking at. ","_key":"5bad6191c5b70"}],"_type":"block"},{"children":[{"text":"","_key":"dd5f6291946b","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"0f57350a66e4","markDefs":[]},{"markDefs":[],"children":[{"_key":"5880887274b2","_type":"span","marks":[],"text":"The drug appeared to be quite successful from a safety standpoint. The treatment adverse events, there was 1 serious adverse event. It was cellulitis within a few days of the study, not considered to be associated with a drug; no other serious adverse events in either group. The rate of immersion adverse events that led to discontinuation was very low, around the 1% range with roflumilast and about twice that, actually, in the vehicle group. There was a little bit of a upper respiratory infection that was seen with roflumilast, and then a little bit of diarrhea and vomiting that was a little higher than the vehicle group; this was generally quite mild and considered unrelated in most of the patients. "}],"_type":"block","style":"normal","_key":"f9c2d609014b"},{"children":[{"_type":"span","marks":[],"text":"","_key":"2ecc91b652b2"}],"_type":"block","style":"normal","_key":"e8329c1bf795","markDefs":[]},{"_key":"6a4126108de8","markDefs":[],"children":[{"text":"When it comes to the tolerability, there were particular tests that were looking at that because that's important in a topical agent. There was a investigated rater local tolerability score that was essentially a 0, 1, 2, 3 score, looking at aspects of redness in the population. It was essentially zero throughout the course of the study, pretty much overlapping curves between the roflumilast and the vehicle cream. ","_key":"e8ec11b4aaaa","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"18e01e6fa80d"}],"_type":"block","style":"normal","_key":"b7beaa848aa7"},{"_type":"block","style":"normal","_key":"cda59b1ae0a0","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The patient-rated tolerability was really quite good, actually, with the roflumilast cream being considered more tolerable than the vehicle cream, which is interesting, I guess because of the beneficial effects on eczema. That was throughout the course of the study.","_key":"4ed20fd5f506"}]}],"updatedOn":null,"title":"Dr Lawrence Eichenfield Discusses Positive Results of Roflumilast Cream 0.05% in Pediatric Patients With AD","ExcludeFromPubMedXML":false,"link":"/view/dr-lawerence-eichenfield-discusses-positive-results-of-roflumilast-cream-0-05-in-pediatric-patients-with-ad","articleType":"Commentary","published":"2024-04-08T16:00:00.000Z","summary":"Lawrence Eichenfield, MD, of Rady Children's Hospital - San Diego, discusses the implications of the findings from INTEGUMENT-PED, the phase 3 study assessing the efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients with atopic dermatitis (AD).","documentGroupMapping":[{"_ref":"2fa14601-28b8-47d1-a9f2-6b0ea39b92ac","_type":"reference","_key":"5f18ef80a521"},{"_ref":"132c11b2-1f54-4649-9fcf-d7d3788643f7","_type":"reference","_key":"a1d573bfd531"}],"taxonomyMapping":[{"summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block","style":"normal","_key":"dd8ad578cd0b"}],"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_type":"taxonomy","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z"},{"identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis","summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal","_key":"f8a866978242"}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z"},{"name":"Conference","_id":"1862ee25-8e65-4dbe-8fd3-d4c11642b211","_updatedAt":"2022-07-31T01:47:04Z","identifier":"conference","_createdAt":"2020-03-30T19:06:53Z","_rev":"Zzg2CQjl4x3UedGJkY3tyu","_type":"taxonomy"},{"_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews"}],"source":null,"url":{"current":"dr-lawerence-eichenfield-discusses-positive-results-of-roflumilast-cream-0-05-in-pediatric-patients-with-ad","_type":"slug"},"_rev":"SHnSQZzCPyvV9dutMHVx1f","contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"authorMapping":[{"_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl ","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"}},{"_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke","displayName":"Brooke McCormick","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"style":"normal","_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block"},{"style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block"},{"markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd"}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal","_key":"98aee68dab9d"}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z"}]},{"url":{"current":"dr-jonathan-silverberg-describes-ad-diagnosis-treatment-in-children-vs-adults","_type":"slug"},"authorMapping":[{"_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl ","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"}},{"_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"style":"normal","_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block"},{"style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block"},{"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"_key":"80a1c1a9d7cd","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/"}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke","displayName":"Brooke McCormick","_type":"author"}],"ExcludeFromPubMedXML":false,"documentGroupMapping":[{"_ref":"132c11b2-1f54-4649-9fcf-d7d3788643f7","_type":"reference","_key":"4dbb131c1eab"},{"_ref":"2fa14601-28b8-47d1-a9f2-6b0ea39b92ac","_type":"reference","_key":"56e10c40bbcd"}],"articleType":"Commentary","updatedOn":null,"thumbnail":{"asset":{"_updatedAt":"2024-03-26T18:54:59Z","extension":"png","_rev":"coS43koPbpwHNDDY1PRZ2W","_type":"sanity.imageAsset","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/c604364841a910a2075536c659ada17f2fcbdc43-658x352.png","assetId":"c604364841a910a2075536c659ada17f2fcbdc43","_id":"image-c604364841a910a2075536c659ada17f2fcbdc43-658x352-png","metadata":{"dimensions":{"aspectRatio":1.8693181818181819,"height":352,"_type":"sanity.imageDimensions","width":658},"isOpaque":true,"blurHash":"MLRMVkfR_Nof00_4M{4nRjtQbZRjMxkC%g","_type":"sanity.imageMetadata","palette":{"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.68,"background":"#554540"},"muted":{"foreground":"#fff","title":"#fff","population":0.03,"background":"#b4745c","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"background":"#fcf4ec","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.04},"darkVibrant":{"title":"#fff","population":0.01,"background":"#4c2814","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.91,"background":"#c8bcaa"},"vibrant":{"background":"#dc9c6c","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0},"dominant":{"background":"#554540","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.68}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"originalFilename":"Screenshot 2024-03-26 at 2.54.33 PM.png","mimeType":"image/png","sha1hash":"c604364841a910a2075536c659ada17f2fcbdc43","size":117987,"_createdAt":"2024-03-26T18:54:59Z","uploadId":"cHJ1TvgJKwAglNc13W4LHfVmlUVr0KIk","path":"images/0vv8moc6/ajmc/c604364841a910a2075536c659ada17f2fcbdc43-658x352.png"}},"seoTag":["dr jonathan silverberg","atopic dermatitis","AAD"],"source":null,"_rev":"kPLVtBcpCqnIEOEvE7MRw2","_type":"article","contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"is_visible":true,"_id":"64278475-9ab0-474d-9e7a-ddef2c251924","taxonomyMapping":[{"_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical","_id":"topic_clinical","summary":[{"_key":"dd8ad578cd0b","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block","style":"normal"}],"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_type":"taxonomy"},{"identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis","summary":[{"_key":"f8a866978242","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal"}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z"},{"_id":"1862ee25-8e65-4dbe-8fd3-d4c11642b211","_updatedAt":"2022-07-31T01:47:04Z","identifier":"conference","_createdAt":"2020-03-30T19:06:53Z","_rev":"Zzg2CQjl4x3UedGJkY3tyu","_type":"taxonomy","name":"Conference"},{"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z","sortOrder":3}],"link":"/view/dr-jonathan-silverberg-describes-ad-diagnosis-treatment-in-children-vs-adults","factCheckAuthorMapping":null,"title":"Dr Jonathan Silverberg Describes AD Diagnosis, Treatment in Children vs Adults","_createdAt":"2024-03-26T18:36:16Z","_updatedAt":"2024-04-03T14:59:35Z","published":"2024-04-02T16:00:00.000Z","summary":"Jonathan Silverberg, MD, PhD, MPH, FAAD, of George Washington University School of Medicine and Health Sciences, discusses atopic dermatitis (AD) diagnosis and treatment differences in children vs adults.","body":[{"_type":"video","videoID":"6349757902112","disableAutoPlayVideo":false,"source":"brightcove","_key":"68f6bffc3bfd","videoObject":{"videoDuration":"PT3M55S","videoDescription":"dr jonathan silverberg, atopic dermatitis, AAD","_type":"videoDetails","videoTitle":"Dr Jonathan Silverberg","thumbnail":{"asset":{"_ref":"image-c604364841a910a2075536c659ada17f2fcbdc43-658x352-png","_type":"reference"},"_type":"image"}}},{"markDefs":[],"children":[{"_type":"span","marks":["em"],"text":"This content was produced independently by","_key":"692f2b1b29f20"},{"_type":"span","marks":[],"text":" The American Journal of Managed Care® ","_key":"692f2b1b29f21"},{"_key":"692f2b1b29f22","_type":"span","marks":["em"],"text":"and is not endorsed by the American Academy of Dermatology."}],"_type":"block","style":"normal","_key":"eb0029ba71ed"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"9620fc9d138c0"}],"_type":"block","style":"normal","_key":"aaabbeaed04c"},{"_type":"block","style":"normal","_key":"25beeb080cd1","markDefs":[],"children":[{"marks":[],"text":"Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology and director of clinical research and patch testing at George Washington University School of Medicine and Health Sciences, discusses how dermatologists diagnose and treat atopic dermatitis (AD) in children vs adults. ","_key":"0c34da265560","_type":"span"}]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"39b1a2a29f81"}],"_type":"block","style":"normal","_key":"7c142159407c"},{"markDefs":[{"blank":true,"_type":"link","href":"https://www.ajmc.com/view/dr-jonathan-silverberg-discusses-findings-on-the-safety-efficacy-of-nemolizumab-at-48-weeks","_key":"b24a98f9b4f3","nofollow":false}],"children":[{"_key":"59c73b1f942d","_type":"span","marks":[],"text":"He also described how the "},{"_type":"span","marks":["strong","b24a98f9b4f3"],"text":"ARCADIA-1 and ARCADIA-2 study results","_key":"55ab3fc40ccb"},{"_type":"span","marks":["strong"],"text":" ","_key":"cbbe30f0f971"},{"_key":"cc3957596dc4","_type":"span","marks":[],"text":"show nemolizumab's potential as a maintenance therapy for AD."}],"_type":"block","style":"normal","_key":"cb0a942933aa"},{"_type":"block","style":"normal","_key":"5a516713f35e","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"e0a5e22cba7e"}]},{"_type":"block","style":"normal","_key":"98969401a0e3","markDefs":[],"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"824fb463b332"}]},{"_key":"2d6fc2b2872c","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"f292ab01866f0"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":["strong"],"text":"How do dermatologists diagnose AD in children? How does AD present differently in adults?","_key":"fb2d456200af"}],"_type":"block","style":"normal","_key":"ef59d4e0d1d2","markDefs":[]},{"_type":"block","style":"normal","_key":"204c64b4e011","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"c5238ea8f7b9"}]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Atopic dermatitis is really a clinical diagnosis. We look at a constellation of clinical history, physical exam, family history, etc, looking at things like presence of itch, age of onset, the distribution of lesions, etc. The criteria for diagnosing atopic dermatitis are generally the same between children and adults, but the the presentation can vary substantially across age groups. ","_key":"b04e6a2e22b80"}],"_type":"block","style":"normal","_key":"0c981bdac113"},{"children":[{"_type":"span","marks":[],"text":"","_key":"cbd75f447e47"}],"_type":"block","style":"normal","_key":"386126c6fc0a","markDefs":[]},{"children":[{"_key":"9f93b905a107","_type":"span","marks":[],"text":"So, in children, it's usually a fairly straightforward diagnosis, although, certainly, there are mimics that we have to think about. But in adults, it can be much more challenging because the differential diagnosis is broader, we see a lot less flexural involvement, we tend to see more of these sort of morphologic variants that are a little less common in childhood appear more so in adults. So there's a lot of different things that we need to take into account as we're trying to make this diagnosis correctly in adults."}],"_type":"block","style":"normal","_key":"42923b13a5b4","markDefs":[]},{"style":"normal","_key":"8819f8c88196","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"20f521a6e891"}],"_type":"block"},{"_type":"block","style":"normal","_key":"2e1300bd9522","markDefs":[],"children":[{"marks":["strong"],"text":"What are some key differences when treating children with AD compared with treating adults with AD?","_key":"2c3984aa98700","_type":"span"}]},{"style":"normal","_key":"12aebdd81be6","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5c8dbcb099fc0"}],"_type":"block"},{"markDefs":[],"children":[{"marks":[],"text":"So, treatment wise, some of it is just practical. There's certain therapies that are approved down to young children. For example, dupilumab is approved down to age 6 months for moderate to severe disease. Many of the other therapies are not there yet. They're running their studies still for younger children, but, technically, we don't have them approved. ","_key":"8be9c5d834360","_type":"span"}],"_type":"block","style":"normal","_key":"ce88ec00c6d4"},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"f4d91fb1c8ac","_type":"span"}],"_type":"block","style":"normal","_key":"e6886285650b"},{"children":[{"_key":"b2fb69d0a812","_type":"span","marks":[],"text":"Some of it may actually be theoretical differences that turn out to be practical in the sense that it may be that certain targeted therapies will work better in some age groups than others. It may be that some of the targeted therapies may work better in adults than they even do in children. "}],"_type":"block","style":"normal","_key":"bdafbe5dfc76","markDefs":[]},{"_type":"block","style":"normal","_key":"2a1d52c9ff1d","markDefs":[],"children":[{"text":"","_key":"3ac5bf447bee","_type":"span","marks":[]}]},{"_type":"block","style":"normal","_key":"2dfffb8d5865","markDefs":[],"children":[{"_type":"span","marks":[],"text":"For a disease that is so common in childhood, so much of the development really hinges upon the adult population, but then we're often left with that question, will we expect the same response for children as we see for adults?","_key":"f1938ccb7b8f"}]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"fecffbdd07fd"}],"_type":"block","style":"normal","_key":"d547fe97c42f"},{"children":[{"marks":["strong"],"text":"What insights do the ARCADIA-1 and ARCADIA-2 study results provide regarding the potential for nemolizumab as a maintenance therapy for moderate to severe AD?","_key":"44002ac21e41","_type":"span"}],"_type":"block","style":"normal","_key":"fd2056fe6c11","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"","_key":"b9f11c428709"}],"_type":"block","style":"normal","_key":"2461985e3efe","markDefs":[]},{"style":"normal","_key":"a2deb58f804d","markDefs":[],"children":[{"marks":[],"text":"It's important to recognize that atopic dermatitis is a chronic disease and, for many, lifelong, which means it needs to be treated chronically. The field has worked very hard over the past 2 decades to acknowledge that and develop good long-term treatment approaches. ","_key":"f5d436f57dea0","_type":"span"}],"_type":"block"},{"children":[{"_type":"span","marks":[],"text":"","_key":"646d646a3461"}],"_type":"block","style":"normal","_key":"9b46b0123d24","markDefs":[]},{"_type":"block","style":"normal","_key":"289d1fb4af7f","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Like many other targeted therapies, nemolizumab is not supposed to be used for just a quick fix for a few weeks. If we're going to be using it, for many patients, it's going to be necessary to use it for months and perhaps years on end. So, it's very important that we understand what are the long-term efficacy profiles for different drugs that we use, and, particularly, in this case, for nemolizumab. ","_key":"e4518a3742e7"}]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"6137983bb2d7"}],"_type":"block","style":"normal","_key":"acfc3ac5fb0d"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"What we're seeing here is, in that longer-term use scenario, we're seeing nice durability of response, no loss of efficacy over time. We're also seeing an opportunity that there may be a dose-flexibility opportunity where we might, for some patients, not have to even use it every month, but may be able to give it every other month, which is fewer shots and certainly something that is going to be more meaningful for patients. ","_key":"a7b3beec61aa"}],"_type":"block","style":"normal","_key":"52f9a0412b57"},{"style":"normal","_key":"74f08abe98a5","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"ffb6f911fdf0"}],"_type":"block"},{"style":"normal","_key":"693d58c147cf","markDefs":[],"children":[{"_type":"span","marks":[],"text":"For some, there might even be an opportunity to take a little drug holiday and discontinue, as we saw from the placebo arm. So, I think this provides very important information about sort of real-world use long term that is very clinically valuable.","_key":"4ae1e558c2fe"}],"_type":"block"}]},{"url":{"current":"dr-raj-chovatiya-describes-oral-jak-inhibitor-monitoring-protocols-for-ad-treatment","_type":"slug"},"contentCategory":{"name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory"},"articleType":"Commentary","_id":"0b09ce0f-c3fe-479c-a352-71734ebe37b8","taxonomyMapping":[{"_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh"},{"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_type":"taxonomy","summary":[{"_type":"block","style":"normal","_key":"dd8ad578cd0b","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}]}]},{"identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal","_key":"f8a866978242"}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z"},{"_id":"1862ee25-8e65-4dbe-8fd3-d4c11642b211","_updatedAt":"2022-07-31T01:47:04Z","identifier":"conference","_createdAt":"2020-03-30T19:06:53Z","_rev":"Zzg2CQjl4x3UedGJkY3tyu","_type":"taxonomy","name":"Conference"}],"updatedOn":null,"factCheckAuthorMapping":null,"_createdAt":"2024-03-21T20:38:27Z","documentGroupMapping":[{"_ref":"132c11b2-1f54-4649-9fcf-d7d3788643f7","_type":"reference","_key":"9b90f40d4e33"},{"_ref":"2fa14601-28b8-47d1-a9f2-6b0ea39b92ac","_type":"reference","_key":"795ebbd48e99"}],"published":"2024-04-01T16:00:00.000Z","_type":"article","source":null,"_rev":"coS43koPbpwHNDDY1RBEgW","body":[{"_key":"817bd21971df","videoObject":{"_type":"videoDetails","videoTitle":"Dr Raj Chovatiya Describes Oral JAK Inhibitor Monitoring Protocols for AD Treatment","thumbnail":{"_type":"image","asset":{"_ref":"image-6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723-png","_type":"reference"}},"videoDuration":"PT2M37S","videoDescription":"dr raj choyatiya, AD, oral JAK inhibitors"},"_type":"video","videoID":"6349407531112","disableAutoPlayVideo":false,"source":"brightcove"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, described monitoring protocols for clinicians when using oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).","_key":"5b9b077d3a21"}],"_type":"block","style":"normal","_key":"0b687f698d12"},{"children":[{"_type":"span","marks":[],"text":"","_key":"114b7c7b466f"}],"_type":"block","style":"normal","_key":"b445b9bd42cb","markDefs":[]},{"_key":"510872a9e7b7","markDefs":[],"children":[{"text":"Chovatiya is also the founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, Illinois.","_key":"bc24bbb85a4a","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"34d5dc6eec45","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"485fec861020"}]},{"children":[{"_type":"span","marks":["underline","strong"],"text":"Transcript","_key":"3f33d4ea3f26"}],"_type":"block","style":"normal","_key":"64e27e7636aa","markDefs":[]},{"_type":"block","style":"normal","_key":"e8f28e576f13","markDefs":[],"children":[{"marks":[],"text":"","_key":"c60384f35ae0","_type":"span"}]},{"children":[{"marks":["strong"],"text":"Given the systemic nature of oral JAK inhibitors, what are the considerations and monitoring protocols that clinicians should follow when prescribing these medications for patients with AD, particularly in terms of managing adverse effects and assessing treatment response?","_key":"da7e761cc0740","_type":"span"}],"_type":"block","style":"normal","_key":"3ce7a4c7c793","markDefs":[]},{"_type":"block","style":"normal","_key":"72f0b11f7bfc","markDefs":[],"children":[{"_key":"8495b5c684b0","_type":"span","marks":[],"text":""}]},{"_type":"block","style":"normal","_key":"c0dfd2f48189","markDefs":[],"children":[{"_type":"span","marks":[],"text":"I like to tell individuals that I chat with about oral JAK inhibitors, don't be scared or frightened or even a little nervous about the fact that maybe there's a couple more points that you're going to talk about with your patients. If anything, that just makes you a better and more well-informed clinician to really be thinking about what is going to be the best therapy for that patient in front of you. ","_key":"d0337b1076e50"}]},{"style":"normal","_key":"5a7d50e9a1af","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"6180bcc7e78d"}],"_type":"block"},{"style":"normal","_key":"5149e648d722","markDefs":[],"children":[{"_type":"span","marks":[],"text":"When it comes to starting and initiation, on label, both JAK inhibitors abrocitinib and upadacitinib recommend starting at the lowest dose; that would be 100 milligrams of abrocitinib, 15 milligrams for upadacitinib. Then, based on your clinical assessment, if someone was not getting an optimal response—and that could include you feeling like they're not getting fast enough resolution of their itch or lesions—you can bump them up to the higher dose. ","_key":"4c6d2a50c8a4"}],"_type":"block"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"58b5817eb9ce"}],"_type":"block","style":"normal","_key":"92a94274f17e"},{"_key":"d3d425ffaf17","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Now, in terms of monitoring, there's a few labs that we think about monitoring at baseline. Generally, some of the normal infectious stuff we do, just like other systemic therapies, hepatitis B, hepatitis C, TB [tuberculosis] testing. ","_key":"7dd807eda686"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"text":"","_key":"bc3250d5a8cb","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"77e3f1dd5135"},{"children":[{"_type":"span","marks":[],"text":"Then, some of the other additional labs. In the case of abrocitinib, you're going to be thinking about doing a CBC [complete blood count], and, let's say, lipid profile at baseline, and then about 4 weeks after. Then, if you're going to be making a dosing change, another 4 weeks after that. ","_key":"7a471e572703"}],"_type":"block","style":"normal","_key":"131dcab7b7d6","markDefs":[]},{"_type":"block","style":"normal","_key":"e19892007fcc","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"60fe1c9308a7"}]},{"_key":"d2bba5108c4a","markDefs":[],"children":[{"text":"In the case of upadacitinib, slightly different labs. You're going to be doing the same CBC and lipid panel, but also you're going to be adding on liver function tests. Typically, you're going to be taking a look at baseline and then as clinically indicated for most of these. Twelve weeks is kind of a good number that I like just because that's when you're going to be checking lipids anyway. ","_key":"bc1f8e26d340","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"ea69707d6c85","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"65717314948d"}]},{"children":[{"_type":"span","marks":[],"text":"Beyond that, lab monitoring is a snap because it really is up to you and the patient about when you're going to check these things. The nice thing about the data we've gotten so far is that lab abnormalities seem to be pretty rare. If they really were to pop up, it's usually within the first few months of therapy itself when you actually aren't checking labs. Now, thinking about some of the other issues that we would note on the label, if somebody was to develop an infection while on therapy, or had one at baseline, you want to get it treated and pause therapy. ","_key":"3c9be89f8b7f"}],"_type":"block","style":"normal","_key":"151b6283147a","markDefs":[]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"50f28d8cabcb"}],"_type":"block","style":"normal","_key":"aed7adcace3e"},{"style":"normal","_key":"47b033e310d5","markDefs":[],"children":[{"_type":"span","marks":[],"text":"In terms of the other more rare stuff that I just talked about from the boxed warning, whether it be related to heart issues, blood clotting issues, cancer, and things like that. Obviously, at baseline, if this is something you're dealing with, you want to try to get a good handle on that before thinking about therapy. If this was something that developed while you were on therapy itself, you'd want to pause, make sure you assess, and get that under control before considering restarting therapy again.","_key":"0d120e26605f"}],"_type":"block"}],"summary":"Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, described monitoring protocols for clinicians when using oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).","seoTag":["dr raj chovatiya","JAK inhibitors","atopic dermatitis","AD"],"authorMapping":[{"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal","_key":"936ecf4b7f0c"},{"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block","style":"normal","_key":"9af540ce04de","markDefs":[]},{"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd"}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"firstName":"Brooke","displayName":"Brooke McCormick","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"}},{"profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"},"lastName":"Steinzor","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl "}],"is_visible":true,"ExcludeFromPubMedXML":false,"thumbnail":{"asset":{"_rev":"ypHxrhJ2X3QlZSU1ipuiqS","_type":"sanity.imageAsset","mimeType":"image/png","assetId":"6c8cc5e8be7d1555547a5f274c1d4434abd87813","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png","size":543349,"metadata":{"blurHash":"MELgz$oLuOof;{_MWBIBofE29^j]v}f6yD","_type":"sanity.imageMetadata","palette":{"lightMuted":{"population":10,"background":"#c4c4b4","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":3.18,"background":"#cfa88f"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":10,"background":"#c4c4b4"},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":8.44,"background":"#5e605e"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.19,"background":"#ae8875"},"lightVibrant":{"title":"#000","population":5.02,"background":"#e9c1a8","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0,"background":"#5c3c27","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1371,"aspectRatio":1.896265560165975,"height":723},"isOpaque":true},"sha1hash":"6c8cc5e8be7d1555547a5f274c1d4434abd87813","_createdAt":"2024-03-15T20:36:28Z","extension":"png","uploadId":"0M2G8zkbkSoXPaAVnFizfUPiiWYV6WPL","path":"images/0vv8moc6/ajmc/6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png","_id":"image-6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723-png","_updatedAt":"2024-03-15T20:36:28Z","originalFilename":"Screenshot 2024-03-15 at 4.07.46 PM.png"}},"title":"Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment","_updatedAt":"2024-03-27T15:50:20Z","link":"/view/dr-raj-chovatiya-describes-oral-jak-inhibitor-monitoring-protocols-for-ad-treatment"},{"contentCategory":{"_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z"},"is_visible":true,"_id":"fc2e75cf-ef91-42f7-b79d-d1b60ea73e60","taxonomyMapping":[{"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_type":"taxonomy","summary":[{"style":"normal","_key":"dd8ad578cd0b","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block"}],"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"}},{"summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal","_key":"f8a866978242"}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis"},{"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z","sortOrder":3},{"_id":"1862ee25-8e65-4dbe-8fd3-d4c11642b211","_updatedAt":"2022-07-31T01:47:04Z","identifier":"conference","_createdAt":"2020-03-30T19:06:53Z","_rev":"Zzg2CQjl4x3UedGJkY3tyu","_type":"taxonomy","name":"Conference"}],"source":null,"published":"2024-03-24T16:00:00.000Z","seoTag":["dr raj chovatiya","JAK inhibitors","atopic dermatitis","AD"],"documentGroupMapping":[{"_ref":"132c11b2-1f54-4649-9fcf-d7d3788643f7","_type":"reference","_key":"a893a0e0248c"},{"_type":"reference","_key":"3fb9601e8495","_ref":"2fa14601-28b8-47d1-a9f2-6b0ea39b92ac"}],"title":"Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD","_rev":"Kw7ZywWq2biwgCknthlJld","updatedOn":null,"url":{"current":"dr-raj-chovatiya-provides-evidence-supporting-oral-jak-inhibitor-use-to-treat-ad","_type":"slug"},"body":[{"source":"brightcove","_key":"132940158824","videoObject":{"thumbnail":{"_type":"image","asset":{"_ref":"image-6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723-png","_type":"reference"}},"videoDuration":"PT2M39S","videoDescription":"dr raj chovatiya, atopic dermatitis, oral JAK inhibitors, AAD annual meeting","_type":"videoDetails","videoTitle":"Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD"},"_type":"video","videoID":"6349006632112","disableAutoPlayVideo":false},{"_key":"1d20cdeebdd7","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, provided current clinical evidence supporting the use of oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).","_key":"e645a2d102b50"}],"_type":"block","style":"normal"},{"children":[{"marks":[],"text":"","_key":"ae4d0310c31a","_type":"span"}],"_type":"block","style":"normal","_key":"e4462c044df4","markDefs":[]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Chovatiya is also the founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, Illinois.","_key":"a03d4e882cb5"}],"_type":"block","style":"normal","_key":"b8c11c22ec12"},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"bc38404bc499","_type":"span"}],"_type":"block","style":"normal","_key":"d893495c96a9"},{"_key":"385db55abcd5","markDefs":[],"children":[{"_type":"span","marks":["underline","strong"],"text":"Transcript","_key":"4e3ac17fa92c"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_key":"e0daade2631d","_type":"span","marks":["strong"],"text":"Could you provide insights into the current clinical evidence supporting the use of oral JAK inhibitors for patients with AD, including efficacy, safety profiles, and potential long-term outcomes?"}],"_type":"block","style":"normal","_key":"a9c55922e1cd"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"59a3ffb31307"}],"_type":"block","style":"normal","_key":"0cd913935c19"},{"_key":"949c3126be31","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Whenever we're talking about any therapy, oral JAK inhibitors included, you want to give the good with the bad, the positive with the negative. So, I'll start with the good stuff. ","_key":"fc228a19998c0"}],"_type":"block","style":"normal"},{"_key":"f9ababf520ff","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"24d428a2164c"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"fc82cec735c7","markDefs":[],"children":[{"_type":"span","marks":[],"text":"When it comes to thinking about oral JAK inhibitors, particularly at their higher dosing—both abrocitinib and upadacitinib have a lower dose and a higher dose)—it's some of the highest efficacy we've really ever seen for atopic dermatitis therapies. There's been a variety of indirect comparisons in recent years using what's called a network meta-analysis to sort of compare across different trials. What ends up coming out every single time, typically, is that upadacitinib 30 milligrams and abrocitinib 200 milligrams tend to be your best shot at getting the highest rates of clearance and also getting the highest rates of itch response. The biologics then seem to slot right after that. ","_key":"f8bc8b2e1d61"}]},{"style":"normal","_key":"0260f29f373c","markDefs":[],"children":[{"_key":"b47db0d638d8","_type":"span","marks":[],"text":""}],"_type":"block"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Now, what is going to be the trade-off? Well, with the higher doses of the oral JAK inhibitors, you're going to be thinking about some common safety adverse event issues. These aren't really the box warning issues; those are really quite rare, altogether, and there isn't any clear evidence of that being a reliable risk and adverse event in the real world. In the case of abrocitinib: nausea, dizziness, and things like that. In the case of upadacitinib: acne probably being the more common one. Across both of them, thinking about herpes simplex and herpes zoster–related exacerbations. ","_key":"4fc24dd01811"}],"_type":"block","style":"normal","_key":"0ec944d9c88e"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"bc3089c6e0c2"}],"_type":"block","style":"normal","_key":"f5991d3538da"},{"_key":"a608da550588","markDefs":[],"children":[{"text":"Now, the good news is that we've accumulated longer and longer and longer term data, and a bit of real-world data, which gives us some reassurance in a couple of regards. Number one, efficacy sure seems to hold up compared to what we've seen in clinical trials, and I can speak to that for my own practice. If anything, the lower dose of the JAK inhibitors probably performs even better than you may expect based on the clinical trials. ","_key":"bae966a27659","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"style":"normal","_key":"80d5d052c971","markDefs":[],"children":[{"text":"","_key":"480eb08d5702","_type":"span","marks":[]}],"_type":"block"},{"children":[{"_type":"span","marks":[],"text":"Now, when we think about safety, the good news is that the safety profile in the real world has also largely been reflected. If anything, there hasn't been necessarily a clear risk for some of the longer-term extension data. In the case of upadacitinib now, this is the longest we have, going up to about 5 years, of these events of being thromboembolism, major adverse cardiovascular event, and malignancy really being directly connected to the drug itself. ","_key":"633d973606d6"}],"_type":"block","style":"normal","_key":"6568ab957bbe","markDefs":[]},{"markDefs":[],"children":[{"_key":"799fa145dfc7","_type":"span","marks":[],"text":""}],"_type":"block","style":"normal","_key":"c90e2f1242de"},{"markDefs":[],"children":[{"marks":[],"text":"In fact, some nice analyses have shown that, when you sort of look at epidemiologic data in atopic dermatitis patients, generally, and then look at sort of the data from long-term extension arms of these drug studies, it looks like probably you're hovering right around the normal background rate of these events in the atopic dermatitis patient population in general.","_key":"879826856b7b","_type":"span"}],"_type":"block","style":"normal","_key":"063dc87c10e7"}],"articleType":"Commentary","_createdAt":"2024-03-15T20:27:18Z","authorMapping":[{"firstName":"Brooke","displayName":"Brooke McCormick","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}]},{"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"_key":"80a1c1a9d7cd","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/"}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}}},{"_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl ","displayName":"Pearl Steinzor","url":{"current":"pearl-steinzor","_type":"slug"},"lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}}}],"_updatedAt":"2024-03-24T16:00:01Z","_type":"article","summary":"Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, provided current clinical evidence supporting the use of oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).","ExcludeFromPubMedXML":false,"link":"/view/dr-raj-chovatiya-provides-evidence-supporting-oral-jak-inhibitor-use-to-treat-ad","factCheckAuthorMapping":null,"thumbnail":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png","size":543349,"metadata":{"palette":{"lightMuted":{"foreground":"#000","title":"#fff","population":10,"background":"#c4c4b4","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":3.18,"background":"#cfa88f","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"dominant":{"title":"#fff","population":10,"background":"#c4c4b4","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":8.44,"background":"#5e605e"},"muted":{"population":1.19,"background":"#ae8875","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightVibrant":{"background":"#e9c1a8","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":5.02},"darkVibrant":{"background":"#5c3c27","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1371,"aspectRatio":1.896265560165975,"height":723},"isOpaque":true,"blurHash":"MELgz$oLuOof;{_MWBIBofE29^j]v}f6yD","_type":"sanity.imageMetadata"},"sha1hash":"6c8cc5e8be7d1555547a5f274c1d4434abd87813","_createdAt":"2024-03-15T20:36:28Z","_updatedAt":"2024-03-15T20:36:28Z","originalFilename":"Screenshot 2024-03-15 at 4.07.46 PM.png","extension":"png","uploadId":"0M2G8zkbkSoXPaAVnFizfUPiiWYV6WPL","path":"images/0vv8moc6/ajmc/6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723.png","_id":"image-6c8cc5e8be7d1555547a5f274c1d4434abd87813-1371x723-png","_rev":"ypHxrhJ2X3QlZSU1ipuiqS","_type":"sanity.imageAsset","mimeType":"image/png","assetId":"6c8cc5e8be7d1555547a5f274c1d4434abd87813"}}},{"url":{"current":"dr-amy-paller-safety-is-of-paramount-importance-when-choosing-systemic-therapies-for-children-with-ad","_type":"slug"},"factCheckAuthorMapping":null,"summary":"Amy S. Paller, MD, of Feinberg School of Medicine at Northwestern University, noted that safety is of paramount importance when choosing which systemic therapy to use to treat children with atopic dermatitis (AD).","contentCategory":{"name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory"},"_createdAt":"2024-03-11T16:06:44Z","published":"2024-03-17T13:00:00.000Z","body":[{"videoID":"6348679213112","disableAutoPlayVideo":false,"source":"brightcove","_key":"22b5779d242c","videoObject":{"thumbnail":{"_type":"image","asset":{"_ref":"image-1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535-png","_type":"reference"}},"videoDuration":"PT1M12S","videoDescription":"dr amy paller, atopic dermatitis, AD, children with AD, systemic therapies","_type":"videoDetails","videoTitle":"Dr Amy Paller "},"_type":"video"},{"_type":"block","style":"normal","_key":"7e92a798e97e","markDefs":[],"children":[{"_key":"aed77dd41ed6","_type":"span","marks":[],"text":"Amy S. Paller, MD, chair of the department of dermatology at Northwestern University's Feinberg School of Medicine, noted that safety is of paramount importance when choosing which systemic therapy to use to treat children with atopic dermatitis (AD)."}]},{"_key":"55687cf14f1a","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"e12ceef7eba8"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":[],"text":"Specifically, Paller claimed that biologics are currently the safest to use in children, but she explained that, as more is learned about them, Janus kinase (JAK) inhibitors may take over that title in the years to come. ","_key":"87bbb2d1445c"}],"_type":"block","style":"normal","_key":"6c729c882350","markDefs":[]},{"markDefs":[],"children":[{"_key":"52c52fde6b23","_type":"span","marks":[],"text":""}],"_type":"block","style":"normal","_key":"a89bf18aa540"},{"_type":"block","style":"normal","_key":"de1e2a02dddb","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Conversely, Paller noted that the long-term side effects of systemic therapies are not yet known, which, she emphasized, providers must be aware of when using them to treat children with AD. ","_key":"b7536fea7091"}]},{"_type":"block","style":"normal","_key":"b48796db063a","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"20b330957ecd"}]},{"_type":"block","style":"normal","_key":"e1361f2a2564","markDefs":[],"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"4464af2ddddf"}]},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"c9213f3aa66b","_type":"span"}],"_type":"block","style":"normal","_key":"0c56050888e2"},{"markDefs":[],"children":[{"text":"What are the long-term risks of systemic therapy use in children with AD?","_key":"137c551f26c9","_type":"span","marks":["strong"]}],"_type":"block","style":"normal","_key":"59bbebfb07d7"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"1540cd6c5918"}],"_type":"block","style":"normal","_key":"a088a80cfa39"},{"_type":"block","style":"normal","_key":"dacf34138231","markDefs":[],"children":[{"_type":"span","marks":[],"text":"One of the factors that we need to be concerned about with systemic medications in children is that we're talking about longer term than what we may be talking about [for] an adult who's taking a medication. If we start at 2 or 3 years of age, 6 years of age, 10 years of age, we've got a few decades more, potentially, than what we might be doing in treating an adult. ","_key":"0b431e4fcc3a0"}]},{"_key":"bb4aff9b8715","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"b19d7aa44107"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":[],"text":"So, we do pay attention to safety; that's of paramount importance in any systemic therapy we choose for children. Right now, we think that the biologics are safest, but we also may, in a few years, as we learn more about the JAK inhibitors, feel very comfortable with their use, including in children who have atopic dermatitis for years on end. ","_key":"1aaac7751dab"}],"_type":"block","style":"normal","_key":"8ba60709be29","markDefs":[]},{"style":"normal","_key":"4517e89a9801","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"ff58bf46bb2c"}],"_type":"block"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"However, of course, it may take a long period of time before we know about the long-term side effects, even of the biologics, and we have to be aware of that in using them for our patients who are very young with atopic dermatitis.","_key":"2bcbd15f60af"}],"_type":"block","style":"normal","_key":"48f5fb2ec137"}],"link":"/view/dr-amy-paller-safety-is-of-paramount-importance-when-choosing-systemic-therapies-for-children-with-ad","updatedOn":null,"source":null,"is_visible":true,"_id":"9f0e0fcf-8eff-45a4-9e84-114fffc3464f","taxonomyMapping":[{"_type":"taxonomy","summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block","style":"normal","_key":"dd8ad578cd0b"}],"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical"},{"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","summary":[{"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal","_key":"f8a866978242","markDefs":[]}],"_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis","identifier":"atopic-dermatitis"},{"_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews"}],"authorMapping":[{"_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal"},{"style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block"},{"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd","nofollow":true,"blank":true}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick","_createdAt":"2023-06-21T17:59:19Z","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke","displayName":"Brooke McCormick"},{"lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"},"_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl ","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1"}],"_type":"article","_updatedAt":"2024-03-11T16:44:02Z","_rev":"B7EFjM7An2i1ocMyT9yGCC","thumbnail":{"asset":{"sha1hash":"1d4aff0d6882d93a42af0e26832541a9d5658f3d","metadata":{"_type":"sanity.imageMetadata","palette":{"darkMuted":{"background":"#34516b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.71},"muted":{"foreground":"#fff","title":"#fff","population":3.7,"background":"#588db5","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0,"background":"#7cc4dc"},"darkVibrant":{"population":5.48,"background":"#060f83","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"title":"#fff","population":6.33,"background":"#b4bfcf","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"foreground":"#fff","title":"#fff","population":0.18,"background":"#0e26a8","_type":"sanity.imagePaletteSwatch"},"dominant":{"background":"#b4bfcf","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.33},"_type":"sanity.imagePalette"},"hasAlpha":true,"lqip":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAALCAYAAAB/Ca1DAAAACXBIWXMAABYlAAAWJQFJUiTwAAADFUlEQVQokR3F6U+aBwDA4ffDlmXZEpPtw850i3Hd0jabH7bVttZjPeyKaMVJrAxFW4avoiL4cniLUFrxoq1Hi4pXKYgWjYoiVaujJXSryLb/57dsH548wnLsGO9GiseRNKG9f/BH00yuHTG8/Cd9/tdY5xIYpuI0TB7QMhWn+0kSR+A1rmCS4VAS3/of7BymSCTTHMRTCDPbx8xsp5nb+Qv/879ZjKaZ3TpmYfuYxY0knpkwbXYPOusAotOH8VEM23wCafYVxumX3HmaIBh9Q2T/DaFIEiGwe0xwN/2/lb00z/bShHbTrO2nWFpaxS4Z0civofgpn/KyCpq6RnDN7+Jc/B3bzAF9C3EeriTwrSWYDr9EWN07YnUvxX9vHaTYPjhi80WK9dgrRt1D3FaUUHe9iMrCQvKys6lUqnCPL+INxnjwJMqIf5+RwCEPlw6ZWD5ECEQS+DfiLG8nWIslCUcTrO4k8YefY7V0oiotw3KrHqlWpDjvErKr1+noH2Z87hme6RCuRys4vevc80Vw+SIID/w7OCdCjC5sMhV+wWRgi3H/JoPeJXR6CZVCSU+jiXumbnRKDTfk5dQbu7C6xpD6PTT3jNLaP0aH24t014vQdj9ItXUU/d1Zeh+H6b0/T6d7Ask+TM1vBirLNXQ0tuM2OxFV9fx8TUm5Wo9KtHCrpZ1Gcy9N5h5abT00Sl0IFZ3jFIl2FKZBRMc4bfYhDLY+RGM3yupOLhVZ0fzqwN42gFbVSk5ONTkFOhRVBsQWiWaTBW1jK2KTAUkyI5RZBik1Oqloc1Jnc9Bg60LbKqGsa+f7Aiefn7xDboEbk34IXXU3Z0438+mXBvKvWFDXNlFRpUamuEmVWoOhRY9Q09FPlbkTpcFEudiAQqulpFbLObmJj046eOdDF1lnBqlRe6i+OUBmVhfvZlj54isDP+Yq+OHiec4WXuSy7AolChmC1tjCL7fVXK0s5kLJZXKLZeTdqOBUvkjGiR7eznDyceYQxaVjyOUePjnh4K33bLz/gZbPMi/wdXYW3577huzc03x3/hT/AumgI9ktm6ZqAAAAAElFTkSuQmCC","dimensions":{"width":2880,"aspectRatio":1.8762214983713354,"height":1535,"_type":"sanity.imageDimensions"},"isOpaque":true,"blurHash":"MaE{|lx]yCR-Vs?woKxcR*RiSjWBnza~of"},"path":"images/0vv8moc6/ajmc/1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png","originalFilename":"Screenshot 2024-03-11 at 10.54.43 AM.png","extension":"png","uploadId":"QEgPAMgWnuwTdNDEU4ehx8tFbfl7BGHZ","_rev":"gFXie0Ldruy1o91XpplTZ7","_type":"sanity.imageAsset","size":4975558,"assetId":"1d4aff0d6882d93a42af0e26832541a9d5658f3d","mimeType":"image/png","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png","_createdAt":"2024-03-11T15:32:52Z","_id":"image-1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535-png","_updatedAt":"2024-03-11T15:32:52Z"}},"title":"Dr Amy Paller: Safety Is of Paramount Importance When Choosing Systemic Therapies for Children With AD","ExcludeFromPubMedXML":false,"articleType":"Commentary"},{"_createdAt":"2024-03-11T15:25:57Z","articleType":"Commentary","_updatedAt":"2024-03-11T21:28:12Z","link":"/view/dr-amy-paller-discusses-using-systemic-therapies-to-treat-children-with-ad","source":null,"factCheckAuthorMapping":null,"url":{"current":"dr-amy-paller-discusses-using-systemic-therapies-to-treat-children-with-ad","_type":"slug"},"taxonomyMapping":[{"summary":[{"_type":"block","style":"normal","_key":"f8a866978242","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}]}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis"},{"_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical","_type":"taxonomy","summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block","style":"normal","_key":"dd8ad578cd0b"}],"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z"},{"sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z"}],"_id":"ab9bd220-65a0-4f8f-b09c-54a17f62f08b","authorMapping":[{"displayName":"Brooke McCormick","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal","_key":"936ecf4b7f0c"},{"style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block"},{"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd","nofollow":true}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick"},{"firstName":"Pearl ","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","_updatedAt":"2024-10-25T15:48:33Z","lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"}}],"is_visible":true,"body":[{"disableAutoPlayVideo":false,"source":"brightcove","_key":"a295e022efb8","videoObject":{"videoDuration":"PT2M35S","videoDescription":"dr amy paller, atopic dermatitis, AD, children with AD, systemic therapies","_type":"videoDetails","videoTitle":"Dr Amy Paller Discusses Using Systemic Therapies to Treat Children With AD","thumbnail":{"_type":"image","asset":{"_type":"reference","_ref":"image-1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535-png"}}},"_type":"video","videoID":"6348675691112"},{"style":"normal","_key":"d3f6b7460879","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Amy S. Paller, MD, chair of the department of dermatology at Northwestern University's Feinberg School of Medicine, discussed using systemic therapies to treat children with atopic dermatitis (AD). ","_key":"aa5458286b20"}],"_type":"block"},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"483d21f4b432","_type":"span"}],"_type":"block","style":"normal","_key":"8053e3b2ef82"},{"children":[{"text":"More specifically, she listed the main factors considered when deciding whether to treat children with AD using systemic therapies. Paller also discussed implementing lifestyle changes and additional treatments to complement systemic therapies for better results in children with AD.","_key":"d32e27e94b82","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"ee01497bce17","markDefs":[]},{"style":"normal","_key":"64c7c7acb48e","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"56a5ceb90cb7"}],"_type":"block"},{"_key":"1fe91bccd9df","markDefs":[],"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"f74acd3d66fe"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_key":"0b31557978cf","_type":"span","marks":[],"text":""}],"_type":"block","style":"normal","_key":"53f51e455b0f"},{"_type":"block","style":"normal","_key":"e50544635263","markDefs":[],"children":[{"_type":"span","marks":["strong"],"text":"What are some of the main factors you consider when it comes to treating children with AD using systemic therapies?","_key":"65a8176e9362"}]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"efc2f33dc706"}],"_type":"block","style":"normal","_key":"d6064b795bfe"},{"_key":"fa731379e87a","markDefs":[],"children":[{"marks":[],"text":"With respect to systemic therapies for atopic dermatitis, it's really very individualized. Of course, for each patient, we have to optimize topical therapies first, and we have new topical therapies that are coming out; that will be exciting to add to our armamentarium. ","_key":"f18e0540ac570","_type":"span"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"002e6c1a48f6"}],"_type":"block","style":"normal","_key":"642583ea6ac6"},{"markDefs":[],"children":[{"text":"When we advanced to systemic therapies, it really very much is dependent on the needs of the child, the decision-making input from the family, and, very importantly, access. Because, in the United States, we are limited in what we can give a child based on insurance and what they have used previously. ","_key":"94186cbc8b75","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"06367214d8b7"},{"_type":"block","style":"normal","_key":"6881c59f9701","markDefs":[],"children":[{"marks":[],"text":"","_key":"9104fa9ea7c4","_type":"span"}]},{"markDefs":[],"children":[{"text":"Of course, when we're dealing with children, we also have another factor to think about, and that's that we have to give injections now to use some of the systemic therapies that are available to pediatric patients for atopic dermatitis. Even though these are incredibly safe, and we're very comfortable with using them, we do have to inflict some pain through that injection. For some children, for some families, that's just fine, and it may be the treatment of choice. For others, we have to think about the fact that it can be a real struggle, and we may not be able to get past that struggle for the child and have to think about other ways to treat with oral medication.","_key":"9d8cf5c9f406","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"a283c533ad97"},{"children":[{"_type":"span","marks":[],"text":"","_key":"25c6830fa453"}],"_type":"block","style":"normal","_key":"25a11c5409f3","markDefs":[]},{"_key":"bcc0453706d9","markDefs":[],"children":[{"_type":"span","marks":["strong"],"text":"Are there any lifestyle changes or additional treatments that can complement systemic therapies for better results?","_key":"089851f3043a"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":[],"text":"","_key":"0d272bf619cc"}],"_type":"block","style":"normal","_key":"3a7cf18e761e","markDefs":[]},{"_type":"block","style":"normal","_key":"e864badd63e5","markDefs":[],"children":[{"_type":"span","marks":[],"text":"We don't give anyone systemic therapies only. We, of course, complement them with topical therapies to try to get that child 100% clear. We also do other things, like continue the use of emollients; they're critically important to reduce dryness and improve the barrier function of the skin. ","_key":"be530338c7580"}]},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"4aec0d2c1390","_type":"span"}],"_type":"block","style":"normal","_key":"45fa496954f8"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"We encourage people to have a healthy lifestyle in all ways, and that means keeping a neat house and trying to reduce dust and clutter in homes that can increase the risk for many of these children who also have a tendency towards allergic disorders. ","_key":"e96a1108eb9e"}],"_type":"block","style":"normal","_key":"97d744274088"},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"a9c77effe75d","_type":"span"}],"_type":"block","style":"normal","_key":"cd7adb4263f7"},{"_key":"1d06d7516d1f","markDefs":[],"children":[{"_type":"span","marks":[],"text":"We also, in general, just consider a healthy lifestyle for the entire family to be important because good diet and exercise are important for good health for everyone.","_key":"2b007d05ce8b"}],"_type":"block","style":"normal"}],"_rev":"7DPdpVQfYdDKlkK5xRe1Ba","published":"2024-03-12T16:00:00.000Z","thumbnail":{"asset":{"_updatedAt":"2024-03-11T15:32:52Z","mimeType":"image/png","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png","_createdAt":"2024-03-11T15:32:52Z","_id":"image-1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535-png","sha1hash":"1d4aff0d6882d93a42af0e26832541a9d5658f3d","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"width":2880,"aspectRatio":1.8762214983713354,"height":1535,"_type":"sanity.imageDimensions"},"isOpaque":true,"blurHash":"MaE{|lx]yCR-Vs?woKxcR*RiSjWBnza~of","_type":"sanity.imageMetadata","palette":{"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":1.71,"background":"#34516b","_type":"sanity.imagePaletteSwatch"},"muted":{"background":"#588db5","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.7},"lightVibrant":{"foreground":"#000","title":"#fff","population":0,"background":"#7cc4dc","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"background":"#060f83","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":5.48},"lightMuted":{"background":"#b4bfcf","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.33},"vibrant":{"background":"#0e26a8","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.18},"dominant":{"background":"#b4bfcf","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.33}},"hasAlpha":true},"path":"images/0vv8moc6/ajmc/1d4aff0d6882d93a42af0e26832541a9d5658f3d-2880x1535.png","originalFilename":"Screenshot 2024-03-11 at 10.54.43 AM.png","size":4975558,"assetId":"1d4aff0d6882d93a42af0e26832541a9d5658f3d","extension":"png","uploadId":"QEgPAMgWnuwTdNDEU4ehx8tFbfl7BGHZ","_rev":"gFXie0Ldruy1o91XpplTZ7","_type":"sanity.imageAsset"}},"_type":"article","title":"Dr Amy Paller Discusses Using Systemic Therapies to Treat Children With AD","ExcludeFromPubMedXML":false,"updatedOn":null,"contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"summary":"Amy S. Paller, MD, chair of the department of dermatology at Feinberg School of Medicine at Northwestern University, discussed using systemic therapies to treat children with atopic dermatitis (AD)."},{"internalTag":["dr elaine siegfried","atopic dermatitis ","AAD guidelines","interview"],"ExcludeFromPubMedXML":false,"title":"Dr Elaine Siegfried Summarizes AD Treatment Guideline Update ","_updatedAt":"2024-01-10T18:52:48Z","published":"2024-01-10T19:00:43.038Z","_type":"article","factCheckAuthorMapping":null,"is_visible":true,"source":null,"_createdAt":"2024-01-10T16:35:38Z","contentCategory":{"_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos"},"body":[{"disableAutoPlayVideo":false,"source":"brightcove","_key":"0e361de8fcf2","videoObject":{"thumbnail":{"_type":"image","asset":{"_type":"reference","_ref":"image-db081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612-png"}},"videoDuration":"PT6M50S","videoDescription":"dr elaine siegfried, interview, atopic dermatitis, treatment guideline","_type":"videoDetails","videoTitle":"Dr Elaine Siegfried Summarizes AD Treatment Guideline Update "},"_type":"video","videoID":"6344633824112"},{"_key":"4e563c000b02","markDefs":[{"blank":true,"_type":"link","href":"https://medfaculty.slu.edu/details/548/elaine-siegfried-dermatology-pediatric_dermatology-chesterfield-lake_st_louis-st_louis","_key":"c6799c23344d","nofollow":true},{"nofollow":false,"blank":true,"_type":"link","href":"https://www.ajmc.com/view/aad-updates-guidelines-for-ad-treatment-using-phototherapy-systemic-therapies","_key":"f8868f9b6353"},{"blank":true,"_type":"link","href":"https://www.ajmc.com/compendium/atopic-dermatitis","_key":"c9581cfb5793","nofollow":false}],"children":[{"_type":"span","marks":[],"text":"In this interview, ","_key":"4216f00e18f9"},{"_type":"span","marks":["c6799c23344d"],"text":"Elaine Siegfried, MD","_key":"3cdbc069e5761"},{"text":", of Saint Louis University School of Medicine, summarized the American Academy of Dermatology (AAD) ","_key":"3cdbc069e5762","_type":"span","marks":[]},{"_type":"span","marks":["f8868f9b6353"],"text":"guideline update","_key":"609ddf284ff7"},{"_type":"span","marks":[],"text":" published in November 2023 about treating ","_key":"c9c99cdec202"},{"_key":"3e6c120f5c21","_type":"span","marks":["c9581cfb5793"],"text":"atopic dermatitis (AD)"},{"marks":[],"text":" using phototherapy and systemic therapies. She also gave her opinion on guidelines overall.","_key":"20699409f05e","_type":"span"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"135e72ed5387","_type":"span"}],"_type":"block","style":"normal","_key":"b6bf7e91e835"},{"markDefs":[],"children":[{"marks":[],"text":"Siegfried diagnoses and treats skin-related disorders in infants and children; her specialties include AD, psoriasis, vascular birthmarks, and other eczemas. She is interested in research that investigates AD and pediatric drug development, as she participates in clinical trials for new eczema and psoriasis treatments. Siegfried is also a professor of pediatrics and dermatology in the Department of Pediatrics, Division of Dermatology, Saint Louis University School of Medicine.\n","_key":"c036dd3ff8a70","_type":"span"}],"_type":"block","style":"normal","_key":"fcf302bc8918"},{"_key":"270643351c11","markDefs":[],"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"6cccd1bd23b0"}],"_type":"block","style":"normal"},{"_key":"b98fad72df53","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"1ba08c96b421"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":["strong"],"text":"Could you please summarize the AAD's updated guideline recommendations for phototherapy and systemic therapies?","_key":"39a7e047b90b0"}],"_type":"block","style":"normal","_key":"b1852e27f5ee","markDefs":[]},{"_type":"block","style":"normal","_key":"2fef6221223b","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"649379bb59c60"}]},{"children":[{"_type":"span","marks":[],"text":"Just as by way of background, The last comprehensive guidelines were published in the ","_key":"a9651266279e"},{"_type":"span","marks":["em"],"text":"Journal of the American Academy of Dermatology ","_key":"ef7e274b10be"},{"_key":"5d6497ce05d3","_type":"span","marks":[],"text":"in 2014. Because so much has happened with this disease and new drug development for this spectrum of problems, the updated guidelines are much narrower just to try to bite off a smaller piece of that. So, the most recently published guidelines really focused on adults, and they focused on systemic treatments and phototherapy. The summary was very simple, and, just to put that into perspective, guidelines are something that requires broad consensus agreement and tries to look for evidence basis to support that agreement, but, just by virtue of the nature of trying to make guidelines, they're essentially really just oversimplified and are very difficult to draw generalized conclusions about how to manage any individual patient because individual patients are much more complicated than guidelines in general. "}],"_type":"block","style":"normal","_key":"c6783de38ea5","markDefs":[]},{"style":"normal","_key":"68a395e6d135","markDefs":[],"children":[{"marks":[],"text":"","_key":"3f9128872987","_type":"span"}],"_type":"block"},{"_key":"f42fb67b3fb3","markDefs":[],"children":[{"_type":"span","marks":[],"text":"So, the one take-home message that I think there was in this publication was, in no uncertain terms, systemic corticosteroids are considered not a good treatment and even relatively contraindicated, even though that's one of the very few medications that's essentially FDA approved for this condition. That speaks to the issues related to FDA approval and restricting access to medications based on FDA approval and particularly restricting things like step edits based on what's historically been FDA approved. ","_key":"195fb42a74c6"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"7ce966640f03"}],"_type":"block","style":"normal","_key":"d2906ec356a1"},{"style":"normal","_key":"b79f5ebb1566","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Then, they also concentrated on phototherapy, talking about phototherapy in adults. It's an age old treatment, recommended narrowband UV-B as opposed to something like PUVA [psoralen plus UV-A], which has a little bit more risk and less well studied, but it really emphasized the fact that phototherapy is incredibly time consuming. While they didn't say this in the guidelines, and didn't address children at all, many people just can't afford the time; it requires 3 times a week and office visits for a minimum of 2 to 3 months. Then, after that, twice a week, and then, after that, long term. ","_key":"9cc67b63db67"}],"_type":"block"},{"_key":"0972d589564c","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"2ce9730650de"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"9cd2851c8f7d","markDefs":[],"children":[{"_type":"span","marks":[],"text":"They did talk about the the possibility of combining treatments, phototherapy and systemic treatments, or even more than one systemic treatment, which really speaks to the difficulty in treating this condition. Some cases are so severe that you can't really go by what's FDA approved or a single agent to keep the disease under control. So, they didn't say anything about children and phototherapy, but the time commitment is even harder for children who need to be in school and depend on parents for transportation, things like that. ","_key":"b34f264b35e8"}]},{"_key":"265d2f3ca3dd","markDefs":[],"children":[{"marks":[],"text":"","_key":"b9a1f7bc8dcf","_type":"span"}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Of the medications that they discussed, they recommended the FDA-approved ones with confidence, and that's strictly because we have level 1 prospective, double blind, placebo controlled trial data that support efficacy, and that's for adults. For children, it's a little bit different, and just so everyone knows, the number of children included in clinical trials to get that same kind of level 1 evidence is typically one-tenth the number of adults that are included in clinical trials, so much harder to have confidence, particularly in the safety data for such small number of patients and a unique subgroup of patients.","_key":"7b9a0ce4743c"}],"_type":"block","style":"normal","_key":"cc7945fe5a58"},{"style":"normal","_key":"11887dd6e72e","markDefs":[],"children":[{"_key":"1024636f7c6a","_type":"span","marks":[],"text":""}],"_type":"block"},{"_key":"c7f967ebf27a","markDefs":[],"children":[{"text":"Although this guideline was focused on systemic treatment and phototherapy, they also mentioned topical medications that were available—topical corticosteroids, calcineurin inhibitors, pimecrolimus, tacrolimus, crisaborole ointment, and a PDE-4 [phosphodiesterase 4] inhibitor, and then a newer JAK [Janus kinase] inhibitor ruxolitinib cream. There are also some other topical medications that have been FDA approved since then that the guidelines does not include that are probably more promising than, and safer than, the ones that were mentioned. ","_key":"52737e5b6da6","_type":"span","marks":[]}],"_type":"block","style":"normal"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"1f8ae6829b99"}],"_type":"block","style":"normal","_key":"9cd3ba4e4e8d"},{"style":"normal","_key":"1ff1c31b2c68","markDefs":[],"children":[{"text":"In terms of the systemic therapies, they recommended with some confidence the FDA approved treatments dupilumab, that's been FDA approved and available since 2017, and tralokilumab, which was FDA approved I think about a year ago. There is another one that they didn't mention, lebrikizumab, that works through the same mechanism, which is very close to approval. ","_key":"604b2a3c38b6","_type":"span","marks":[]}],"_type":"block"},{"_type":"block","style":"normal","_key":"0faf52e30626","markDefs":[],"children":[{"text":"","_key":"a782a5276714","_type":"span","marks":[]}]},{"children":[{"_type":"span","marks":[],"text":"Then, they recommended 2 FDA-approved JAK inhibitors, upadacitinib and abrocitinib, and mentioned, without the higher level of recommendation because of the quality of the supportive evidence, the systemic treatments that have been used for many, many, many years—over 50 in the case of methotrexate, probably 30 or 40 for cyclosporine, azathioprine less so, and mycophenolate mofetil less so, but those are considered in this publication to be immunosuppressants. I don't consider methotrexate as much of an immunosuppressant as cyclosporine, azathioprine, and mycophenolate; it's more of an immunomodulating agent.","_key":"56fe13200249"}],"_type":"block","style":"normal","_key":"c6b91654d409","markDefs":[]},{"style":"normal","_key":"cf0996641cff","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"82732e1dc3ab"}],"_type":"block"},{"_key":"6331abb4bd30","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Then, it mentioned systemic corticosteroids. There was a strong recommendation against using systemic corticosteroids, and, I do have to say, through some claims database information that we have, that's still probably the number 1 systemic treatment that is still being used in this population, certainly inexpensive, but leads to all kinds of problems when used either repeatedly or long term. ","_key":"999724ae44cf"}],"_type":"block","style":"normal"},{"style":"normal","_key":"903567aced9b","markDefs":[],"children":[{"text":"","_key":"88bc5092a75b","_type":"span","marks":[]}],"_type":"block"},{"_type":"block","style":"normal","_key":"40aa8e5ef8a9","markDefs":[],"children":[{"text":"So, that's the summary of those guidelines, and I have participated in guidelines, but I can't overemphasize that guidelines are an early starting point, and creating step edits and limiting access to medications based on published guidelines is not really what they were intended for and can really cause lots of problems for patients in delaying their access to appropriate personalized medication.\n","_key":"b6056649a005","_type":"span","marks":[]}]}],"articleType":"Commentary","summary":"Elaine Siegfried, MD, of Saint Louis University School of Medicine, summarized the recent American Academy of Dermatology guideline update for atopic dermatitis (AD).","thumbnail":{"asset":{"extension":"png","metadata":{"blurHash":"VkH_iLxZpIt7w]~qRjxuRjIUxuRjn%j[R*M{WBRjoft7","_type":"sanity.imageMetadata","palette":{"lightMuted":{"title":"#fff","population":5.46,"background":"#be9a96","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"population":0,"background":"#cc7c74","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"population":6.94,"background":"#9b756e","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.93,"background":"#3a3d4d"},"muted":{"title":"#fff","population":6.94,"background":"#9b756e","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"title":"#000","population":0.12,"background":"#e2f2f3","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0,"background":"#612923","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2351,"aspectRatio":1.4584367245657568,"height":1612},"isOpaque":true},"uploadId":"FDDlKf1Lg536yu4CHhW787lFocby2wRi","sha1hash":"db081c0c2b277892b449c8e2f422df0bd8a61a80","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/db081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png","path":"images/0vv8moc6/ajmc/db081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612.png","assetId":"db081c0c2b277892b449c8e2f422df0bd8a61a80","_rev":"LpCIq049e4C7n8sr6cS968","size":3491118,"_type":"sanity.imageAsset","_createdAt":"2024-01-10T16:53:10Z","_updatedAt":"2024-01-10T16:53:10Z","originalFilename":"Screenshot 2023-12-12 at 10.11.28 AM.png","mimeType":"image/png","_id":"image-db081c0c2b277892b449c8e2f422df0bd8a61a80-2351x1612-png"}},"taxonomyMapping":[{"_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320","_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews"},{"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","_updatedAt":"2022-05-17T17:50:18Z","summary":[{"_type":"block","style":"normal","_key":"f8a866978242","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}]}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"name":"Atopic Dermatitis","identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht"},{"_type":"taxonomy","summary":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block","style":"normal","_key":"dd8ad578cd0b"}],"identifier":"clinical","_createdAt":"2020-05-04T23:46:13Z","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","name":"Clinical"}],"_rev":"4Lzk84jSGsRXb2thIbGnWa","url":{"current":"dr-elaine-siegfried-summarizes-ad-treatment-guideline-update","_type":"slug"},"seoTag":["dr elaine siegfried","atopic dermatitis","AAD guidelines","interview"],"_id":"2c94be20-4a82-4811-a0ad-4d631f9e6367","authorMapping":[{"_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal","_key":"936ecf4b7f0c"},{"_type":"block","style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}]},{"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd"}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick","displayName":"Brooke McCormick","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke"}],"link":"/view/dr-elaine-siegfried-summarizes-ad-treatment-guideline-update","updatedOn":null},{"contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"_createdAt":"2024-01-03T15:51:50Z","_type":"article","title":"Dr Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors","_updatedAt":"2024-01-03T19:15:35Z","source":null,"ExcludeFromPubMedXML":false,"articleType":"Commentary","is_visible":true,"updatedOn":null,"_rev":"v9ksCIqUgEcDdLush2DhcK","taxonomyMapping":[{"_updatedAt":"2023-10-30T17:48:32Z","identifier":"interviews","_createdAt":"2020-03-30T19:16:54Z","sortOrder":3,"_rev":"xqhc4WIQcOa1P2rns6bqkh","_type":"taxonomy","name":"Interviews","_id":"2d909731-8acf-4e3d-8962-d59b0da85320"},{"_updatedAt":"2022-05-17T17:50:18Z","summary":[{"children":[{"_type":"span","marks":[],"text":"The ","_key":"b81520a412d2"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"978e7b31ca9f"},{"_type":"span","marks":["superscript"],"text":"®","_key":"a07d0cb6d0b8"},{"_type":"span","marks":[],"text":" Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.","_key":"45dab532ef8d"}],"_type":"block","style":"normal","_key":"f8a866978242","markDefs":[]}],"parent":{"_ref":"297fa3d1-5216-46eb-bf51-66c5f77c3c8a","_type":"reference"},"_createdAt":"2021-10-26T13:28:22Z","_type":"taxonomy","_id":"19c99996-848f-4c14-a61f-2d8d2979e191","identifier":"atopic-dermatitis","_rev":"l1CwC9FSSvQkCwYdkBTrht","name":"Atopic Dermatitis"},{"name":"Clinical","_id":"topic_clinical","_updatedAt":"2022-02-18T12:13:55Z","parent":{"_ref":"15012229-f713-4f0a-8f82-7667530bb382","_type":"reference"},"_rev":"HexDiduX8d6Nqnq1ECriVF","_createdAt":"2020-05-04T23:46:13Z","_type":"taxonomy","summary":[{"style":"normal","_key":"dd8ad578cd0b","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"e80c79954e08"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"a8e0f75c5d05"},{"_type":"span","marks":["superscript"],"text":"®","_key":"f7d4dddf7edd"},{"_type":"span","marks":[],"text":" clinical page includes all the published content across AJMC.com, ","_key":"0f03d46e3b3a"},{"text":"The American Journal of Managed Care","_key":"cc409f2da7da","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"2babb3e59bb3"},{"marks":[],"text":" and ","_key":"d86a5bb12052","_type":"span"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology","_key":"40b2eaba6c17"},{"_type":"span","marks":[],"text":"™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.","_key":"b59bef533cdf"}],"_type":"block"}],"identifier":"clinical"},{"_id":"4ee49086-e720-4a65-883e-4efc24de53bb","summary":[{"_key":"3b7c1e2bf551","alignment":"left","asset":{"_ref":"image-5f5a1d7609b5e2167e8398bb48c8734b1ba7aca8-800x212-jpg","_type":"reference"},"widthP":70,"disableTextWrap":false,"disableLightBox":true,"_type":"figure"},{"markDefs":[],"children":[{"marks":[],"text":"The mission of the Center on Health Equity \u0026 Access is to support improvement of health care delivery and health outcomes due to health disparities by maintaining a content platform focused on education, training, frontline perspectives, and practical application of evidence-based methodologies.","_key":"cdef2f34ef460","_type":"span"}],"_type":"block","style":"normal","_key":"973bcb0dcce4"}],"identifier":"center-on-health-equity-and-access","parent":{"_type":"reference","_ref":"15012229-f713-4f0a-8f82-7667530bb382"},"thumbnail":{"_type":"mainImage","alt":"Logo for the Center on Health Equity \u0026 Access","asset":{"_type":"reference","_ref":"image-5f5a1d7609b5e2167e8398bb48c8734b1ba7aca8-800x212-jpg"}},"_type":"taxonomy","name":"Center on Health Equity \u0026 Access","_createdAt":"2022-11-16T22:15:20Z","_rev":"N7mKycgLbGtEq6btkPHYvR","usedForRecommendations":false,"_updatedAt":"2024-06-12T13:58:15Z"}],"documentGroupMapping":[{"_ref":"8f3e99c6-7912-44f1-a082-0772a26e154b","_type":"reference","_key":"53c5cfa56ecb"}],"published":"2024-01-04T17:00:00.000Z","summary":"Jonathan Silverberg, MD, PhD, MPH, of George Washington University School of Medicine and Health Sciences, explains the benefits of using Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).","factCheckAuthorMapping":null,"link":"/view/dr-jonathan-silverberg-lists-which-patients-with-ad-benefit-most-from-jak-inhibitors","internalTag":["atopic dermatitis treatment","JAK inihibitors","safety and accessibility","dr jonathan silverberg"],"seoTag":["atopic dermatitis treatment","JAK inhibitors","safety and accessibility","dr jonathan silverberg"],"authorMapping":[{"displayName":"Brooke McCormick","_type":"author","_updatedAt":"2024-05-20T19:29:20Z","url":{"current":"brooke-mccormick","_type":"slug"},"firstName":"Brooke","_createdAt":"2023-06-21T17:59:19Z","_rev":"m9zO7fOEUWAduYt5irO78Q","_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","biography":[{"style":"normal","_key":"936ecf4b7f0c","markDefs":[],"children":[{"marks":[],"text":"Brooke is an assistant editor for ","_key":"8d68730a8da0","_type":"span"},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9","_type":"span"},{"_key":"0b218fbaa571","_type":"span","marks":[],"text":"® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"_type":"span","marks":[],"text":"®). She joined ","_key":"7de919198f04"},{"marks":["em"],"text":"AJMC","_key":"f31a60d737e2","_type":"span"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block"},{"style":"normal","_key":"9af540ce04de","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block"},{"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd","nofollow":true,"blank":true}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83"},{"marks":["80a1c1a9d7cd"],"text":"LinkedIn","_key":"4bb222fe2840","_type":"span"},{"_key":"c87621477700","_type":"span","marks":[],"text":"."}]}],"profileImage":{"_type":"mainImage","alt":"Brooke McCormick","asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"}},"lastName":"McCormick"},{"_id":"8f51e09f-2c76-4ef0-83e7-d577a5dfcdd1","_updatedAt":"2024-10-25T15:48:33Z","firstName":"Pearl ","displayName":"Pearl Steinzor","_createdAt":"2022-10-05T15:22:49Z","_rev":"r4x1XD7WYsdf9YL1ZVgDGC","_type":"author","lastName":"Steinzor","profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"url":{"current":"pearl-steinzor","_type":"slug"}}],"thumbnail":{"asset":{"extension":"jpg","metadata":{"isOpaque":true,"_type":"sanity.imageMetadata","palette":{"lightVibrant":{"background":"#f3d0b3","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":1.41},"darkVibrant":{"population":0,"background":"#723d12","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0,"background":"#d4bcb4"},"vibrant":{"title":"#fff","population":0,"background":"#dc7622","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"foreground":"#fff","title":"#fff","population":7.03,"background":"#958576","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":4.68,"background":"#3f3023","_type":"sanity.imagePaletteSwatch"},"muted":{"background":"#958576","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.03}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAALABQDASIAAhEBAxEB/8QAFwABAQEBAAAAAAAAAAAAAAAABwABBP/EACEQAAICAQQCAwAAAAAAAAAAAAECAAMEBQYRIQcTMTJR/8QAFAEBAAAAAAAAAAAAAAAAAAAAA//EABcRAAMBAAAAAAAAAAAAAAAAAAABESH/2gAMAwEAAhEDEQA/AGvMIQGH1mte7U78drCWViPWF6A/eYnYNSXZLi1QwC8jmGegIh8valSUU1cfUgEdwGnkEU2nLbeDYe5TN41JjbizKqFCVq3Sj4EogZ//2Q==","dimensions":{"_type":"sanity.imageDimensions","width":1280,"aspectRatio":1.7777777777777777,"height":720}},"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/a1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg","path":"images/0vv8moc6/ajmc/a1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720.jpg","_id":"image-a1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720-jpg","_updatedAt":"2021-04-12T16:20:30Z","originalFilename":"SilverbergTN3.jpg","mimeType":"image/jpeg","assetId":"a1f3330fe4848b899f70486f31b7c8a73df8f3f8","_createdAt":"2021-04-12T16:20:30Z","uploadId":"pi4klBXVUcOOajcQ8iZFR4mmkZazvwgC","_rev":"60y3Ekykf8LsCTufw6itAp","_type":"sanity.imageAsset","sha1hash":"a1f3330fe4848b899f70486f31b7c8a73df8f3f8","size":80909}},"_id":"703577bd-f690-4699-8fb9-756523837a56","body":[{"_type":"video","videoID":"6344221039112","disableAutoPlayVideo":false,"source":"brightcove","_key":"70b22f84049c","videoObject":{"_type":"videoDetails","videoTitle":"Dr Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors","thumbnail":{"asset":{"_ref":"image-a1f3330fe4848b899f70486f31b7c8a73df8f3f8-1280x720-jpg","_type":"reference"},"_type":"image"},"videoDuration":"PT2M18S","videoDescription":"atopic dermatitis treatment, JAK inhibitors, dr jonathan silverberg"}},{"style":"normal","_key":"6124d6850608","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Jonathan Silverberg, MD, PhD, MPH, discusses how Janus kinase (JAK) inhibitors are used to treat patients with atopic dermatitis (AD) and which patients could benefit from them most. Silverberg is a professor of dermatology and director of clinical research and patch testing at the George Washington University School of Medicine and Health Sciences.","_key":"c5e636def63e"}],"_type":"block"},{"_type":"block","style":"normal","_key":"67554111e0ee","markDefs":[],"children":[{"text":"","_key":"e0ebbc8f0105","_type":"span","marks":[]}]},{"children":[{"_type":"span","marks":["strong","underline"],"text":"Transcript","_key":"7130e98ccd2a"}],"_type":"block","style":"normal","_key":"7a82f1bdf665","markDefs":[]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"1e119162a8e1"}],"_type":"block","style":"normal","_key":"79ba6eb175d0"},{"_key":"e223ed749a34","markDefs":[],"children":[{"_type":"span","marks":["strong"],"text":"How have JAK inhibitors changed the AD landscape since their FDA approval? What are patient perspectives on the safety and accessibility of JAK inhibitors?","_key":"28dcbb0b478f"}],"_type":"block","style":"normal"},{"children":[{"_type":"span","marks":[],"text":"","_key":"c69d14ed96fa"}],"_type":"block","style":"normal","_key":"980a6a9d6541","markDefs":[]},{"style":"normal","_key":"586370d83891","markDefs":[],"children":[{"_type":"span","marks":[],"text":"A lot is happening now in the JAK inhibitor space. We are seeing a tremendous amount of additional data coming out in terms of post hoc analysis from the trials, and real world studies now, and exploration of new indications beyond atopic dermatitis or new subsets of the patients within atopic dermatitis; it's definitely a lot happening. ","_key":"c90651b0a0440"}],"_type":"block"},{"markDefs":[],"children":[{"text":"","_key":"e11ebc96eea6","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"5ba10d6c3e64"},{"_type":"block","style":"normal","_key":"d65489e5b331","markDefs":[],"children":[{"_type":"span","marks":[],"text":"I think, first and foremost, JAK inhibitors offer us a new treatment option to reach those who've already had an inadequate response or adverse events to a prior systemic therapy; in the United States, that would be the on-label use. For some patients, they [JAK inhibitors] are the appropriate first-line systemic therapy to be considering in different clinical scenarios. For many patients where injections are just not preferred or ideal, having an oral option that's highly effective is truly welcome. ","_key":"e4ed90986b28"}]},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"984e4b1f2c71"}],"_type":"block","style":"normal","_key":"dd37f6655062"},{"style":"normal","_key":"1f0b3cfe3937","markDefs":[],"children":[{"_type":"span","marks":[],"text":"We have certainly seen an expansion of our toolbox for managing patients with atopic dermatitis, but we're starting now to understand additional subsets of patients that may benefit from JAK inhibitors, in particular that may not even be so appropriate for biologics. Perhaps patients with more seasonal, or intermittently severe, disease where use of a biologic doesn't really make so much sense in those patients with less chronic disease. Potentially, for patients who have much more fluctuating disease where sometimes they need a little more medicine to get them through a tough flare, a little less for flare prevention, we're seeing opportunities for dose flexibility. ","_key":"03e38ff9e52f"}],"_type":"block"},{"markDefs":[],"children":[{"marks":[],"text":"","_key":"a42ad4e66a39","_type":"span"}],"_type":"block","style":"normal","_key":"bc9ef0c29a58"},{"_key":"636ec4b95a07","markDefs":[],"children":[{"marks":[],"text":"Our whole paradigm is really starting to shift now with JAK inhibitors, and I think we have to figure out how we can best incorporate them into the overall approach of trying to achieve long-term control in the disease, but they're really giving us a whole new approach for how to do that.","_key":"bf7aa5c7fb91","_type":"span"}],"_type":"block","style":"normal"}],"url":{"current":"dr-jonathan-silverberg-lists-which-patients-with-ad-benefit-most-from-jak-inhibitors","_type":"slug"}}],"topArticlesData":[{"_id":"f13e1ed9-5a17-4b9c-97fc-fe9291489ad1","title":"Study Finds Increased Impaired Mobility by Sex, Age in Atopic Dermatitis","thumbnail":{"_type":"mainImage","alt":"man resting hands on top of walking cane | Image Credit: sergign - stock.adobe.com","asset":{"_ref":"image-e6b3b6b3d78e9239230f37b63841610cbf291d32-3794x2515-jpg","_type":"reference"}},"source":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"url":"study-finds-increased-impaired-mobility-by-sex-age-in-atopic-dermatitis","summary":"Patients with atopic dermatitis, particularly males and those aged 40 to 59 years, have significantly higher rates of impaired mobility.","published":"2024-06-30T13:00:00.000Z","updatedOn":null,"factCheckAuthors":null},{"_id":"14eb8e4b-07ea-4fc8-861b-d0383b13d56e","source":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"title":"Parental e-Cigarette Use May Increase Pediatric AD Risk","url":"parental-e-cigarette-use-may-increase-pediatric-ad-risk","thumbnail":{"_type":"mainImage","alt":"E-cigarettes | Image Credit: lezinav - stock.adobe.com","asset":{"_ref":"image-f6215ae71443cb99064e408b0bbdecb1537b5add-5472x3648-jpg","_type":"reference"}},"summary":"Parental e-cigarette use was associated with an increased risk of pediatric atopic dermatitis (AD) in a new study.","published":"2024-05-22T15:05:00.000Z","updatedOn":null,"factCheckAuthors":null},{"title":"Study: Visible AD Impacts Romantic Relationships, Occupation, Sexual Health of French Female Patients ","url":"study-visible-ad-impacts-romantic-relationships-occupation-sexual-health-of-french-female-patients","thumbnail":{"_type":"mainImage","alt":"Female patient with AD | Image Credit: Prostock-studio - stock.adobe.com","asset":{"_ref":"image-bb58cbab9510b81e2030e6fd7b01c1172a3e319e-6720x4480-jpg","_type":"reference"}},"published":"2024-05-19T16:00:00.000Z","source":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"_id":"6b69d752-d56a-4b77-a9f0-6c82fe816d62","summary":"Atopic dermatitis (AD) in visible areas significantly impacts the romantic relationships, occupations, and sexual health of French female adult patients, according to a new study. ","updatedOn":null,"factCheckAuthors":null},{"url":"patients-with-ad-prioritize-itch-control-in-treatment-preferences","thumbnail":{"_type":"mainImage","alt":"Patient scratching atopic dermatitis (AD) on hand | Image Credit: Ольга Тернавская - stock.adobe.com","asset":{"_type":"reference","_ref":"image-a5584ad0be33e4c3620bef9c95fbf17faa44d9df-5472x3648-jpg"}},"factCheckAuthors":null,"_id":"f4cdef23-e4c4-46bb-9ae1-7f2a07106081","title":"Patients With AD Prioritize Itch Control in Treatment Preferences","summary":"A US-based discrete choice experiment survey found that patients with atopic dermatitis (AD) prioritize treatments that effectively control itching.","published":"2024-05-14T21:00:40.594Z","updatedOn":null,"source":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}]},{"published":"2024-05-10T19:00:00.000Z","updatedOn":null,"source":null,"authors":[{"displayName":"Brooke McCormick","url":"brooke-mccormick"}],"title":"Study: Educational Interventions Substantially Reduce AD Severity","url":"study-educational-interventions-substantially-reduce-ad-severity","thumbnail":{"_type":"mainImage","alt":"Patient scratching AD on arm | Image Credit: lial88 - stock.adobe.com","asset":{"_type":"reference","_ref":"image-1c55d84e2c4048da3c25f2cc3ed1e24e1c5c8ac7-4256x2832-jpg"}},"summary":"Educational interventions for patients, including both in-person and online methods, significantly reduced atopic dermatitis (AD) severity.","factCheckAuthors":null,"_id":"534601f0-8f9e-448a-81c2-139177778aed"}],"features":[{"sortOrder":1,"is_active":true,"_rev":"voFIS1WzAH5xQtfqgzdXHa","hide_title_body":false,"feature_img":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/3752f89404f2f63f6cf870dedac919c4371f881f-492x300.png"}},"_id":"82104318-40b6-4514-ba47-927d91e89822","_type":"feature","feature_url":"/compendium/atopic-dermatitis","feature_title":"Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access","_createdAt":"2024-08-01T20:23:51Z","_updatedAt":"2024-08-01T20:24:22Z","feature_body":"Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies. ","feature_link":"https://www.ajmc.com/payer-perspectives/topical-therapies-for-the-treatment-of-atopic-dermatitis-balancing-safety-efficacy-and-access","feature_alt":"Atopic Dermatitis Payer Perspectives"}],"cmeData":{"msg":"Missing Keywords","fail":true},"videoData":{}},"queryString":{"slug":["compendium","atopic-dermatitis"]}},"host":"www.ajmc.com"},"__N_SSP":true},"page":"/[...slug]","query":{"slug":["compendium","atopic-dermatitis"]},"buildId":"jIKMoC-9mMyLq4v4Ma7Tv","isFallback":false,"gssp":true,"appGip":true,"scriptLoader":[]}</script></body></html>

Pages: 1 2 3 4 5 6 7 8 9 10